PANCREATIC BETA CELLS (MEDICINAL PLANT REGENERATION)

/ SCIENCE, SOLUTIONS / By
  1. Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic β-cells against oxidative stress
  2. Dihydroavenanthramide D protects pancreatic β-cells from cytokine and streptozotocin toxicity
  3. … expression and nuclear factor-κB-dependent apoptosis in pancreatic β-cells: potential mechanisms for viral-induced insulitis and β-cell death in type 1 diabetes …
  4. Autoimmune destruction of pancreatic β cells
  5. Suppressor of cytokine signaling-1 overexpression protects pancreatic β cells from CD8+ T cell-mediated autoimmune destruction
  6. Suppression of SOCS3 expression in the pancreatic β-cell leads to resistance to type 1 diabetes
  7. Silymarin Protects pancreatic β-cells against Cytokine-Mediated Toxicity: Implication of c-Jun NH2-Terminal Kinase and Janus Kinase/Signal Transducer and …
  8. Pronounced cytosolic aggregation of cellular prion protein in pancreatic β-cells in response to hyperglycemia
  9. Cytokine-induced inhibition of insulin release from mouse pancreatic β-cells deficient in inducible nitric oxide synthase
  10. Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferon-γ-induced apoptosis in primary pancreatic β-cells
  11. Tissue inhibitor of metalloproteinase-2 inhibits T-cell infiltration and preserves pancreatic β-cell function in an in vitro type 1 diabetes mellitus model
  12. Urocortin III is expressed in pancreatic β-cells and stimulates insulin and glucagon secretion
  13. Specific expression of Bax-ω in pancreatic β-cells is down-regulated by cytokines before the onset of apoptosis
  14. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners
  15. Potential role of NO in modulation of COX-2 expression and PGE2 production in pancreatic β-cells
  16. Spontaneous regeneration of pancreatic β-cells in EMC-D virus-induced diabetic mice and reversion from diabetic to normal state
  17. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic β cells develop insulin-dependent diabetes without insulitis
  18. The a3 isoform of V-ATPase regulates insulin secretion from pancreatic β-cells
  19. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library
  20. T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins
  21. Melatonin protects against streptozotocin, but not interleukin‐1β‐induced damage of rodent pancreatic β‐cells
  22. Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic β cells
  23. Mouse models for type 1 diabetes
  24. Partial preservation of pancreatic β-cells by vanadian: Evidence for long-term amelioration of diabetes
  25. Fulminant type 1 diabetes in Caucasians: a report of three cases
  26. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic β cells
  27. β-cell proliferation is the major source of new pancreatic β cells
  28. Leaking gut in type 1 diabetes
  29. IFNβ accelerates autoimmune type 1 diabetes in nonobese diabetic mice and breaks the tolerance to β cells in nondiabetes-prone mice
  30. Direct effects of cyclosporin A on human pancreatic β-cells
  31. Beneficial effect of Flos magnoliae extract on multiple low dose streptozotocin-induced type 1 diabetes development and cytokine-induced β-cell damage
  32. Expression of neurexin, neuroligin, and their cytoplasmic binding partners in the pancreatic β-cells and the involvement of neuroligin in insulin secretion
  33. Protective effect of retinoic acid on interleukin-1β-induced cytotoxicity of pancreatic β-cells
  34. Significance of serum CXCL10/IP-10 level in type 1 diabetes
  35. Interferon-α and interferon-γ differentially affect pancreatic β-cell phenotype and function
  36. Increased expression of GAD65 and GABA in pancreatic β-cells impairs first-phase insulin secretion
  37. Notch signaling: a mediator of β-cell de-differentiation in diabetes?
  38. Tumor necrosis factor-related apoptosis-inducing ligand and CD56 expression in patients with type 1 diabetes mellitus
  39. Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic β cells by Bcl-2 and X-linked inhibitor of …
  40. Bacteria of food and human intestine are the most possible sources of the gad-trigger of type 1 diabetes
  41. Production and Characterization of Reg Knockout Mice: Reduced Proliferation of pancreatic β-cells in Reg Knockout Mice
  42. Nitric oxide stimulates insulin gene transcription in pancreatic β-cells
  43. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic β-cells in vitro: implication of the α/β T-cell receptor and of major histocompatibility …
  44. Calmodulin overexpression causes Ca2+-dependent apoptosis of pancreatic β cells, which can be prevented by inhibition of nitric oxide synthase
  45. Glycosyltransferase B4GALNT1 and type 1 diabetes in Croatian population: clinical investigation
  46. Toll-like Receptor 2 and Type 1 diabetes
  47. Peptide-specific cytotoxicity of T lymphocytes against glutamic acid decarboxylase and insulin in type 1 diabetes mellitus
  48. A common stromal cell–derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes
  49. Viral trigger for diabetes?
  50. Dissociation between Fas expression and induction of apoptosis in human islets of Langerhans
  51. Repression of GAD autoantigen expression in pancreas β-cells by delivery of antisense plasmid/PEG-g-PLL complex
  52. Beneficial effect of supplementation with copper sulfate on STZ-diabetic mice (IDDM)
  53. Prostaglandins inhibit pancreatic β-cell replication and long-term insulin secretion by pertussis toxin-insensitive mechanisms but do not mediate the actions of …
  54. Modelling the onset of Type 1 diabetes: can impaired macrophage phagocytosis make the difference between health and disease?
  55. Physiological β cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model
  56. SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes
  57. Oxidative stress in type 1 diabetes
  58. HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example
  59. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-β–TGF-β receptor interactions in type 1 diabetes
  60. Target cell defense prevents the development of diabetes after viral infection
  61. Methylmercury induces pancreatic β-cell apoptosis and dysfunction
  62. CD8+ T-cells and their interaction with other cells in damage to islet β-cells
  63. Guggulsterone, a plant sterol, inhibits NF-κB activation and protects pancreatic β cells from cytokine toxicity
  64. Natural killer cells are required for accelerated type 1 diabetes driven by interferon-β
  65. Among CXCR3 chemokines, IFN-γ-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-γ (CXCL9) imprints a pattern for …
  66. Down regulation of NF-kappa B as a therapeutic strategy for type 1 diabetes: effect of flavonoids
  67. pancreatic Β-cell protective effect of rutin and apigenin isolated from Teucrium polium
  68. A virus–gene collaboration
  69. Inhibitory effects of epicatechin on interleukin-1β-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of …
  70. Enteroviral capsid protein detected in pancreatic islets
  71. Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells
  72. Hypoglycemic effect of Egyptian Morus alba root bark extract: effect on diabetes and lipid peroxidation of streptozotocin-induced diabetic rats
  73. NIT-1, a pancreatic β-cell line established from a transgenic NOD/Lt mouse
  74. Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes
  75. Anti-diabetic activity of fruits of Terminalia chebula on streptozotocin induced diabetic rats
  76. Cytokine profile in children during the first 3 months after the diagnosis of type 1 diabetes
  77. Biochemical and molecular actions of interleukin-1 on pancreatic β-cells
  78. Facilitative glucose transporter 9 expression affects glucose sensing in pancreatic β-cells
  79. Islet proteins implicated in pathogenesis of type 1 diabetes mellitus
  80. Immunological aspects of ‘fulminant type 1 diabetes‘
  81. Constitutive expression of placental lactogen in pancreatic β cells: effects on cell morphology, growth, and gene expression
  82. Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients
  83. Putative environmental factors in type 1 diabetes
  84. Association between type 1 diabetes age-at-onset and intercellular adhesion molecule-1 (ICAM-1) gene polymorphism
  85. Increased Susceptibility to Streptozotocin-Induced β-Cell Apoptosis and Delayed Autoimmune diabetes in Alkylpurine- DNA-N-Glycosylase-Deficient Mice
  86. Type 1 diabetes mellitus associated with clinical acute pancreatitis in an adult
  87. How viral infections affect the autoimmune process leading to type 1 diabetes
  88. Molecular target structures in alloxan-induced diabetes in mice
  89. Neuronal elements in the pathogenesis of type 1 diabetes
  90. A Low Voltage-Activated Ca2+ Current Mediates Cytokine-Induced pancreatic β-Cell Death
  91. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice
  92. Evidence from transgenic mice that interferon-β may be involved in the onset of diabetes mellitus
  93. Insulin in oral immune “tolerance”: a one-amino acid change in the B chain makes the difference
  94. IL-2 and its high-affinity receptor: genetic control of immunoregulation and autoimmunity
  95. The metabolic basis of insulin secretion
  96. Autoimmune diabetes in HLA‐DR3/DQ8 transgenic mice expressing the co‐stimulatory molecule B7‐1 in the β cells of islets of Langerhans
  97. Vitamin D target proteins: function and regulation
  98. A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody
  99. Double-stranded ribonucleic acid (RNA) induces β-cell Fas messenger RNA expression and increases cytokine-induced β-cell apoptosis
  100. Autoimmune islet destruction in spontaneous type 1 diabetes is not β-cell exclusive
  101. Understanding autoimmune diabetes: insights from mouse models
  102. STAT4: a risk factor for type 1 diabetes?
  103. DESIGN AND SYNTHESIS OF DNA MINOR GROOVE METHYLATING COMPOUNDS THAT TARGET pancreatic β-cells
  104. Enteroviruses: new findings on the role of enteroviruses in type 1 diabetes
  105. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event
  106. Pregnancy-induced rise in serum C-peptide concentrations in women with type 1 diabetes
  107. Innate immunity and intestinal microbiota in the development of Type 1 diabetes
  108. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis
  109. TGFβ plasmid construction and delivery for the prevention of type 1 diabetes
  110. The protective effect of Amomum xanthoides extract against alloxan-induced diabetes through the suppression of NFκB activation
  111. Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus
  112. In situ characterization of dendritic cells occurring in the islets of nonobese diabetic mice during the development of insulitis
  113. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection
  114. Dietary microbial toxins and type 1 diabetes
  115. Islet regeneration needed for overcoming autoimmune destruction–considerations on the pathogenesis of type 1 diabetes
  116. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in β cells
  117. Sulforaphane protects against cytokine-and streptozotocin-induced β-cell damage by suppressing the NF-κB pathway
  118. Evidence for a locus (IDDM16) in the immunoglobulin heavy chain region on chromosome 14q32. 3 producing susceptibility to type 1 diabetes
  119. The ABBOS-peptide from bovine serum albumin causes an IFN-γ and IL-4 mRNA response in lymphocytes from children with recent onset of type 1 diabetes
  120. Is innervation an early target in autoimmune diabetes?
  121. Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL
  122. Remission of the newly diagnosed type 1 diabetes by radiation of the pancreas
  123. Vesicular autoantigens of type 1 diabetes
  124. Aire Deficiency Causes Increased Susceptibility to Streptozotocin‐induced Murine Type 1 diabetes
  125. Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes?
  126. Murder mysteries in type 1 diabetes
  127. Supplementation of N‐acetylcysteine inhibits NFκB activation and protects against alloxan‐induced diabetes in CD‐1 mice
  128. Making insulin-deficient type 1 diabetic rodents thrive without insulin
  129. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus
  130. In situ β cell death promotes priming of diabetogenic CD8 T lymphocytes
  131. Novel epitope begets a novel pathway in type 1 diabetes progression
  132. A dual role for TNF-α in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis
  133. Pituitary adenylate cyclase-activating polypeptide prevents cytokine-induced cytotoxicity via inhibition of inducible nitric oxide synthase expression in βTC cells
  134. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self‐antigen‐specific immunoglobulin receptors
  135. Thymic expression of insulin‐related genes in an animal model of autoimmune type 1 diabetes
  136. Expression of Calbindin-D28k in a pancreatic Isletβ -Cell Line Protects against Cytokine-Induced Apoptosis and Necrosis
  137. Intracellular Ca2+ Modulation of ATP-Sensitive K+ Channel Activity in Acetylcholine-Induced Activation of Rat pancreatic β-cells
  138. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes
  139. GABA in the endocrine pancreas: its putative role as an islet cell paracrine-signalling molecule
  140. Ontogeny of regeneration of β-cells in the neonatal rat after treatment with streptozotocin
  141. Stimulation of insulin release by glucose is associated with an increase in the number of docked granules in the β-cells of rat pancreatic islets
  142. Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer
  143. Expression of cholera toxin B–proinsulin fusion protein in lettuce and tobacco chloroplasts–oral administration protects against development of insulitis in non‐obese …
  144. Role of gelatinase B in diabetes and long-term complications of hyperglycaemia
  145. Come and get me!
  146. Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: evidence for involvement of CCR8 and CCL1
  147. The molecular genetics of type 1 diabetes: new genes and emerging mechanisms
  148. Tomographic molecular imaging and 3D quantification within adult mouse organs
  149. Effect of Eugenia jambolana seed kernel on antioxidant defense system in streptozotocin-induced diabetes in rats
  150. CBLB variants in type 1 diabetes and their genetic interaction with CTLA4
  151. Transgenic animal models for type 1 diabetes: linking a tetracycline-inducible promoter with a virus-inducible mouse model
  152. Polymorphisms of CXCR3-binding chemokines in type 1 diabetes
  153. Endothelin inhibition delays onset of hyperglycemia and associated vascular injury in type I diabetes: Evidence for endothelin release by pancreatic islet β-cells
  154. Analysis of eluted peptides from type 1 diabetes-susceptible HLA class II molecules identified novel islet protein, heparin/heparan sulfate-interacting protein
  155. Severe hyperglycaemia caused by autoimmunization to β cells in rats
  156. Antioxidant and protective effects of major flavonoids from Teucrium polium on β-cell destruction in a model of streptozotocin-induced diabetes
  157. Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin‐induced diabetic rats fed with Momordica charantia fruit extract
  158. Transient but not permanent neonatal diabetes mellitus is associated with paternal uniparental isodisomy of chromosome 6
  159. Recent advances in the immunogenetics of human type 1 diabetes
  160. Effect of selenium on pancreatic proinflammatory cytokines in streptozotocin-induced diabetic mice
  161. High-level expression of interleukin-4 following electroporation-mediated gene transfer accelerates type 1 diabetes in NOD mice
  162. Autoantibodies in recent onset type-1 diabetic patients to a Mr 60K microsomal hepatic protein: new evidence for autoantibodies to the type-2 glucose transporter
  163. INTERLEUKIN 1βINCREASES ARGININE ACCUMULATION AND ACTIVATES THE CITRULLINE–NO CYCLE IN RAT pancreaticβCELLS
  164. Enteropathy precedes type 1 diabetes in the BB rat
  165. Interferon-γ independently activates the MHC class I antigen processing pathway and diminishes glucose responsiveness in pancreatic β-cell lines
  166. Normal T cell development in the absence of thymic insulin expression
  167. The perks of balancing glucose
  168. Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes
  169. Identification of a novel type 1 diabetes susceptibility gene, T-bet
  170. Diacerhein downregulate proinflammatory cytokines expression and decrease the autoimmune diabetes frequency in nonobese diabetic (NOD) mice
  171. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats
  172. Antidiabetic and ameliorative potential of Ficus bengalensis bark extract in streptozotocin induced diabetic rats
  173. CD11a expression and soluble ICAM-1 levels in peripheral blood in high-risk and overt type 1 diabetes subjects
  174. Autoantibodies and CD4 T cells target a β cell retroviral envelope protein in non‐obese diabetic mice
  175. Retinoic acid promotes the generation of pancreatic endocrine progenitor cells and their further differentiation into β-cells
  176. Evidence for recognition of novel islet T cell antigens by granule-specific T cell lines from new onset type 1 diabetic patients
  177. Modeling the onset of type 1 diabetes
  178. Infection and autoimmunity: are we winning the war, only to lose the peace?
  179. Effect of Intraperitoneal Needling on pancreatic β-Cell Cytotoxicity Mediated via Alloxan in Mice with an FVB/N Genetic Background
  180. Metabolism genes are among the differentially expressed ones observed in lymphomononuclear cells of recently diagnosed type 1 diabetes mellitus patients
  181. In vivo reprogramming of adult pancreatic exocrine cells to β-cells
  182. The genetics of canine diabetes: a candidate gene study
  183. Increased islet antigen presentation leads to type‐1 diabetes in mice with autoimmune susceptibility
  184. Interleukin-1β activates a short STAT-3 isoform in clonal insulin-secreting cells
  185. Helminth infection can reduce insulitis and type 1 diabetes through CD25-and IL-10-independent mechanisms
  186. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel β cell autoantigen in type 1 diabetes
  187. Vitamin D in type 1 diabetes prevention
  188. Downregulation of apoptosis in the target tissue prevents low-dose streptozotocin-induced autoimmune diabetes
  189. Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes
  190. A key role for ICAM-1 in generating effector cells mediating inflammatory responses
  191. Cellular distribution and contribution of cyclooxygenase (COX)-2 to diabetogenesis in NOD mouse
  192. Increased cytokine-induced cytotoxicity of pancreatic islet cells from transgenic mice expressing the Src-like tyrosine kinase GTK
  193. Effects of tyrosine kinase inhibitors on cell death induced by sodium fluoride and pertussis toxin in the pancreatic β‐cell line, RINm5F
  194. Effect of Undaria pinnatifida Extract on Insulin Secretion from the Pancreas of Diabetic Rats
  195. Insulitis in type 1 diabetes: a sticky problem
  196. Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes
  197. Transplacental exposure to bafilomycin disrupts pancreatic islet organogenesis and accelerates diabetes onset in NOD mice
  198. β cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice
  199. MafA differentiates rat intestinal cells into insulin-producing cells
  200. Selective autoantibody production against CCL3 is associated with human type 1 diabetes mellitus and serves as a novel biomarker for its diagnosis
  201. Glucose regulated protein synthesis in pancreatic β-cells
  202. The Effect of Parental Imprinting on the INS-IGF2 Locus of Korean Type I Diabetic Patients
  203. Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus
  204. Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells
  205. Engineering and expression of the intracellular domain of insulinoma-associated tyrosine phosphatase (IA-2ic), a type 1 diabetes autoantigen, in plants
  206. Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice
  207. The possible role of autoimmunity in the pathogenesis of diabetes in beta-thalassemia major
  208. MIN6 β-cell–β-cell interactions influence insulin secretory responses to nutrients and non-nutrients
  209. NKT cells and IFN-γ establish the regulatory environment for the control of diabetogenic T cells in the nonobese diabetic mouse
  210. Trace element changes in the pancreas during viral infection in mice
  211. The specific p38 mitogen-activated protein kinase pathway inhibitor FR167653 keeps insulitis benign in nonobese diabetic mice
  212. Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro
  213. A new look at viruses in type 1 diabetes
  214. Cryptic infection and autoimmunity
  215. Acute activation of acid ceramidase affects cytokine-induced cytotoxicity in rat islet β-cells
  216. Biophysical evidence that connexin-36 forms functional gap junction channels between pancreatic mouse β-cells
  217. Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset
  218. pancreatic lymph node-derived CD4+ CD25+ Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals
  219. Fas/Fas ligand interactions play an essential role in the initiation of murine autoimmune diabetes
  220. Regulation of insulin secretion and GLUT4 trafficking by the calcium sensor synaptotagmin VII
  221. Clearance of apoptotic β-cells is reduced in neonatal autoimmune diabetes-prone rats
  222. Zurina Hassan*, Mariam Ahmad A. Pauzi M. Yusof, S. Raghava Naidu1
  223. An early but intense cytokine production within the islets may be predictive for type 1 diabetes occurrence in the Bio Breeding (BB) rat
  224. A biphasic role of nuclear transcription factor (NF)‐κB in the islet β‐cell apoptosis induced by interleukin (IL)‐1β
  225. Administration of NF‐κB decoy inhibits pancreatic activation of NF‐κB and prevents diabetogenesis by alloxan in mice
  226. Peroxynitrite is a mediator of cytokine-induced destruction of human pancreatic islet β cells
  227. SUMO wrestling with type 1 diabetes
  228. Mechanism of exocrine pancreatic insufficiency in streptozotocin‐induced type 1 diabetes mellitus
  229. Postprandial hyperinsulinaemic hypoglycaemia and type 1 diabetes mellitus
  230. Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes
  231. Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes
  232. Genetics and molecular biology: HDLs and their multiple ways to protect cells
  233. Intron polymorphism in the KIAA0350 gene is reproducibly associated with susceptibility to type 1 diabetes (T1D) in the Han Chinese population
  234. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families
  235. Gene gun-mediated DNA vaccination enhances antigen-specific immunotherapy at a late preclinical stage of type 1 diabetes in nonobese diabetic mice
  236. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response
  237. Genetic and phenotypic diversity of echovirus 30 strains and pathogenesis of type 1 diabetes
  238. Peripherin is a relevant neuroendocrine autoantigen recognized by islet-infiltrating B lymphocytes
  239. Fas ligand down-regulates cytokine-induced Fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice
  240. Effect of fusidic acid on interleukin-1 (IL-1)-and IL-6-induced pancreatic β-cell functions in rats
  241. Localized gene expression following administration of adeno-associated viral vectors via pancreatic ducts
  242. Altered phenotype and function of dendritic cells in children with type 1 diabetes
  243. Mucosal exposure to antigen: cause or cure of type 1 diabetes?
  244. Congenic mapping of type 1 diabetes—protective gene (s) in an interval of 4 Mb on rat chromosome 6q32
  245. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models
  246. Putting the pieces of the puzzle together–a series of hypotheses on the etiology and pathogenesis of type 1 diabetes
  247. Intestinal microbiota gives a nod to the hygiene hypothesis in type 1 diabetes
  248. Development of autoreactive diabetogenic T cells in the thymus of NOD mice
  249. Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes
  250. No Evidence for Linkage in Swedish Multiplex T1DM Families to IL12B on Chromosome 5q33‐34
  251. A novel mutation of WFS1 gene in a Japanese man of Wolfram syndrome with positive diabetes-related antibodies
  252. An altered self-peptide with superagonist activity blocks a CD8-mediated mouse model of type 1 diabetes
  253. Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM)
  254. Type 1 diabetes in the BB rat: a polygenic disease
  255. A critical role of STAT1 in streptozotocin-induced diabetic liver injury in mice: controlled by ATF3
  256. A review of the use of Streptozotocin (STZ) in the induction of diabetes in rats and subsequent ocular tissue changes
  257. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes
  258. Requirement for both H-2Db and H-2Kd for the induction of diabetes by the promiscuous CD8+ T cell clonotype AI4
  259. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset
  260. High-resolution three-dimensional imaging of islet-infiltrate interactions based on optical projection tomography assessments of the intact adult mouse pancreas
  261. Environmental risk factors for type 1 diabetes in Rome and province
  262. Protective effects of combined micronutrients on islet β-cells of streptozotocin-induced diabetic mice
  263. Characterization of two porcine proinsulin reactive monoclonal antibodies by immunostaining of β-cells in pancreatic sections of different species
  264. Type 1 diabetes mellitus and multiple sclerosis: common etiological features
  265. Simultaneous type 1 diabetes onset in mother and son coincident with an enteroviral infection
  266. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus
  267. Coxsackie virus B antibodies are increased in HLA DR3-MICA5. 1 positive type 1 diabetes patients in the Linköping region of Sweden
  268. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study
  269. Immunology in diabetes: an update
  270. Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFκB activation offering protection against chemically induced diabetes
  271. A type 1 diabetes-related protein from wheat (Triticum aestivum): cDNA clone of a wheat storage globulin, Glb1, linked to islet damage
  272. CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes
  273. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide
  274. Possible role of gangliosides in salivary gland complications of diabetes
  275. Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo
  276. Reovirus delays diabetes onset but does not prevent insulitis in nonobese diabetic mice
  277. Atrial natriuretic peptide promotes pancreatic islet β-cell growth and Akt/Foxo1a/cyclin D2 signaling
  278. Association of IL‐18 promoter polymorphisms with predisposition to Type 1 diabetes
  279. Divergence between Genetic Determinants of IGF2 Transcription Levels in Leukocytes and of IDDM2-Encoded Susceptibility to Type 1 diabetes
  280. Pathogenesis of insulin-dependent diabetes mellitus
  281. PDX-1 mediates glucose responsiveness of GAD67, but not GAD65, gene transcription in islets of Langerhans
  282. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats
  283. Improved β-Cell Survival and Reduced Insulitis in a Type 1 Diabetic Rat Model After Treatment With a β-Cell–Selective KATP Channel Opener
  284. Correlation between residual β-cell function and age at onset of spontaneous diabetes in Long Evans Tokushima Lean rats
  285. Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway
  286. Rotavirus infection of infant and young adult nonobese diabetic mice involves extraintestinal spread and delays diabetes onset
  287. Enhanced alloxan-induced β-cell damage and delayed recovery from hyperglycemia in mice lacking extracellular-superoxide dismutase
  288. Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes
  289. Drug insight: New immunomodulatory therapies in type 1 diabetes
  290. Study of interleukin-10 promoter region polymorphisms (− 1082A/G,− 819T/C and− 592A/C) in type 1 diabetes mellitus in Turkish population
  291. Role of innate immunity in triggering and tuning of autoimmune diabetes
  292. The GM2-1 Ganglioside Islet Autoantigen in Insulin-Dependent diabetes Mellitus Is Expressed in Secretory Granules and Is Notβ-Cell Specific
  293. Cutting edge: B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice
  294. Cellular and molecular roles of β cell autoantigens, macrophages and T cells in the pathogenesis of autoimmune diabetes
  295. Coxsackievirus B3 infection affects metal-binding/transporting proteins and trace elements in the pancreas in mice
  296. Immunokinetics of autoreactive CD4 T cells in blood: a reporter for the “hit-and-run” autoimmune attack on pancreas and diabetes progression
  297. Processing in the endoplasmic reticulum generates an epitope on the insulin A chain that stimulates diabetogenic CD8 T cell responses
  298. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes
  299. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-γ-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine …
  300. Follow-up of exocrine pancreatic function in type-1 diabetes mellitus
  301. ATP-sensitive K+ channel openers: old drugs with new clinical benefits for the heart
  302. Arginase expression and modulation of IL-1β-induced nitric oxide generation in rat and human islets of Langerhans
  303. Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells
  304. Acute onset of type 1 diabetes accompanied by acute hepatitis C: the potential role of proinflammatory cytokine in the pathogenesis of autoimmune diabetes
  305. Regeneration of pancreatic endocrine cells in interferon-gamma transgenic mice
  306. Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells
  307. Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse
  308. Differential immune response to B: 9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes
  309. Activated T lymphocytes from patients with high risk of type I diabetes mellitus have different ability to produce interferon-γ, interleukin-6 and interleukin-10 and …
  310. Remission of diabetes mellitus in cats with diabetic ketoacidosis
  311. VIP and tolerance induction in autoimmunity
  312. Virus-induced diabetes in a transgenic model: role of cross-reacting viruses and quantitation of effector T cells needed to cause disease
  313. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non–class II gene
  314. Biochemical Characteristics of the γ-Aminobutyric Acid System in the Insulinoma Cell Lines HIT-T15, RIN-m5F, βTC3, and Comparison with Rat Brain
  315. An Imidazoline Compound Completely Counteracts Interleukin-1β toxic Effects to Rat pancreatic Islet β cells
  316. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms
  317. Streptozotocin-induced type 1 diabetes mellitus alters the morphology, secretory function and acyl lipid contents in the isolated rat parotid salivary gland
  318. Novel effectors of directed and Ngn3-mediated differentiation of mouse embryonic stem cells into endocrine pancreas progenitors
  319. First signature of islet β-cell-derived naturally processed peptides selected by diabetogenic class II MHC molecules
  320. Polymorphism of bovine beta-casein and its potential effect on human health
  321. Paraneoplastic encephalomyelitis associated with pancreatic tumor and anti-GAD antibodies
  322. Effect of proinflammatory cytokines on gene expression of the diabetes-associated autoantigen IA-2 in INS-1 cells
  323. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells
  324. Bovine serum albumin and insulin-dependent diabetes mellitus: is cow’s milk still a possible toxicological causative agent of diabetes?
  325. Editorial [Hot Topic: Nutritional Modulation of Autoimmune diabetes (Guest Editor: Fraser W. Scott)]
  326. Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocin-induced diabetic rats
  327. Prophylactic Oral Administration of Metabolically Active Insulin Entrapped in Isobutylcyanoacrylate Nanocapsules Reduces the Incidence of diabetes inNonobese …
  328. Induction, acceleration or prevention of autoimmunity by molecular mimicry
  329. Diet promotes β-cell loss by apoptosis in prediabetic nonobese diabetic mice
  330. Molecular and biological analysis of echovirus 9 strain isolated from a diabetic child
  331. Effects of Syzygium Cumini bark on blood glucose, plasma insulin and C-peptide in streptozotocininduced diabetic rats
  332. Genetic association of HLA DQB1 with CD4+ CD25+ high T-cell apoptosis in type 1 diabetes
  333. Expression of somatostatin receptor subtypes 1–5 in pancreatic islets of normoglycaemic and diabetic NOD mice
  334. Still Waiting Their Turn
  335. Killer cell immunoglobulin‐like receptor genotypes in Japanese patients with type 1 diabetes
  336. Distinct local immunogenic stimuli dictate differential requirements for CD4+ and CD8+ T cell subsets in the pathogenesis of spontaneous autoimmune diabetes
  337. Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus
  338. Type 1 diabetes intervention trials 2007: where are we and where are we going?
  339. Tertiary lymphoid structures in the pancreas promote selection of B lymphocytes in autoimmune diabetes
  340. Interleukin-1β swiftly down-regulates UCP-2 mRNA in β-cells by mechanisms not directly coupled to toxicity
  341. IFN-γ affects homing of diabetogenic T cells
  342. Polymorphisms of interferon-γ gene CA-Repeat and interleukin-10 promoter region (-592A/C) in Japanese type I diabetes
  343. Improved efficacy of a tolerizing DNA vaccine for reversal of hyperglycemia through enhancement of gene expression and localization to intracellular sites
  344. A review on the mechanisms involved in hyperglycemia induced by organophosphorus pesticides
  345. Direct administration of interleukin-1 and interferon-γ to rat pancreas leads to the in vivo production of nitric oxide and expression of inducible nitric oxide synthase and …
  346. Screening of diabetes, thyroid, and celiac diseases-related autoantibodies in a sample of Turkish children with type 1 diabetes and their siblings
  347. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes
  348. Influence of sex and age at onset on autoantibodies against insulin, GAD65 and IA2 in recent onset type 1 diabetic patients
  349. The effect of long-term swimming program on glycemia control in 14–19-year aged healthy girls and girls with type 1 diabetes mellitus
  350. Prostaglandin E2 mediates inhibition of insulin secretion by interleukin-1β
  351. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner
  352. IL4 and IL4R α Genes Are Not Linked or Associated with Type 1 diabetes
  353. Antidiabetic activity of angelan isolated from Angelica gigas Nakai
  354. Experimental diabetes treated with Achillea santolina: Effect on pancreatic oxidative parameters
  355. Infections and autoimmune diseases
  356. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice
  357. Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine kinase signalling pathway and subsequent suppression of nitric oxide …
  358. Homotypic cell contact enhances insulin but not glucagon secretion
  359. Sex‐specific association of the human PTPN22 1858T‐allele with type 1 diabetes
  360. Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus
  361. Adipose tissue-derived nerve growth factor and brain-derived neurotrophic factor: results from experimental stress and diabetes
  362. Maternal enterovirus infection during pregnancy as a risk factor in offspring diagnosed with type 1 diabetes between 15 and 30 years of age
  363. Microorganisms and autoimmunity: making the barren field fertile?
  364. Phenotypic and genetic changes in coxsackievirus B5 following repeated passage in mouse pancreas in vivo
  365. Cytokines: promoters and dampeners of autoimmunity
  366. Apoptotic and effector pathways in autoimmunity
  367. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase
  368. Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia …
  369. Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells
  370. Decreased prevalence of atopic diseases in children with diabetes
  371. Antioxidant enzyme activity and mRNA expression in the islets of Langerhans from the BB/S rat model of type 1 diabetes and an insulin-producing cell line
  372. Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis
  373. Bipotential mouse embryonic liver (BMEL) cells spontaneously express Pdx1 and Ngn3 but do not undergo further pancreatic differentiation upon Hes1 down …
  374. Survey of mRNAs encoding zinc transporters and other metal complexing proteins in pancreatic islets of rats from birth to adulthood: similar patterns in the Sprague …
  375. Impaired CD4+ and CD8+ T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children
  376. Autoantibodies against Aromatic l-Amino Acid Decarboxylase Identifies a Subgroup of Patients with Addison’s Disease
  377. A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse
  378. Remodeling of the innervation of pancreatic islets accompanies insulitis preceding onset of diabetes in the NOD mouse
  379. Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 diabetes Genetics Consortium
  380. Amomum xanthoides extract prevents cytokine-induced cell death of RINm5F cells through the inhibition of nitric oxide formation
  381. The possible role of enteroviruses in diabetes mellitus
  382. Pediatric Diabetic Ketoacidosis
  383. Alteration of intra-pancreatic target-organ specificity by abrogation of Aire in NOD mice
  384. Cytokines and chemokines in virus-induced autoimmunity
  385. Th1-like cytokine production profile and individual specific alterations in TCRBV-gene usage of T cells from newly diagnosed type 1 diabetes patients after stimulation …
  386. Initiation of autoimmunity
  387. The effect of local production of cytokines in the pathogenesis of insulin-dependent diabetes mellitus
  388. The autoimmune diabetes locus Idd9 regulates development of type 1 diabetes by affecting the homing of islet-specific T cells
  389. A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families
  390. Natural killer cells in human autoimmunity
  391. pancreatic lymph nodes are required for priming of β cell reactive T cells in NOD mice
  392. Developmental Biology of the β-Cell
  393. Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir
  394. Complete nucleotide sequence of a coxsackievirus B4 strain that establishes infection in ICR mice pancreas and induces glucose intolerance
  395. Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression
  396. IFIH1-GCA-KCNH7 locus: influence on multiple sclerosis risk
  397. A mathematical model for pattern of change in β-cell reserve and factors affecting residual reserve within the first 2 years of Type 1 diabetes
  398. Effect of prostaglandins against alloxan-induced diabetes mellitus
  399. Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets
  400. Human leukocyte antigen class IB and C loci contribute to Type 1 diabetes (T1D) susceptibility and age at T1D onset
  401. Transgenic expression of Hsc70 in pancreatic islets enhances autoimmune diabetes in response to β cell damage
  402. Interleukin-1 stimulates β-cell necrosis and release of the immunological adjuvant HMGB1
  403. Cell type-specific activation of metabolism reveals that β-cell secretion suppresses glucagon release from α-cells in rat pancreatic islets
  404. NK3-like NK cells are involved in protective effect of polyinosinic-polycytidylic acid on type 1 diabetes in nonobese diabetic mice
  405. Association of fulminant type 1 diabetes with pregnancy
  406. Combination therapy of Nigella sativa and human parathyroid hormone on bone mass, biomechanical behavior and structure in streptozotocin-induced diabetic rats
  407. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice
  408. Increased Transcriptional Preproinsulin II β-Cell Activity in Neonatal Nonobese Diabetic Mice: In Situ Hybridization Analysis
  409. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice
  410. diabetes produced in mice by smoked/cured mutton
  411. Effective control of blood glucose status and toxicity in streptozotocin-induced diabetic rats by orally administration of vanadate in an herbal decoction
  412. Difficulties in assessing the relationship, if any, between mumps vaccination and diabetes mellitus in childhood
  413. Infusion of UVB-treated splenic stromal cells induces suppression of β cell antigen-specific T cell responses in NOD mice
  414. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients
  415. Susceptibility to type 1 diabetes conferred by the PTPN22C1858T polymorphism in the Spanish population
  416. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes
  417. Kinin B1 receptor antagonists inhibit diabetes-induced hyperalgesia in mice
  418. B Cells Promote Intra-Islet CD8 Cytotoxic T Lymphocyte Survival To Enhance Type 1 diabetes
  419. Combination of HLA DR and DQ molecules determine the susceptibility to Insulin Dependent diabetes Mellitus in Iraqi Patients
  420. Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention
  421. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of β cell autoantigens
  422. Animal models of spontaneous autoimmune diabetes: notes on their relevance to the human disease
  423. Hypoglycemic effect of Swietenia macrophylla seeds against type II diabetes
  424. Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse
  425. Immune mechanisms leading to type 1 insulin-dependent diabetes mellitus
  426. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas
  427. Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus
  428. Early reaction of astroglial cells in rat hippocampus to streptozotocin-induced diabetes
  429. The identification and sequence analysis of a new Reg3gamma and Reg2 in the Syrian golden hamster
  430. IDO mediates TLR9-driven protection from experimental autoimmune diabetes
  431. Zinc influx and physiological consequences in the β-insulinoma cell line, Min6
  432. New insights into managing the risk of hypoglycaemia associated with intermittent high-intensity exercise in individuals with type 1 diabetes mellitus: implications for …
  433. The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse
  434. [Ca2+]i regulates trafficking of Cav1.3 (α1D Ca2+ channel) in insulin-secreting cells
  435. … CT60 Polymorphism May Not Be Affected by Vitamin D Receptor Gene Bsm I Polymorphism or HLA DR9 in Autoimmune‐Related Type 1 diabetes in the Japanese
  436. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice
  437. Increased Level of Interferon-α in Blood of Patients with Insulin-Dependent diabetes Mellitus: Relationship with Coxsackievirus B Infection
  438. … and interaction of the TNF‐alpha gene with other pro‐and anti‐inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India
  439. An insight into the genetics of type 1 diabetes
  440. An islet-cell protein tyrosine phosphatase is a likely precursor to the 37-kDa autoantigen in type 1 diabetes: human and macaque sequences, tissue …
  441. Effector lymphocytes in autoimmunity
  442. NOD mouse diabetes: the ubiquitous mouse hsp60 is a β-cell target antigen of autoimmune T cells
  443. Centromeric interval of chromosome 4 derived from C57BL/6 mice accelerates type 1 diabetes in NOD. CD72b congenic mice
  444. The HMG box transcription factor Sox4 contributes to the development of the endocrine pancreas
  445. Efficacy of clonal deletion vs. anergy of self-reactive CD4 T-cells for the prevention and reversal of autoimmune diabetes
  446. Human CD8 responses to a complete epitope set from preproinsulin: implications for approaches to epitope discovery
  447. Serum IFN‐γ and IL‐10 levels are associated with disease progression in non‐obese diabetic mice
  448. Protective role for cytosolic phospholipase A2α in autoimmune diabetes of mice
  449. T regulatory cells in autoimmune diabetes: past challenges, future prospects
  450. Modulation and detection of IDDM by membrane associated antigens from the islet beta cell line NIT-1
  451. T-cell reactivity to insulin peptide A1–12 in children with recently diagnosed type 1 diabetes or multiple β-cell autoantibodies
  452. Polymorphic variation in the CBLB gene in human type 1 diabetes
  453. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-γ-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL …
  454. Islet β-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets
  455. Gene expression profiling in type 1 diabetes prone NOD mice immunized with a disease protective autoantigenic peptide
  456. Overexpression of extracellular-SOD in islets of nonobese diabetic mice and development of diabetes
  457. The mutation of the LEW.1AR1-iddm rat maps to the telomeric end of rat chromosome 1
  458. Failure of high-dose insulin treatment to increase β-cell insulin content in diabetic non obese diabetic (NOD) mice
  459. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis
  460. Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk
  461. Low protein diet confers resistance to the inhibitory effects of interleukin 1β on insulin secretion in pancreatic islets☆
  462. Combined insulin and bicarbonate therapy elicits cerebral edema in a juvenile mouse model of diabetic ketoacidosis
  463. Retinoids differentially regulate the progression of autoimmune diabetes in three preclinical models in mice
  464. Ethanolic extract of Ocimum sanctum leaves partially attenuates streptozotocin-induced alterations in glycogen content and carbohydrate metabolism in rats
  465. Hypoglycemic and antioxidant effects of phenolic extracts and purified hydroxytyrosol from olive mill waste in vitro and in rats
  466. Monoclonal antibody 76F distinguishes IA-2 from IA-2β and overlaps an autoantibody epitope
  467. Prolonged Viral RNA Detection in Blood and Lymphoid Tissues from Coxsackievirus B4 E2 Orally‐Inoculated Swiss Mice
  468. Functional variants in SUMO4, TAB2, and NFκB and the risk of type 1 diabetes
  469. Potential health benefits of avenanthramides of oats
  470. Cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes
  471. Prolactin receptors are critical to the adaptation of islets to pregnancy
  472. The role of somatolactogenic hormones and receptors in the growth and function of the endocrine pancreas
  473. Vitamin D Supplementation in Early Childhood and
  474. A wheat-based, diabetes-promoting diet induces a Th1-type cytokine bias in the gut of NOD mice
  475. Islet β-Cell Apoptosis Triggered in Vivo by Interleukin-1β Is Not Related to the Inducible Nitric Oxide Synthase Pathway: Evidence for Mitochondrial Function …
  476. Inhibition of membrane type-1 matrix metalloproteinase by cancer drugs interferes with the homing of diabetogenic T cells into the pancreas
  477. Innocuous IFNγ induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production
  478. Environmental determinants: The role of viruses and standard of hygiene
  479. Insulin trigger for diabetes
  480. Combinations of common chronic paediatric diseases deviate the immune response in diverging directions
  481. Notch-responsive cells initiate the secondary transition in larval zebrafish pancreas
  482. Soluble adhesion molecules in preclinical type 1 diabetes
  483. Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease
  484. Extracellular lysosome‐associated membrane protein‐1 (LAMP‐1) mediates autoimmune disease progression in the NOD model of type 1 diabetes
  485. Association of the PTPN22 polymorphism C1858T with type 1 diabetes mellitus
  486. Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts
  487. Tolerance mechanisms in murine autoimmune diabetes induced by anti-ICAM-1/LFA-1 mAb and anti-CD8 mAb
  488. Involvement of Gut Immune System in the pathogenesis of type 1 diabetes: detection of T cell reactivity to Gliadin
  489. The NF-kB pathway as a potential target for autoimmune disease therapy
  490. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers
  491. Characterization and isolation of a β-cell surface receptor for diabetogenic EMC-D virus and studies on the relationship between receptor number and pathogenesis in …
  492. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus
  493. Association of the chromosomal region 2q35 with type 1 diabetes mellitus in the Russian patients from Moscow
  494. Biochemical studies on the effect of Terminalia chebula on the levels of glycoproteins in streptozotocin-induced experimental diabetes in rats.
  495. … early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
  496. CD4+ CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion
  497. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes
  498. Diabetic neuropathy models: Are they relevant?
  499. Absence of Heterozygous K83E and R257X Mutations of the AIRE-1 Gene in 46 Children with Type 1 diabetes and 44 Children with Graves’ Disease
  500. The islet-specific glucose-6-phosphatase-related protein, implicated in diabetes, is a glycoprotein embedded in the endoplasmic reticulum membrane
  501. Hypoglycemic and antioxidative effects of fermented chaga mushroom (Inonotus obliquus) on streptozotocin-induced diabetic rats
  502. PYY in the expanding pancreatic epithelium
  503. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity
  504. Web-Based Simulations for Dynamic Variations in Blood-Glucose Concentration of Patients with Type 1 diabetes
  505. Enhanced β-cell mass without increased proliferation following chronic mild glucose infusion
  506. Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient
  507. Cytokine-induced apoptosis and necrosis are preceded by disruption of the mitochondrial membrane potential (Δψm) in pancreatic RINm5F cells: prevention by Bcl-2
  508. Trigonella foenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic …
  509. IL-4 AND INTERFERON GAMMA IN RECENTLY DIAGNOSED TYPE I diabetes, A CASE-CONTROL STUDY
  510. A novel drug delivery system for type 1 diabetes: Insulin-mimetic vanadyl-poly (γ-glutamic acid) complex
  511. Macrophage activation phenotypes in type 1 diabetes pathogenesis and therapy: Master thesis
  512. Norepinephrine and epinephrine-deficient mice are hyperinsulinemic and have lower blood glucose
  513. Relationships among islet cell antibodies, residual β-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a …
  514. Mapping of the murine type 1 diabetes locus Idd20 by genetic interaction
  515. Effect of targeted disruption of signal transducer and activator of transcription (Stat) 4 and Stat6 genes on the autoimmune diabetes development induced by multiple …
  516. Impaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathy
  517. Poly (lactide-co-glycolide)-Polymethacrylate Nanoparticles for Intramuscular Delivery of Plasmid Encoding Interleukin-10 to Prevent Autoimmune diabetes in Mice
  518. Effects of parsley (Petroselinum crispum) extract versus glibornuride on the liver of streptozotocin-induced diabetic rats
  519. The new paradigm of T-cell homeostatic proliferation-induced autoimmunity
  520. Polyunsaturated fatty acids alter the rules of engagement
  521. No evidence for association of the TATA-box binding protein glutamine repeat sequence or the flanking chromosome 6q27 region with type 1 diabetes
  522. Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection
  523. Distribution of C→ T and T→ C polymorphisms of the urokinase-type plasminogen activator gene in children with type 1 diabetes mellitus and insulin resistance
  524. Daily nasal inoculation with the insulin gene ameliorates diabetes in mice
  525. Complete nucleotide sequence of a Coxsackievirus B‐4 strain capable of establishing persistent infection in human pancreatic islet cells: Effects on insulin release …
  526. Nuclear factor-κB translocation mediates double-stranded ribonucleic acid-induced NIT-1 β-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor …
  527. Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab
  528. Essential roles of TGF‐β in anti‐CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells
  529. Clioquinol effects on tissue chelatable zinc in mice
  530. Convergence of bone morphogenetic protein and laminin-1 signaling pathways promotes proliferation and colony formation by fetal mouse pancreatic cells
  531. Localization of insulinoma associated protein 2, IA-2 in mouse neuroendocrine tissues using two novel monoclonal antibodies
  532. Involvement of JAK2 and Src kinase tyrosine phosphorylation in human growth hormone-stimulated increases in cytosolic free Ca2+ and insulin secretion
  533. The T-cell receptor beta chain CDR3 region of BV8S1/BJ1S5 transcripts in type 1 diabetes
  534. HYPERINSULINISM IN INFANCY: TOPOGRAPHICAL LOCALISATION OF A pancreatic FOCAL LESION BY TRANSHEPATIC PORTAL CATHETERISM …
  535. Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks
  536. Persistent infection of human thymic epithelial cells by coxsackievirus B4
  537. Tacrolimus, but not cyclosporine A, significantly increases expression of ICAM‐1 and IFN‐γ in the NOD mouse
  538. Beta cell antigens
  539. Inhibition of type 1 diabetic hyperalgesia in streptozotocin-induced Wistar versus spontaneous gene-prone BB/Worchester rats: efficacy of a selective bradykinin B1 …
  540. Glucose transport in brain and retina: implications in the management and complications of diabetes
  541. Evidence for a Type 1 diabetes Susceptibility Locus (IDDM10) on Chromosome 10p11‐q11 in a Russian Population
  542. Colocalization of γ-aminobutyrate and gastrin in the rat antrum: An immunocytochemical and in situ hybridization study
  543. Cyclosporin depresses pancreatic islet expression of antigens for islet cell autoantibodies in non obese diabetic mice
  544. Fibronectin and laminin induce expression of islet cell markers in hepatic oval cells in culture
  545. Cell type specific and glucose responsive expression of interleukin-4 by using insulin promoter and water soluble lipopolymer
  546. Genetic control of diabetes progression
  547. … of C [arrow right] T and T [arrow right] C polymorphisms of the urokinase-type plasminogen activator gene in children with type 1 diabetes mellitus and insulin …
  548. Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide
  549. Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice
  550. Characterization of human brain nicotinamide 5′-mononucleotide adenylyltransferase-2 and expression in human pancreas
  551. Codelivery of a tea extract prevents morbidity and mortality associated with oral vanadate therapy in streptozotocin-induced diabetic rats
  552. Association analyses of the vitamin D receptor gene in 1654 families with type I diabetes
  553. The weight of leptin in immunity
  554. Development of autoimmune diabetes in glutamic acid decarboxylase 65 (GAD65) knockout NOD mice
  555. Proapoptosis and antiapoptosis-related molecules during postnatal pancreas development in control and nonobese diabetic mice: relationship with …
  556. Loss of invariant chain protects nonobese diabetic mice against type 1 diabetes
  557. Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21
  558. Dynamic changes in CD4+ CD25+ high T cell apoptosis after the diagnosis of type 1 diabetes
  559. Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitis
  560. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction
  561. γδ T-cells alterations in the peripheral blood of high risk diabetes type 1 subjects with subclinical pancreatic B-cells impairment
  562. Coxsackievirus-mediated hyperglycemia is enhanced by reinfection and this occurs independent of T cells
  563. Glucose Dependence of Imidazoline-Induced Insulin Secretion: Different Characteristics of Two ATP-Sensitive K+ Channel–Blocking Compounds
  564. Common susceptibility and transmission pattern of human leukocyte antigen DRB1-DQB1 haplotypes to Korean and Caucasian patients with type 1 diabetes
  565. Proinsulin C-peptide activates vagus efferent output in rats
  566. Primary Sjögren’s syndrome and deficiency of ICA69
  567. 12: Is multiple injection therapy the treatment of choice in type 1 diabetes?
  568. Self-representation in the thymus: an extended view
  569. Effect of X‐and Y‐Box Deletions on the Development of diabetes in H‐2Eα‐Chain Transgenic Nonobese Diabetic Mice
  570. Obstacles to identifying viruses that cause autoimmune disease
  571. Autoimmune diabetes mellitus—much progress, but many challenges
  572. E-cadherin interactions regulate β-cell proliferation in islet-like structures
  573. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell …
  574. Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases
  575. Oral administration of branched chain amino acids improves virus-induced glucose intolerance in mice
  576. Intramuscular injection of interleukin-10 plasmid DNA prevented autoimmune diabetes in mice
  577. Sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation
  578. Gene expression of pancreatic glutamic acid decarboxylase in the nonobese diabetic mouse
  579. B cells are crucial for determinant spreading of T cell autoimmunity among β cell antigens in diabetes-prone nonobese diabetic mice
  580. Minority participation in health research—facts and fiction
  581. Cytokine-induced PGE2 formation is reduced from iNOS deficient murine islets
  582. IL-23 drives pathogenic IL-17-producing CD8+ T cells
  583. FGFR3 is a negative regulator of the expansion of pancreatic epithelial cells
  584. Glucagon inhibits ghrelin secretion in humans
  585. Intraperitoneal co-administration of thymosin α-1 ameliorates streptozotocin-induced pancreatic lesions and diabetes in C57BL/6 mice
  586. Effect of prostaglandins against alloxan-induced cytotoxicity to insulin secreting insulinoma RIN cells in vitro
  587. Islet abnormalities associated with an early influx of dendritic cells and macrophages in NOD and NODscid mice
  588. Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit–insulin B chain fusion protein vaccine produced in …
  589. The autoimmune contrivance: genetics in the mouse model
  590. Glucose regulates the release of orexin-a from the endocrine pancreas
  591. Transcriptional regulation of type I diabetes by NF-κB
  592. Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air?
  593. Overexpression of the Pdx-1 homeodomain transcription factor impairs glucose metabolism in cultured rat hepatocytes
  594. Extracellular matrix distribution and islet morphology in the early postnatal pancreas: anomalies in the non-obese diabetic mouse
  595. Two distinctly HLA-associated contiguous linear epitopes uniquely expressed within the islet antigen 2 molecule are major autoantibody epitopes of the diabetes …
  596. Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal …
  597. Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain
  598. Role of bradykinin B1 receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice
  599. Low expression of insulin in the thymus of non-obese diabetic mice
  600. Cutting edge: interactions through the IL-10 receptor regulate autoimmune diabetes
  601. Modulation of vasoconstrictor and dilator pancreatic metabolites in streptozotocine diabetic rats:: Effect of bradykinin blockage and NO inhibition
  602. Human bone marrow-derived mesenchymal stem cells differentiate into insulin, somatostatin and glucagon expressing cells
  603. Effects of Syzygium cordatum (Hochst.)[Myrtaceae] leaf extract on plasma glucose and hepatic glycogen in streptozotocin-induced diabetic rats
  604. Detection of autoantibodies to protein tyrosine phosphatase-like protein IA-2 with a novel time-resolved fluorimetric assay
  605. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets
  606. CD8+ T lymphocytes specific for glutamic acid decarboxylase 90–98 epitope mediate diabetes in NODSCID mouse
  607. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression
  608. Imaging of the brain in children with type I diabetes mellitus
  609. Immunohistochemical evidence for the presence of glucokinase in the gonadotropes and thyrotropes of the anterior pituitary gland of rat and monkey
  610. Subsets of macrophages and dendritic cells in nonobese diabetic mouse pancreatic inflammatory infiltrates: correlation with the development of diabetes
  611. Autoantibodies to pancreatic hsp60 precede the development of glucose intolerance in patients with cystic fibrosis
  612. Oral DNA vaccination with a plasmid encoding soluble ICAM-1 modulates cytokine expression profiles in nonobese diabetic mice
  613. Immunoregulation during disease progression in prediabetic NOD mice: inverse expression of arginase and prostaglandin H synthase 2 vs. interleukin-15
  614. Evaluation of hypoglycemic activity of Opuntia dillenii haw fruit juice in streptozotocin-induced diabetic rats
  615. Good riddance: thymocyte clonal deletion prevents autoimmunity
  616. Is antigen specificity of autoreactive T cells the key to islet entry?
  617. Sex steroids influence pancreatic islet hypertrophy and subsequent autoimmune infiltration in nonobese diabetic (NOD) and NODscid mice
  618. Maternal diabetes adversely affects preovulatory oocyte maturation, development, and granulosa cell apoptosis
  619. Evidence for immunological priming and increased frequency of CD4+ CD25+ cord blood T cells in children born to mothers with type 1 diabetes
  620. The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility
  621. Imprinted and Genotype-specific Expression of Genes at theIDDM2Locus in Pancreas and Leucocytes
  622. Effect of X-and Y-Box Deletions on the Development of diabetes in H-2Eα-Chain Transgenic Nonobese Diabetic Mice
  623. Neurogenin3 triggers beta-cell differentiation of retinoic acid-derived endoderm cells
  624. Glucose lowering efficacy of the aqueous stem bark extract of Trema orientalis (Linn) Blume in normal and streptozotocin diabetic rats
  625. Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage
  626. MCP-1 and MIP-2 expression and production in BB diabetic rat: effect of chronic hypoxia
  627. Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice
  628. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes
  629. Hyperinsulinism and Beckwith-Wiedemann syndrome
  630. Interleukin-21 as a new therapeutic target for immune-mediated diseases
  631. Early and quantal (by litter) expression of insulin autoantibodies in the nonobese diabetic mice predict early diabetes onset
  632. Sustained enhancement of Ca2+ influx by glibenclamide induces apoptosis in RINm5F cells
  633. The role of ghrelin and ghrelin analogues in wasting disease
  634. N-3 fatty acids modulate Th1 and Th2 dichotomy in diabetic pregnancy and macrosomia
  635. Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease
  636. The role of the activating receptor NKG2D in autoimmunity
  637. Glucose-induced preproinsulin gene expression is inhibited by the free fatty acid palmitate
  638. Insulin Gene Expression
  639. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes
  640. Immunology section
  641. Immune deficiency or hyperactivity-Nf-κb illuminates autoimmunity
  642. Demonstration of natural autoantibodies against the neurofilament protein α-internexin in sera of patients with endocrine autoimmunity and healthy individuals
  643. DNA vaccine containing the mycobacterial hsp65 gene prevented insulitis in MLD-STZ diabetes
  644. The Reactive d-Glucopyranose Moiety of Streptozotocin Is Responsible for Activation of Macrophages and Subsequent Stimulation of CD8+ T Cells
  645. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease …
  646. Streptozotocin-induced diabetes and glucocorticoid receptor regulation: tissue-and age-specific variation
  647. Structural analysis of H2-Db class I molecules containing two different allelic forms of the type 1 diabetes susceptibility factor beta-2 microglobulin: Implications for the …
  648. Antidiabetogenic effect of pentoxifylline is associated with systemic and target tissue modulation of cytokines and nitric oxide production
  649. Plant-based vaccines for protection against infectious and autoimmune diseases
  650. Serum Thymic Factor Prevents LPS‐Induced pancreatic Cell Damage in Mice via Up‐Regulation of Bcl‐2 Expression in Pancreas
  651. Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression
  652. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice
  653. Delayed exposure to wheat and barley proteins reduces diabetes incidence in non-obese diabetic mice
  654. Global profiling of double stranded RNA-and IFN-γ-induced genes in rat pancreatic beta cells
  655. Gene expression of islet cell antigen p69 in human, mouse, and rat
  656. Molecular profile of the T cell receptors of regulatory and effector CD4+ T cells recognizing overlapping determinants on glutamic acid decarboxylase (524–543)
  657. Impact of plastic adhesion in vitro on analysis of Th1 and Th2 cytokines and immune cell distribution from mice with multiple low-dose streptozotocin-induced diabetes
  658. β cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct
  659. Insulin-Dependent diabetes Mellitus (IDDM) Is Associated with CTLA4 Polymorphisms in Multiple Ethnic Groups
  660. Cytokines affect PDX-1 expression, insulin and proinsulin secretion from iNOS deficient murine islets
  661. PD-1 and its ligands in T-cell immunity
  662. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes
  663. Reciprocal regulation between natural killer cells and autoreactive T cells
  664. Self and non-self antigen in diabetic autoimmunity: molecules and mechanisms
  665. Dual T cell receptor expressing CD8+ T cells with tumor-and self-specificity can inhibit tumor growth without causing severe autoimmunity
  666. CD18 deficiency protects against multiple low-dose streptozotocin-induced diabetes
  667. Diabetic Perspectives
  668. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells
  669. Autoimmune thyroid disease: new models of cell death in autoimmunity
  670. Autocrine and paracrine roles of sphingosine-1-phosphate
  671. Prevention of Spontaneous Autoimmune diabetes in NOD Mice by Transferring in VitroAntigen-Pulsed Syngeneic Dendritic Cells
  672. Insulitis and mechanisms of disease resistance: studies in an animal model of insulin dependent diabetes mellitus
  673. Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects
  674. Cytokines in autoimmunity
  675. Chronic alcohol intake differently influences glucose metabolism according to nutritional status
  676. Insights into autoimmunity gained from structural analysis of MHC–peptide complexes
  677. Neonatal diabetes mellitus and cerebellar hypoplasia/agenesis: report of a new recessive syndrome
  678. Toll‐like receptors and diabetes
  679. Identifying tumor antigens in endocrine malignancies
  680. The initiation of autoimmune diabetes
  681. No evidence for activation of TH1 or TH17 pathways in unstimulated peripheral blood mononuclear cells from children with β-cell autoimmunity or T1D
  682. Th1 and Th2 cytokines exert regulatory effects upon islet microvascular areas in the NOD mouse
  683. … K+ and Ca2+ channels and soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins to cholesterol-rich lipid rafts in pancreatic α-cells: effects on …
  684. Intra-Peritoneal Administration of Interleukin-1β Induces Impaired Insulin Release from the Perfused Rat Pancreas
  685. Superoxide, nitric oxide, peroxynitrite and cytokine combinations all cause functional impairment and morphological changes in rat islets of Langerhans and insulin …
  686. Human monoclonal antibodies isolated from type I diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen
  687. CTLA-4 differentially regulates T cell responses to endogenous tissue protein versus exogenous immunogen
  688. Novel insulin/GIP co‐producing cell lines provide unexpected insights into Gut K‐cell function in vivo
  689. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content
  690. Detection of glutamic acid decarboxylase (GAD) autoantibodies by indirect immunofluorescence using CHO cells expressing recombinant human GAD65
  691. … ′, 5′-oligoadenylate synthetase (2′ 5′ AS) antiviral enzyme activity and apoptosis following IFN-α or poly (I: C) treatment than pancreatic alpha TC3 cells
  692. Specific Inhibition of Autoimmune T Cell Transmigration Contributes to β Cell Functionality and Insulin Synthesis in Non-obese Diabetic (NOD) Mice
  693. pancreatic hormone expression in the murine thymus: localization in dendritic cells and macrophages
  694. Inhibition of Ca2+-Independent Phospholipase A2 Results in Insufficient Insulin Secretion and Impaired Glucose Tolerance
  695. Interleukin 18 promoter polymorphisms are not strongly associated with type I diabetes in a UK population
  696. Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2Kd that stimulates CD8 T cells in insulin-dependent diabetes …
  697. Long‐Term Expression of an HLA‐DQ Molecule in the EBV‐Transformed Bare Lymphocyte Cell Line, BLS‐1, using a Plasmid Vector
  698. diabetes incidence is unaltered in glutamate decarboxylase 65-specific TCR retrogenic nonobese diabetic mice: generation by retroviral-mediated stem cell gene …
  699. Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells
  700. Linomide Increases Plasma Corticosterone in Normal Rats, but does not Prevent the Inhibitory Action of IL-1 on β-cells in Vivo or ex Vivo
  701. Glibenclamide prevents increased extracellular matrix formation induced by high glucose concentration in mesangial cells
  702. NOD mice are defective in proteasome production and activation of NF-κB
  703. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity
  704. T‐cell tolerance and autoimmunity to systemic and tissue‐restricted self‐antigens
  705. Somatostatin and its receptors in the development of the endocrine pancreas
  706. Peptide YY is secreted after oral glucose administration in a gender-specific manner
  707. Influence of a non-NK complex region of chromosome 6 on CD4+ invariant NK T cell homeostasis
  708. An extension to the compartmental model of type 1 diabetic patients to reproduce exercise periods with glycogen depletion and replenishment
  709. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis
  710. Dendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer
  711. Selected contribution: Association of gender-related LMP2 inactivation with autoimmune pathogenesis
  712. Visualizing immune system complexity
  713. Genetic dissection reveals diabetes loci proximal to the gimap5 lymphopenia gene
  714. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent
  715. Glucose-and metabolically regulated hepatic insulin gene therapy for diabetes
  716. Monoclonal autoantibodies from insulin-dependent diabetic patients: autoantibodies against β-cell surface or cytoplasmic antigens
  717. βIV spectrin, a new spectrin localized at axon initial segments and nodes of Ranvier in the central and peripheral nervous system
  718. A Th1-recognized peptide P277, when tandemly repeated, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in nonobese …
  719. CD154-dependent priming of diabetogenic CD4+ T cells dissociated from activation of antigen-presenting cells
  720. IFN-γ-dependent regulatory circuits in immune inflammation highlighted in diabetes
  721. Islet endocrine-cell behavior from birth onward in mice with the nonobese diabetic genetic background
  722. Identical β cell-specific CD8+ T cell clonotypes typically reside in both peripheral blood lymphocyte and pancreatic islets
  723. Proteinn-X, pancreatic Stone-, pancreatic Thread-, reg-Protein, P19, Lithostathine, and Now What
  724. The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals
  725. Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans
  726. … Greater-Oligoadenylate Synthetase (AS) Antiviral Enzyme Activity and Apoptosis Following IFN-or Poly (I: C) Treatment than pancreatic Alpha TC3 Cells
  727. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction
  728. HIP/PAP, a member of the reg family, is expressed in glucagon-producing enteropancreatic endocrine cells and tumors
  729. Antibodies to CD1d enhance thymic expression of invariant NKT TCR and increase the presence of NOD thymic invariant NKT cells
  730. Effect of Linomide on adhesion molecules, TNF-α, nitrogen oxide, and cell adhesion
  731. CTSL2 as a candidate gene for autoimmune diseases: genetic and functional studies to explore its role in type 1 diabetes and myasthenia gravis
  732. Early neonatal events and the disease incidence in nonobese diabetic mice
  733. Expression of cyclooxygenase‐2 in intestinal goblet cells of pre‐diabetic NOD mice
  734. Celiac disease-associated autoimmune endocrinopathies
  735. Ghrelin and insulin gene expression changes in streptozotocin-induced diabetic rats after rosiglitazone pretreatment
  736. The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form
  737. Virus-Induced Autoimmune diabetes in the LEW.1WR1 Rat Requires Iddm14 and a Genetic Locus Proximal to the Major Histocompatibility Complex
  738. Interferon-α-induced endogenous superantigen: a model linking environment and autoimmunity
  739. S100A1 and S100B expression and target proteins in type I diabetes
  740. Transgenic Ly-49A inhibits antigen-driven T cell activation and delays diabetes
  741. The coxsackie-and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis
  742. Major histocompatibility class II genes polymorphism in insulin dependent diabetes mellitus with or without associated thyroid autoimmunity
  743. The enlarged population of marginal zone/CD1dhigh B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11
  744. Dense-core vesicle proteins IA-2 and IA-2β affect renin synthesis and secretion through the β-adrenergic pathway
  745. Probable mechanism of the antihyperglycemic effect of standardized extract from Momordica charantia in streptozotocin diabetic rats
  746. Patent application title: CHLOROPLASTS ENGINEERED TO EXPRESS PHARMACEUTICAL PROTEINS IN EDIBLE PLANTS Inventors: Henry Daniell (Winter …
  747. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial
  748. A novel role for CD4+ T cells in the control of cachexia
  749. Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia
  750. Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination
  751. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes
  752. IL-18 in autoimmunity
  753. Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses
  754. Plant-made vaccine antigens and biopharmaceuticals
  755. Informant consensus selection method: A reliability assessment on medicinal plants used in north western Nigeria for the treatment of diabetes mellitus
  756. In vivo effect of Trigonella foenum graecum on the expression of pyruvate kinase, phosphoenolpyruvate carboxykinase, and distribution of glucose transporter …
  757. Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival
  758. Exogenous activin increases the proportion of insulin cells in the developing chick pancreas in culture
  759. Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4-and B3-induced synthesis of alpha interferon
  760. Paternally TransmittedIDDM2Influences diabetes Susceptibility Despite Biallelic Expression of the Insulin Gene in Human Pancreas
  761. Biosynthesis of peptide hormones derived from precursor sequences
  762. The effects of vanadium treatment on bone in diabetic and non-diabetic rats
  763. Both TH1 and TH2 Cytokine mRNAs are Expressed in the NOD Mouse Pancreas in vivo
  764. Evidence for the presence of insulin-dependent diabetes-associated alleles on the distal part of mouse chromosome 6
  765. DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes
  766. Osteopontin deficiency impacts the pancreatic TH1/TH2 cytokine profile following multiple low dose streptozotocin-induced diabetes
  767. Early changes with diabetes in renal medullary hemodynamics as evaluated by fiberoptic probes and BOLD magnetic resonance imaging
  768. diabetes resistance/susceptibility in T cells of nonobese diabetic mice conferred by MHC and MHC-linked genes
  769. Distinct regulation of autoreactive CD4 T cell expansion by interleukin‐4 under conditions of lymphopenia
  770. Characteristics of Rat CD4+CD25+ T Cells and Their Ability to Prevent Not Only diabetes But Also Insulitis in an Adoptive Transfer Model in BB Rats
  771. Novel genes identified by manual annotation and microarray expression analysis in the pancreas
  772. Evaluation of [18F]Fluoro-l-DOPA Positron Emission Tomography-Computed Tomography for Surgery in Focal Congenital Hyperinsulinism
  773. Insulin-like growth factor binding protein-3 is a novel mediator of apoptosis in insulin-secreting cells
  774. Differential contributions of APC subsets to T cell activation in nonobese diabetic mice
  775. Effect of 5-α dihydrotestosterone on T-cell proliferation of the female nonobese diabetic mouse
  776. Antigen-specific therapy for autoimmune disease: prospects for the prevention of insulin-dependent diabetes
  777. α-glucosidase inhibition and glucose-uptake stimulation by ethanol extracts from edible mushroom Hinmogi (Tremella fuciformis)
  778. The role of environmental factors in modulating insulin dependent diabetes
  779. Elevated NF-κB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function
  780. Preserved pulsatile insulin release from prediabetic mouse islets
  781. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice
  782. Interaction of genetic and environmental factors in the pathogenesis of insulin-dependent diabetes mellitus
  783. Zinc sulphate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin
  784. Paradoxical dampening of anti-islet self-reactivity but promotion of diabetes by OX40 ligand
  785. Stimulation of insulin secretion by denatonium, one of the most bitter-tasting substances known
  786. Macrophages in the murine pancreas and their involvement in fetal endocrine development in vitro
  787. Identification of a key protein associated with cerebral ischemia
  788. TNF-α mediated modulation of T cell development and exacerbation of in vitro T1DM in fetal thymus organ culture
  789. Glucose-induced release of nitric oxide from mouse pancreatic islets as detected with nitric oxide-selective glass microelectrodes
  790. Schistosoma mansoni and α-galactosylceramide: prophylactic effect of Th1 immune suppression in a mouse model of Graves’ hyperthyroidism
  791. Monoclonal (auto) antibodies in insulin-dependent diabetes mellitus
  792. E2f1 mutation induces early onset of diabetes and Sjogren’s syndrome in nonobese diabetic mice
  793. Down-regulation of Th1 mediated autoimmune pathology
  794. Antibodies to new beta cell antigen ICA12 in Latvian diabetes patients
  795. Inflammatory rather than infectious insults play a role in exocrine tissue damage in a mouse model for coxsackievirus B4‐induced pancreatitis
  796. Enhanced proinflammatory response to endotoxin after priming of macrophages with lead ions
  797. Activation of the intrinsic cell death pathway, increased apoptosis and modulation of astrocytes in the cerebellum of diabetic rats
  798. Role of IP-10/CXCL10 in the progression of pancreatitis-like injury in mice after murine retroviral infection
  799. The glycosphingolipid sulfatide in the islets of Langerhans in rat pancreas is processed through recycling: possible involvement in insulin trafficking
  800. The stromal cell–derived factor-1α/CXCR4 ligand–receptor axis is critical for progenitor survival and migration in the pancreas
  801. Similar Peptides from Two β Cell Autoantigens, Proinsulin and Glutamic Acid Decarboxylase, Stimulate T Cells of Individuals at Risk for Insulin-Dependent …
  802. Recruitment and activation of naive T cells in the islets by lymphotoxin β receptor-dependent tertiary lymphoid structure
  803. Infections and autoimmunity: a panorama
  804. Autoimmune Epilepsy
  805. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome
  806. Mechanisms of hyperinsulinaemia in Child’s disease grade B liver cirrhosis investigated in free living conditions
  807. A critical role for lymphotoxin-β receptor in the development of diabetes in nonobese diabetic mice
  808. Peripheral antigen-expressing cells and autoimmunity
  809. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity
  810. Metallothionein suppresses collagen-induced arthritis via induction of TGF-β and down-regulation of proinflammatory mediators
  811. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes
  812. Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator
  813. Genetics and autoimmunity: HLA and MHC genes
  814. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein …
  815. GM-CSF-induced autoimmune gastritis in interferon α receptor deficient mice
  816. Hyperglycaemia and the very preterm baby
  817. Development of genetically engineered human intestinal cells for regulated insulin secretion using rAAV-mediated gene transfer
  818. Notch3 and pTα/pre-TCR sustain the in vivo function of naturally occurring regulatory T cells
  819. Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice
  820. Cytokine-based immunointervention in the treatment of autoimmune diseases
  821. Effects of hyperglycemia on the modulation of vascular function by perivascular adipose tissue
  822. PANDER-induced cell-death genetic networks in islets reveal central role for caspase-3 and cyclin-dependent kinase inhibitor 1A (p21)
  823. NOD. c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis
  824. Individuals from multiplex insulin-dependent diabetes mellitus (IDDM) families express higher levels of TCRBV2S1 than controls
  825. Suppression of insulitis and diabetes in B cell-deficient mice treated with streptozocin: B cells are essential for the TCR clonotype spreading of islet-infiltrating T cells
  826. Analysis of antibody reactivity against cysteine sulfinic acid decarboxylase, a pyridoxal phosphate-dependent enzyme, in endocrine autoimmune disease
  827. Role of regulatory T cells in the pathogenesis of autoimmune diabetes
  828. Pivotal roles of CD8+ T cells restricted by MHC class I–like molecules in autoimmune diseases
  829. Gene expression analysis reveals novel functions of vitamin D and glucocorticoids
  830. Regulation of inflammation in Th1 CD4 T cell mediated autoimmune responses
  831. Does O-GlcNAc play a role in neurodegenerative diseases?
  832. The design and construction of a scanning photo-acoustic calorimeter
  833. TCR repertoire dynamics in the pancreatic lymph nodes of non-obese diabetic (NOD) mice at the time of disease initiation
  834. αL-Integrin I domain cyclic peptide antagonist selectively inhibits T cell adhesion to pancreatic islet microvascular endothelium
  835. Functional Genetic Variations in Cytotoxic T-Lymphocyte Antigen 4 and Susceptibility to Multiple Types of Cancer
  836. Antigen Presentation, Dendritic Cells, and Autoimmunity
  837. Glutamic acid decarboxylase 65 and 67 isoforms in fetal, neonatal and adult porcine islets: predominant beta cell co-localization by light and confocal microscopy
  838. An indirect competitive immunoassay for insulin autoantibodies based on surface plasmon resonance
  839. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice
  840. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes
  841. It’stheecology, stupid!
  842. Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study
  843. Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in …
  844. Expression profile of MODY3/HNF-1α protein in the developing mouse pancreas
  845. Transcriptional regulation by AIRE: molecular mechanisms of central tolerance
  846. Expression of the human insulin gene in the gastric G cells of transgenic mice
  847. Decreased basal non-insulin-stimulated glucose uptake by diaphragm in streptozotocin-induced diabetic mice infected with Schistosoma mansoni
  848. Gene fragment polymerization gives increased yields of recombinant human proinsulin C-peptide
  849. Autoimmunity during thymectomy-induced lymphopenia: role of thymus ablation and initial effector T cell activation timing in nonobese diabetic mice
  850. Amino acid-modified calcitonin immunization induces tumor epitope-specific immunity in a transgenic mouse model for medullary thyroid carcinoma
  851. KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model
  852. Autoimmunity: Thoughts for the millenium
  853. Apoptosis and remodelling of beta cells by paracrine interferon-γ without insulitis in transgenic mice
  854. Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat
  855. Lacritin and other new proteins of the lacrimal functional unit
  856. Control of cellular GADD34 levels by the 26S proteasome
  857. Permanent neonatal diabetes mellitus: clinical presentation and epidemiology in Oman
  858. Bone marrow precursors of nonobese diabetic mice develop into defective macrophage-like dendritic cells in vitro
  859. Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus
  860. Unravelling autoimmune pathogenesis by screening random peptide libraries with human sera
  861. Peptide dose, MHC affinity, and target self-antigen expression are critical for effective immunotherapy of nonobese diabetic mouse prediabetes
  862. Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide …
  863. Activin signaling: effects on body composition and mitochondrial energy metabolism
  864. Stimulating effect of bovine lactoferrin (bLF) on the level of lipopolisaccharide-binding protein (LBP) during experimental diabetes in mice
  865. Cytokine and cytokine receptor genes in the susceptibility and resistance to organ-specific autoimmune diseases
  866. Altered glucose homeostasis and oxidative impairment in pancreas of rats subjected to dimethoate intoxication
  867. Sub-clinical enterovirus infections in Norwegian infants: A prospective cohort study on viral circulation and predictors of infection
  868. MILD FORM OF INSULIN-RESISTANT NON-OBESE NIDDM OR IGT OF CHILDHOOD-ONSET
  869. Detection of autoantibodies to the pancreatic islet heat shock protein 60 in insulin-dependent diabetes mellitus
  870. B cell–deficient NOD.H-2h4 mice have CD4+CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis
  871. Leukocyte matrix metalloproteinase-9 is elevated and contributes to lymphocyte activation in type I diabetes
  872. Effects of prolonged exposure in vitro to interferon-γ and tumour necrosis factor-α on nitric oxide and insulin production of rat pancreatic islets
  873. Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an islet cell antigen
  874. Gender difference in the glucagon response to glucopenic stress in mice
  875. Expression of glutamic acid decarboxylase (GAD) and its role as an autoantigen in insulin-dependent diabetes
  876. Innate Regulatory iNKT Cells
  877. Characterization of human AIRE promoter and analysis of AIRE expression in monocyte-derived dendritic cells and thymomas
  878. The role of coxsackie B viruses in the pathogenesis of type I diabetes
  879. Changing patterns of self-management in youth with type I diabetes
  880. Effect of maternal triglycerides and free fatty acids on placental LPL in cultured primary trophoblast cells and in a case of maternal LPL deficiency
  881. Production and purification of recombinant mouse cathepsin S
  882. The enhancement of the hyperglycemic effect of S-nitrosoglutathione and S-nitroso-N-acetylpenicillamine by vitamin C in an animal model
  883. Islet inflammation during initiation of type I diabetes: Virus infection and the role of cytokines in gene expression and β-cell death
  884. Role of Pathogenic Mediators in murine Arthritis and Levels of Serum Soluble CD21 and CD23 in autoimmune patients
  885. Genetic screening of infertile men
  886. Peptides presented in vivo by HLA-DR in thyroid autoimmunity
  887. The interface between innate and acquired immunity
  888. Effects of intensity of acute-resistance exercise on rates of protein synthesis in moderately diabetic rats
  889. PROPERTIES, FUNCTIONS AND BIOLOGICAL SIGNIFICANCE OF T LYMPHOCYTE SUBSETS
  890. Shared gene expression profiles in individuals with autoimmune disease and unaffected first-degree relatives of individuals with autoimmune disease
  891. Monogenic model for autoimmune diseases: molecular basis of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
  892. Progress in virus research
  893. The Physiological Function of Endothelin-2 in Mice
  894. Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration
  895. SUMO proteases: redox regulation and biological consequences
  896. The microRNA-21− PDCD4 axis prevents type 1 diabetes by blocking pancreatic β cell death
  897. Mulberry fruit extract protects pancreatic β-cells against hydrogen peroxide-induced apoptosis via antioxidative activity
  898. PTPN2, a Candidate Gene for Type 1 diabetes, Modulates pancreatic β-Cell Apoptosis via Regulation of the BH3-Only Protein Bim
  899. MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic β-cell responses to the viral by-product double-stranded RNA
  900. Phagocytosis of enterovirus-infected pancreatic β-cells triggers innate immune responses in human dendritic cells
  901. Quantification and three-dimensional imaging of the insulitis-induced destruction of β-cells in murine type 1 diabetes
  902. Butein from Rhus verniciflua protects pancreatic β cells against cytokine-induced toxicity mediated by inhibition of nitric oxide formation
  903. Constitutive and inflammatory immunopeptidome of pancreatic β-cells
  904. Cyclin D3 promotes pancreatic β-cell fitness and viability in a cell cycle-independent manner and is targeted in autoimmune diabetes
  905. STAT1 is a master regulator of pancreatic β-cell apoptosis and islet inflammation
  906. Diagnosis of fulminant type 1 diabetes mellitus in an autopsy case with postmortem changes
  907. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes
  908. mt-Nd2a Modifies Resistance Against Autoimmune Type 1 diabetes in NOD Mice at the Level of the pancreatic β-Cell
  909. The histopathologic effects of Morus alba leaf extract on the pancreas of diabetic rats
  910. Mechanisms in endocrinology: insulin and type 1 diabetes: immune connections
  911. Enteroviruses as causative agents in type 1 diabetes: loose ends or lost cause?
  912. Investigation of antidiabetic action of Antidesma bunius extract in type 1 diabetes
  913. Advances in our understanding of the pathophysiology of type 1 diabetes: lessons from the NOD mouse
  914. Primary prevention for type 1 diabetes mellitus?
  915. In vitro callus and in vivo leaf extract of Gymnema sylvestre stimulate β-cells regeneration and anti-diabetic activity in Wistar rats
  916. Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope
  917. Generation of functional insulin-producing cells in the gut by Foxo1 ablation
  918. Virus infections: lessons from pancreas histology
  919. Polymorphisms in the TLR3 gene are associated with risk for type 1 diabetes mellitus
  920. Type 1 diabetes vaccine development: Animal models vs. humans
  921. Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised …
  922. ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes
  923. Biochemical evaluation of oxidative stress in type 1 diabetes
  924. Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay
  925. … in ATP levels triggers immunoproteasome activation by the 11S (PA28) regulator during early antiviral response mediated by IFNβ in mouse pancreatic β-cells
  926. TCR bias of in vivo expanded T cells in pancreatic islets and spleen at the onset in human type 1 diabetes
  927. Arsenic induces pancreatic β-cell apoptosis via the oxidative stress-regulated mitochondria-dependent and endoplasmic reticulum stress-triggered signaling …
  928. CD4+ type II NKT cells mediate ICOS and programmed death-1–dependent regulation of type 1 diabetes
  929. Enteroviral pathogenesis of type 1 diabetes: queries and answers
  930. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice
  931. The protective effect of testosterone on streptozotocin-induced apoptosis in β cells is sex specific
  932. Type 1 diabetes mellitus and hyperadrenocorticism in a ferret
  933. Dendritic cell-directed CTLA-4 engagement during pancreatic β cell antigen presentation delays type 1 diabetes
  934. Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice
  935. Effect of combined leaf extracts of Vernonia amygdalina (bitter leaf) and Gongronema latifolium (utazi) on the pancreatic [beta]-cells of streptozotocin-induced …
  936. Cutting edge: merocytic dendritic cells break T cell tolerance to β cell antigens in nonobese diabetic mouse diabetes
  937. Increased vulnerability to β-cell destruction and diabetes in mice lacking NAD (P) H: quinone oxidoreductase 1
  938. Differential responses of pancreatic β-cells to ROS and RNS
  939. Modulation of autoimmune diabetes by antibodies specific for N-acetyl-D-glucosamine (P4026)
  940. Protective effects of polyamine depletion in mouse models of type 1 diabetes: implications for therapy
  941. Small-molecule inducer of β cell proliferation identified by high-throughput screening
  942. Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation
  943. Innate cell crosstalk in T1DM
  944. PTPN2 restrains CD8+ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice
  945. Virus infections and type 1 diabetes risk
  946. Expression of IL-2 in β cells by AAV8 gene transfer in pre-diabetic NOD mice prevents diabetes through activation of FoxP3-positive regulatory T cells
  947. Alterations in glucose homeostasis in a murine model of Chagas disease
  948. … the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes
  949. Plasmid-Encoded Proinsulin Preserves C-Peptide While Specifically Reducing Proinsulin-Specific CD8+ T Cells in Type 1 diabetes
  950. Environmental trigger (s) of type 1 diabetes: why so difficult to identify?
  951. What is the key environmental trigger in type 1 diabetes—is it viruses, or wheat gluten, or both?
  952. Overexpression of β-catenin in dendritic cells from type 1 diabetes patients and NOD mice may drive induction of T cells involved in β-cells destruction (123.34)
  953. Promoting pancreatic Cell Proliferation
  954. Thalidomide attenuates multiple low-dose streptozotocin-induced diabetes in mice by inhibition of proinflammatory cytokines
  955. Posttranslational modifications of proteins in type 1 diabetes: the next step in finding the cure?
  956. Differences in the humoral autoreactivity to zinc transporter 8 between childhood-and adult-onset type 1 diabetes in Japanese patients
  957. Viral infections and diabetes
  958. Hypoglycemic, hepatoprotective and nephroprotective effects of methanolic leaf extract of Heinsia crinita (Rubiaceae) in alloxan-induced diabetic albino Wistar …
  959. Lower serum 25 (OH) D concentrations in type 1 diabetes: a meta-analysis
  960. Treating type-1 diabetes with an epigenetic drug
  961. Altered expression of nerve growth factor and its receptors in the kidneys of diabetic rats
  962. Fulminant type 1 diabetes mellitus
  963. Virus-induced models for type 1 diabetes in mice
  964. Eukaryotic translation initiation factor 5A inhibition alters physiopathology and immune responses in a “humanized” transgenic mouse model of type 1 diabetes
  965. Immune therapy in type 1 diabetes mellitus
  966. Developing a vaccine for type 1 diabetes through targeting enteroviral infections
  967. … mutations E6 27X and I923V of IFIH1 are associated with lower poly (I: C)–induced interferon-β production in peripheral blood mononuclear cells of type 1 diabetes …
  968. Diminished adenosine A1 receptor expression in pancreatic α-cells may contribute to the pathology of type 1 diabetes
  969. MIF contributes to Type 1 diabetes favors insulitis by mediating macrophages and dendritic cells maturation (P4533)
  970. Amelioration of streptozotocin-induced diabetes by Agrocybe chaxingu polysaccharide
  971. Novel SIRT1 mutation linked to autoimmune diabetes in humans
  972. Ablation of Rnf213 retards progression of diabetes in the Akita mouse
  973. Early suppression of immune response pathways characterizes children with prediabetes in genome-wide gene expression profiling
  974. Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?
  975. Prevention of type 1 diabetes through infection with an intestinal nematode parasite requires IL-10 in the absence of a Th2-type response
  976. Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
  977. B cell-directed therapies in type 1 diabetes
  978. Assessment of the antidiabetic and antilipidemic properties of Bacillus subtilis SPB1 biosurfactant in alloxan‐induced diabetic rats
  979. Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα
  980. IL-21 promotes CD8+ CTL activity via the transcription factor T-bet
  981. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
  982. Nickel (II) induced JNK activation-regulated mitochondria-dependent apoptotic pathway leading to cultured rat pancreatic β-cell death
  983. Mathematical modelling of immune regulation of type 1 diabetes
  984. Early determinants of type 1 diabetes: experience from the BABYDIAB and BABYDIET studies
  985. Re-evaluating gut insulin instinct
  986. Type 1 diabetes is associated with enterovirus infection in gut mucosa
  987. Characterization of membrane-shed microvesicles from cytokine-stimulated β-cells using proteomics strategies
  988. An AP-3-dependent mechanism drives synaptic-like microvesicle biogenesis in pancreatic islet β-cells
  989. High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition
  990. CASE STUDY 9 The young person with type 1 diabetes mellitus
  991. Mast cells control insulitis and increase Treg cells to confer protection against STZ‐induced type 1 diabetes in mice
  992. Nitric oxide is a mediator of antiproliferative effects induced by proinflammatory cytokines on pancreatic beta cells
  993. Autoreactive cytotoxic T lymphocytes acquire higher expression of cytotoxic effector markers in the islets of NOD mice after priming in pancreatic lymph nodes
  994. Effect of Nigella sativa on pancreatic β-cell damage in streptozotocin-induced diabetic rats: histological and immunohistochemical study
  995. Immunomodulatory and antidiabetic effects of a new herbal preparation (HemoHIM) on streptozotocin-induced diabetic mice
  996. Autoreactive T cell trafficking into pancreatic islets during type 1 diabetes is more permissive as infiltration increases and requires CD11c+ APCs.(CAM4P. 153)
  997. Lack of association of IL-6 polymorphism with rheumatoid arthritis/type 1 diabetes: a meta-analysis
  998. Infant feeding and timing of complementary foods in the development of type 1 diabetes
  999. Interleukin-35 administration counteracts established murine type 1 diabetes–possible involvement of regulatory T cells
  1000. Persistent C-peptide: what does it mean?
  1001. Blockade but not overexpression of the junctional adhesion molecule C influences virus-induced type 1 diabetes in mice
  1002. Loss of Fbw7 reprograms adult pancreatic ductal cells into α, δ, and β cells
  1003. Zn (II) ions co-secreted with insulin suppress inherent amyloidogenic properties of monomeric insulin
  1004. Lactobacillus plantarum TN627 significantly reduces complications of alloxan-induced diabetes in rats
  1005. Protection against cytokine toxicity through endoplasmic reticulum and mitochondrial stress prevention by prostacyclin synthase overexpression in insulin …
  1006. Interaction of Nck1 and PERK phosphorylated at Y561 negatively modulates PERK activity and PERK regulation of pancreatic β-cell proinsulin content
  1007. Dysregulated TLR3-dependent signaling and innate immune activation in superoxide-deficient macrophages from nonobese diabetic mice
  1008. Activation of peritoneal macrophages during the evolution of type 1 diabetes (insulitis) in streptozotocin-treated mice
  1009. Low frequency of regulatory T cells in the peripheral blood of children with type 1 diabetes diagnosed under the age of five
  1010. Hyaluronic Acid Target Receptors (CD44 and RHAMM) involved in treatment of type 1 diabetes
  1011. A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes
  1012. Catenarin prevents type 1 diabetes in nonobese diabetic mice via inhibition of leukocyte migration involving the MEK6/p38 and MEK7/JNK pathways
  1013. Polymeric delivery of therapeutic RAE-1 plasmid to the pancreatic islets for the prevention of type 1 diabetes
  1014. Aqueous bark extract of cinnamomum zeylanicum: a potential therapeutic agent for streptozotocin-induced type 1 diabetes mellitus (T1DM) rats
  1015. Persian Shallot (Allium hirtifolium Boiss) Extract Elevates Glucokinase (GCK) Activity and Gene Expression in Diabetic Rats
  1016. … Insulitis In aly/aly MaleMice as an Animal Model of Autoimmune Pancreatitis: Activation of CD11c+, CD4+, and Th2 Cells and Predominant Destruction of β-cells
  1017. Increased blood levels of growth factors, proinflammatory cytokines, and Th17 cytokines in patients with newly diagnosed type 1 diabetes
  1018. In vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agent
  1019. Novel diagnostic and therapeutic approaches for autoimmune diabetes—a prime time to treat insulitis as a disease
  1020. Microbes and Type 1 diabetes
  1021. Selecting probiotics with the abilities of enhancing GLP-1 to mitigate the progression of type 1 diabetes in vitro and in vivo
  1022. Evaluation of antidiabetic antihyperlipidemic and pancreatic regeneration, potential of aerial parts of Clitoria ternatea
  1023. Role of topology in complex functional networks of beta cells
  1024. Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in type 1 diabetes
  1025. E2-2 dependent plasmacytoid dendritic cells control autoimmune diabetes
  1026. Genetics of the HLA region in the prediction of type 1 diabetes
  1027. Heligmosomoides polygyrus infection reduces severity of type 1 diabetes induced by multiple low-dose streptozotocin in mice via STAT6-and IL-10-independent …
  1028. Infant and childhood diet and type 1 diabetes risk: recent advances and prospects
  1029. The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes
  1030. cDNA cloning and mRNA expression of canine pancreatic and duodenum homeobox 1 (Pdx-1)
  1031. Sardinian Type 1 diabetes patients, Transthyretin and Mycobacterium avium subspecies paratuberculosis infection
  1032. Molecular anatomy and number of antigen specific CD8 T cells required to cause type 1 diabetes
  1033. Immunohistochemical analysis of IA-2 family of protein tyrosine phosphatases in rat gastrointestinal endocrine cells
  1034. MAKING THE PAPER
  1035. Small-molecule inhibitors of cytokine-mediated STAT1 signal transduction in β-cells with improved aqueous solubility
  1036. Prevention and treatment of type 1 diabetes mellitus by the manipulation of invariant natural killer T cells
  1037. Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases?
  1038. Generation of transgenic fibroblasts expressing pancreas‑specific and doxycycline-inducible ICER Iγ for the establishment of a porcine model of human …
  1039. Evaluation of antidiabetic activity of polysaccharide isolated from Phellinus linteus in non-obese diabetic mouse
  1040. Partial ablation of leptin signaling in mouse pancreatic α-cells does not alter either glucose or lipid homeostasis
  1041. Evaluation of the hypoglycemic effect of aqueous extract of Phyllanthus amarus in alloxan-induced diabetic albino rats
  1042. PD‐L1 gene polymorphisms and low serum level of PD‐L1 protein are associated to type 1 diabetes in Chile
  1043. The Potential of Jamur Dewa (Agaricusblazei Murril) Extract to Decrease Blood Glucose Diabetic Mice (Mus musculus)
  1044. Detecting early-warning signals of type 1 diabetes and its leading biomolecular networks by dynamical network biomarkers
  1045. The Roles of Iddm30 and Iddm24 in the Immunopathogenesis of Type 1 diabetes in BioBreeding Rats
  1046. Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Terminalia bellerica Roxb. in streptozotocin-induced diabetic rats
  1047. Intra-arterial targeted islet-specific expression of Sirt1 protects β cells from streptozotocin-induced apoptosis in mice
  1048. Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type 1 diabetes
  1049. Association investigation of BACH2 rs3757247 and SOD2 rs4880 polymorphisms with the type 1 diabetes and diabetes long-term complications risk in the …
  1050. Eosinophils from patients with type 1 diabetes mellitus express high level of myeloid alpha-defensins and myeloperoxidase
  1051. Osteoprotegerin and denosumab stimulate human beta cell proliferation through inhibition of the receptor activator of NF-κB ligand pathway
  1052. ERα signalling drives β-cell formation and replication
  1053. Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects
  1054. D-saccharic acid-1, 4-lactone ameliorates alloxan-induced diabetes mellitus and oxidative stress in rats through inhibiting pancreatic beta-cells from apoptosis via …
  1055. Non-viral systemic delivery of Fas siRNA suppresses cyclophosphamide-induced diabetes in NOD mice
  1056. Immunomodulatory effect of leaf extract of Murraya koenigii in diabetic mice
  1057. Biobreeding rat islets exhibit reduced antioxidative defense and N-acetyl cysteine treatment delays type 1 diabetes
  1058. Transthyretin binds to glucose-regulated proteins and is subjected to endocytosis by the pancreatic β-cell
  1059. HPTLC/HPLC and gravimetric methodology for the identification and quantification of gymnemic acid from Gymnema sylvestre methanolic extracts
  1060. Meta-analysis of STAT4 and IFIH1 polymorphisms in type 1 diabetes mellitus patients with autoimmune polyglandular syndrome type III
  1061. Genetically engineered Lactobacilli reprogram intestinal cells to secrete insulin and ameliorate hyperglycaemia
  1062. Kin of IRRE-like protein 2 is a phosphorylated glycoprotein that regulates basal insulin secretion
  1063. Deficiency in type I interferon signaling prevents the early inteferon-gene signature in pancreatic islets but not type 1 diabetes in non-obese diabetic mice
  1064. Association of major histocompatibility complex class 1 chain-related gene a dimorphism with type 1 diabetes and latent autoimmune diabetes in adults in the Algerian …
  1065. Helminth mediated modulation of Type 1 diabetes (T1D)
  1066. Asian Journal of Biological and Life Sciences Original Research
  1067. Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats
  1068. pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+ CD11b+ dendritic cells
  1069. Tc17 CD8+ T cells potentiate Th1-mediated autoimmune diabetes in a mouse model
  1070. … measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes …
  1071. Infection of human islets of Langerhans with two strains of Coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes …
  1072. Research Article Catenarin Prevents Type 1 diabetes in Nonobese Diabetic Mice via Inhibition of Leukocyte Migration Involving the MEK6/p38 and MEK7/JNK …
  1073. Anti-Saccharomyces cerevisiae Antibodies are Frequent in Type 1 diabetes
  1074. Enterovirus RNA in blood is linked to the development of type 1 diabetes
  1075. Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3/GAD65 combination therapy in new-onset type 1 diabetes
  1076. Inhibition of Ca2+-Independent Phospholipase A2β (iPLA2β) Ameliorates Islet Infiltration and Incidence of diabetes in NOD Mice
  1077. Inorganic nitrite stimulates pancreatic islet blood flow and insulin secretion
  1078. Animals models for studying diabetes mellitus
  1079. New insulin analogues and perioperative care of patients with type 1 diabetes
  1080. Changes of the expressions of multiple metabolism genes in rat pancreatic islets after ventromedial hypothalamic lesioning
  1081. From Toll-like receptors to the toll house of type 1 diabetes mellitus
  1082. Identifying challenges of living with type 1 diabetes: child and youth perspectives
  1083. The dual role of scavenger receptor class A in development of diabetes in autoimmune NOD mice
  1084. Investigation of secreted protein transcripts as early biomarkers for type 1 diabetes in the mouse model
  1085. Sudden death of a 15-year-old girl due to fulminant type 1 diabetes mellitus—Diabetic ketoacidosis induced cerebral edema?
  1086. Pak3 promotes cell cycle exit and differentiation of β-cells in the embryonic pancreas and is necessary to maintain glucose homeostasis in adult mice
  1087. Temporal induction of immunoregulatory processes coincides with age-dependent resistance to viral-induced type 1 diabetes
  1088. N-terminal additions to the WE14 peptide of chromogranin A create strong autoantigen agonists in type 1 diabetes
  1089. Activated macrophages create lineage-specific microenvironments for pancreatic acinar-and β-cell regeneration in mice
  1090. Peptide immunotherapies in Type 1 diabetes: lessons from animal models
  1091. The role of interferon alpha in initiation of type I diabetes in the NOD mouse
  1092. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6. 2-mediated Th17 bias
  1093. PTGS-2–PTGER2/4 Signaling Pathway Partially Protects From Diabetogenic Toxicity of Streptozotocin in Mice
  1094. Regeneration of pancreatic b‑cells on streptozotocin induced diabetic rats under the effect of Swietenia macrophylla seeds
  1095. Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor
  1096. Can we vaccinate against Type 1 diabetes?
  1097. Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes
  1098. Antihyperglycemic activity and antidiabetic effect of methyl caffeate isolated from Solanum torvum Swartz. fruit in streptozotocin induced diabetic rats
  1099. Do β-cells generate peroxynitrite in response to cytokine treatment?
  1100. Regeneration and DNA demethylation do not trigger PDX-1 expression in rat hepatocytes
  1101. Morphological changes and Antihyperglycemic effect of M. champaca leaves extract on Beta-cell in alloxan induced diabetic rats
  1102. Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves’ disease but not with rheumatoid arthritis in Russian population
  1103. Articles in PresS. Am J Physiol Endocrinol Metab (January 28, 2014). doi: 10.1152/ajpendo. 00681.2013
  1104. Early childhood infections and the risk of islet autoimmunity: the diabetes Autoimmunity Study in the Young (DAISY)
  1105. Antidiabetic efficacy of bradykinin antagonist R-954 on glucose tolerance test in diabetic type 1 mice
  1106. Imaging the pancreas: new aspects on lobular development and adult constitution
  1107. CCR7 directs the recruitment of T cells into inflamed pancreatic islets of nonobese diabetic (NOD) mice
  1108. Effects of Caffeic Acid Phenethyl Ester As anti-diabetic Therapy on Induced Immunoregulated Type 1 diabetes in Mice
  1109. Historical perspective: beginnings of the β-cell: current perspectives in β-cell development
  1110. Investigation of CTLA-4-318C/T gene polymorphism in cases with type 1 diabetes of Azerbaijan, Northwest Iran
  1111. Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development
  1112. Study on genetic variance of miR-541 in type 1 diabetes
  1113. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: viruses, autoimmunity and immunoregulation
  1114. Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice
  1115. Discovery of Molecular Pathways Mediating 1,25-Dihydroxyvitamin D3 Protection Against Cytokine-Induced Inflammation and Damage of Human and Male Mouse …
  1116. Enteroviruses, hygiene and type 1 diabetes: toward a preventive vaccine
  1117. Fermented ginseng protects streptozotocin‐induced damage in rat pancreas by inhibiting nuclear factor‐κB
  1118. Effect of chronic noise stress on serum glucose and lipids and morphology of Langerhans islets in neonatal rats
  1119. Obestatin enhances in vitro generation of pancreatic islets through regulation of developmental pathways
  1120. Rhinacanthus nasutus ameliorates cytosolic and mitochondrial enzyme levels in streptozotocin-induced diabetic rats
  1121. Toll-like receptors and type 1 diabetes
  1122. Immunotherapy for T1DM—targeting innate immunity
  1123. Associations between two polymorphisms (FokI and BsmI) of vitamin D receptor gene and type 1 diabetes mellitus in Asian population: a meta-analysis
  1124. Type 1 diabetes and gut microbiota: Friend or foe?
  1125. Pathogenic and regulatory T cells in type 1 diabetes: losing self-control, restoring it, and how to take the temperature
  1126. Is autoimmune diabetes caused by aberrant immune activity or defective suppression of physiological self-reactivity?
  1127. Insulin rescues impaired spermatogenesis via the hypothalamic-pituitary-gonadal axis in Akita diabetic mice and restores male fertility
  1128. Increased GABAA channel subunits expression in CD8+ but not in CD4+ T cells in BB rats developing diabetes compared to their congenic littermates
  1129. Proteomic analysis of plasma proteins in diabetic rats by 2D electrophoresis and MALDI-TOF-MS
  1130. The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity
  1131. Endocrine and metabolic aspects of the Wolfram syndrome
  1132. Targeting CD44 augments the efficacy of Tregs in autoimmune diabetes
  1133. Tolerance induction using Ag-ECDI-PLGA prevents autoimmunity in the BDC2. 5 AT model for T1D (P5208)
  1134. Brugia malayi soluble and excretory‐secretory proteins attenuate development of streptozotocin‐induced type 1 diabetes in mice
  1135. Molecular analysis of innate immunity in type 1 diabetes
  1136. Normal glucagon signaling and β-cell function after near-total α-cell ablation in adult mice
  1137. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice
  1138. Manipulation of CD98 resolves type 1 diabetes in nonobese diabetic mice
  1139. Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes
  1140. RNase L contributes to experimentally induced type I diabetes onset in mice
  1141. Research resource: dkCOIN, the National Institute of diabetes, Digestive and Kidney Diseases (NIDDK) consortium interconnectivity network: a pilot program to …
  1142. Thymic development of insulin reactive T cells (BA11P. 128)
  1143. Transduced Tat-glyoxalase protein attenuates streptozotocin-induced diabetes in a mouse model
  1144. Enhanced islet expansion by β‐cell proliferation in young diabetes‐prone rats fed a protective diet
  1145. Conditional meta-analysis stratifying on detailed HLA genotypes identifies a novel type 1 diabetes locus around TCF19 in the MHC
  1146. Interferon and interferon‐inducible gene activation in patients with Type 1 diabetes
  1147. Lactobacillus johnsonii N6.2 Mitigates the Development of Type 1 diabetes in BB-DP Rats
  1148. TAP1 I333V gene polymorphism and type 1 diabetes mellitus: a meta‐analysis of 2248 cases
  1149. Hypoglycemic effect of polysaccharides produced by submerged mycelial culture of Laetiporus sulphureus on streptozotocininduced diabetic rats
  1150. On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes
  1151. Oral ingestion of Capsaicin, the pungent component of chili pepper, enhances a discreet population of macrophages and confers protection from autoimmune …
  1152. A distinct role of CD4+ Th17-and Th17-stimulated CD8+ CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis
  1153. First presentation of diabetes as diabetic ketoacidosis in a case of Friedreich’s ataxia
  1154. Milk A1 and A2 peptides and diabetes
  1155. Plasma high sensitivity C-reactive protein and its relationship with cytokine levels in children with newly diagnosed type 1 diabetes and ketoacidosis
  1156. Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+ CD25+ regulatory T cell function
  1157. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes
  1158. A Distinct Role of CD4+ Th17- and Th17-Stimulated CD8+ CTL in the Pathogenesis of Type 1 diabetes and Experimental Autoimmune Encephalomyelitis
  1159. Viral infection prevents diabetes by inducing regulatory T cells through NKT cell–plasmacytoid dendritic cell interplay
  1160. Islet antigen-specific T cells and regulatory T cells in type 1 diabetes
  1161. The role of IL-22 produced by Th17 cells in Type 1 diabetes
  1162. IL-7 uniquely maintains Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization (115.10)
  1163. Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of disease
  1164. Hypoglycemic and antihyperglycemic effects of different extracts and combinations of Withania coagulans Dunal and Acacia arabica Lamk in Normal and …
  1165. The interplay between the gut microbiota and the immune system in the mechanism of type 1 diabetes
  1166. Type 1 diabetes in BioBreeding rats is critically linked to an imbalance between Th17 and regulatory T cells and an altered TCR repertoire
  1167. Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis
  1168. Multiple mechanisms involved in diabetes protection by lipopolysaccharide in non-obese diabetic mice
  1169. Skeletal muscle contractile functions in streptozotocin induced type 1 diabetes mellitus
  1170. In vivo reprogramming of Sox9+ cells in the liver to insulin-secreting ducts
  1171. Unconventional recognition of peptides by T cells and the implications for autoimmunity
  1172. Effects of physiological quercetin metabolites on interleukin-1β-induced inducible NOS expression
  1173. Anti-diabetic activity of aqueous extract of Cochlospermum planchonii root in alloxan-induced diabetic rats
  1174. Infant feeding in relation to islet autoimmunity and type 1 diabetes in genetically susceptible children: the MIDIA Study
  1175. A novel concept for tolerization of diabetogenic CD4+ T cells by intranasal treatment with CTA1R7K-peptide-DD (THER6P. 859)
  1176. Interleukin-18 promoter-607 C/A and-137 G/C polymorphisms and susceptibility to type 1 diabetes: A meta-analysis
  1177. Expression of Ins1 and Ins2 genes in mouse fetal liver
  1178. Evaluation of antidiabetic and antioxidative effect of seed of Eeugenia jambolana in streptozotocin induced diabetic male rat
  1179. Genetic inducible fate mapping in larval zebrafish reveals origins of adult insulin-producing β-cells
  1180. An islet-specific pulse of TGF-β abrogates CTL function and promotes β cell survival independent of Foxp3+ T cells
  1181. Out of the F-box: reawakening the pancreas
  1182. In vivo anti-hyperglycemic activity of saliva extract from the tropical leech Hirudinaria manillensis
  1183. Inducible regulatory T cells (iTregs) from recent-onset type 1 diabetes subjects show increased in vitro suppression and higher ITCH levels compared with controls
  1184. Collection protocol for human pancreas
  1185. Antibody-dependent enhancement of coxsackievirus-b infection: role in the pathogenesis of Type 1 diabetes
  1186. Galectin-1 synthesis in type 1 diabetes by different immune cell types: Reduced synthesis by monocytes and Th1 cells
  1187. The putative role of proteolytic pathways in the pathogenesis of Type 1 diabetes mellitus: the ‘autophagy’hypothesis
  1188. A critical update on the immunopathogenesis of Stiff Person Syndrome
  1189. ABOUT A PROPHYLAXIS AND TREATMENT OF TYPE 1 diabetes USING DOT METHOD
  1190. IFIH1 gene polymorphisms in type 1 diabetes: genetic association analysis and genotype-phenotype correlation in Chinese Han population
  1191. Low‐cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C‐peptide
  1192. TNF receptor 1 deficiency increases regulatory T cell function in nonobese diabetic mice
  1193. Association of the interleukin‑18‑137 C/G,‑607 A/C polymorphisms with type 1 diabetes: A meta‑analysis
  1194. Effect of CXCL10 receptor antagonist on islet cell apoptosis in a type I diabetes rat model
  1195. Hygiene hypothesis and autoimmune diseases
  1196. The role of synaptogenic synaptic adhesion molecules in insulin secretion
  1197. The intestinal microbiome: relationship to type 1 diabetes
  1198. Apoptosis, senescence, and autophagy in rat nucleus pulposus cells: implications for diabetic intervertebral disc degeneration
  1199. Functional specialization of islet dendritic cell subsets
  1200. Antibodies recognizing specific Mycobacterium avium subsp. paratuberculosis’s MAP3738c protein in type 1 diabetes mellitus children are associated with serum Th1 …
  1201. Ethanolic leaf extract of Vernonia amygdalina improves islet morphology and upregulates pancreatic G6PDH activity in streptozotocin-induced diabetic Wistar …
  1202. Novel biomarkers in type 1 diabetes
  1203. Antidiabetic potential of salvianolic acid B in multiple low-dose streptozotocin-induced diabetes
  1204. PD‐L1 blockade overrides Salmonella typhimurium‐mediated diabetes prevention in NOD mice: No role for Tregs
  1205. Anti-diabetic actions of carbon monoxide-releasing molecule (CORM)-A1: Immunomodulation and regeneration of islet beta cells
  1206. Differentiation potential of mouse embryonic stem cells into insulin producing cells in pancreatic islet microenvironment
  1207. Enhanced insulin clearance in mice lacking TRPM8 channels
  1208. Recovery from diabetes in neonatal mice after a low-dose streptozotocin treatment
  1209. Regulation of type 1 diabetes, tuberculosis, and asthma by parasites
  1210. Bacille Calmette–Guérin/DNAhsp65 prime-boost is protective against diabetes in non-obese diabetic mice but not in the streptozotocin model of type 1 diabetes
  1211. Early milestones in glucagon research
  1212. Recognition of Ii-Key/MHC class II epitope hybrids derived from proinsulin and GAD peptides by T cells in type 1 diabetes
  1213. A single base-pair deletion in the WFS1 gene causes Wolfram syndrome
  1214. Antidiabetic activity of alcoholic stem extract of Gymnema montanum in streptozotocin-induced diabetic rats
  1215. Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic …
  1216. A maternal gluten-free diet reduces inflammation and diabetes incidence in the offspring of NOD mice
  1217. The H1-receptor antagonist Cetirizine protects partially against cytokine-and hydrogen peroxide–induced β-TC6 cell death in vitro
  1218. β‐Casomorphin‐7 Cause Decreasing in Oxidative Stress and Inhibiting NF‐κB‐iNOS‐NO Signal Pathway in Pancreas of diabetes Rats
  1219. Distribution of C-peptide and its determinants in North American children at risk for type 1 diabetes
  1220. Interrelationships between the pancreas and the thyroid
  1221. NKG2D blockade facilitates diabetes prevention by antigen-specific Tregs in a virus-induced model of diabetes
  1222. Cyclic GMP kinase I modulates glucagon release from pancreatic α-cells
  1223. Anti-diabetic effect of Wen-pi-tang-Hab-Wu-ling-san extract in streptozotocin-induced diabetic rats
  1224. Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism
  1225. Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based …
  1226. Hypoglycemic activity and potential mechanism of a polysaccharide from the loach in streptozotocin-induced diabetic mice
  1227. … insulin secretion in pancreas-specific signal transducer and activator of transcription-3 knockout mice are associated with microvascular alterations in the pancreas
  1228. An innate triple hit initiates diabetes
  1229. Type 1 diabetes mellitus in a patient with homozygous sickle cell anemia
  1230. Blockade but Not Overexpression of the Junctional Adhesion Molecule C Influences
  1231. Parp1 deficient mice are protected from streptozotocin-induced diabetes but not caerulein-induced pancreatitis, independent of the induction of Reg family genes
  1232. pancreatic duodenal homeobox 1 protein is a novel β-cell-specific autoantigen for type I diabetes
  1233. Case-control analysis of the ERAP1 polymorphism rs30187 in Italian type 1 diabetes mellitus patients
  1234. Relationship between vitamin D during perinatal development and health
  1235. Ptpn22 silencing in the NOD model of type 1 diabetes indicates the human susceptibility allele of PTPN22 is a gain-of-function variant
  1236. B‐1 cells produce insulin and abrogate experimental streptozotocin‐induced diabetes
  1237. NOX2 deficiency protects against streptozotocin-induced β-cell destruction and development of diabetes in mice
  1238. MDA5 and MAVS mediate type I interferon responses to coxsackie B virus
  1239. Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients
  1240. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes
  1241. Improvement of biochemical parameters in type 1 diabetic rats after the roots aqueous extract of yacon [Smallanthus sonchifolius (Poepp. & Endl.)] treatment
  1242. CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L
  1243. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope
  1244. Immunomodulatory effects of environmental endocrine disrupting chemicals
  1245. Idd9.1 Locus Controls the Suppressive Activity of FoxP3+CD4+CD25+ Regulatory T-Cells
  1246. Pam3CSK4 enhanced beta cell loss and diabetogenesis: the roles of IFN-gamma and IL-17
  1247. Role of the phospatase LYP in T cell fuction: clinical, molecular and immunological correlates in a cohort of children affected by type 1 diabetes
  1248. The vitamin D system is deregulated in pancreatic diseases
  1249. T cell populations in the pancreatic lymph node naturally and consistently expand and contract in NOD mice as disease progresses
  1250. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection
  1251. Open Access Scientific Reports
  1252. Thymoquinone enhances the activities of enzymes related to energy metabolism in peripheral leukocytes of diabetic rats
  1253. Differential effects of HNF-1α mutations associated with familial young-onset diabetes on target gene regulation
  1254. Serum metabolite signature predicts the acute onset of diabetes in spontaneously diabetic congenic BB rats
  1255. α-Galactosylceramide ameliorates autoimmune diabetes in non-obese diabetic mice through a suppressive effect mediated by CD8+ T cells
  1256. Impact of milk derived β-casomorphins on physiological functions and trends in research: a review
  1257. Isolation of antidiabetic principle from fruit rinds of Punica granatum
  1258. Helminth infections: therapeutic potential in autoimmune disorders
  1259. Genome–virome interactions: examining the role of common viral infections in complex disease
  1260. Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes
  1261. Secreted Proteins from the Helminth Fasciola hepatica Inhibit the Initiation of Autoreactive T Cell Responses and Prevent diabetes in the NOD Mouse
  1262. Experimental encephalomyocarditis virus infection in small laboratory rodents
  1263. Cerebrum malformation in offspring of diabetic mothers
  1264. The levels of circulating TRAIL at the onset of type 1 diabetes are markedly decreased in patients with ketoacidosis and with the highest insulin requirement
  1265. Gut-pancreatic axis AMPlified in islets of langerhans
  1266. Peripherin-reactive antibodies in mouse, rabbit, and human blood
  1267. A novel single nucleotide polymorphism in the protein tyrosine phosphatase N22 gene (PTPN22) is associated with Type 1 diabetes in a Chinese population
  1268. Beyond HLA-A* 0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes
  1269. Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets
  1270. EFFECT of Aloe vera EXTRACT TO THE INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) LEVELS FROM VISCERAL FAT TISSUE IN Rattus norvegicus WISTAR …
  1271. Inference of gene networks from time series expression data and application to type 1 diabetes
  1272. Cooperative ‘bots’ don’t need a boss
  1273. Antigen recognition in the islets changes with progression of autoimmune islet infiltration
  1274. Virus-Related diabetes in Cattle
  1275. Anti-diabetic and haematological effects of n-butanol fraction of Alchornea cordifolia leaf extract in streptozotocin-induced diabetic wistar rats
  1276. Epigallocatechin-3-gallate modulates anti-oxidant defense enzyme expression in murine submandibular and pancreatic exocrine gland cells and human HSG cells
  1277. Synthesis of diosgenin-ibuprofen derivatives and their activities against insulin-dependent diabetes mellitus
  1278. Genetic Testing of Newborns for Type 1 diabetes Susceptibility–The MIDIA Study
  1279. Immunotargeting of insulin reactive CD8 T cells to prevent diabetes
  1280. The protective effects of Ziziphus vulgaris L. fruits on biochemical and histological abnormalities induced by diabetes in rats
  1281. Mitochondrial proteome analysis reveals depression of the Ndufs3 subunit and activity of complex I in diabetic rat brain
  1282. Genetic deletion of granzyme B does not confer resistance to the development of spontaneous diabetes in non-obese diabetic mice
  1283. Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis
  1284. Previous contact with Strongyloides venezuelensis contributed to prevent insulitis in MLD-STZ diabetes
  1285. HLA-DR* 0401 expression in the NOD mice prevents the development of autoimmune diabetes by multiple alterations in the T-cell compartment
  1286. Development of a multipurpose time-resolved fluorescence immunoassay for rat insulin
  1287. Cardiac energy metabolism and oxidative stress biomarkers in diabetic rat treated with resveratrol
  1288. Elevated IFN-alpha/beta levels in a streptozotocin-induced type I diabetic mouse model promote oxidative stress and mediate depletion of spleen-homing CD8+ T …
  1289. Regenerating gene Iα is a biomarker for diagnosis and monitoring of celiac disease: a preliminary study
  1290. Analysis of multifocal electroretinograms from a population with type 1 diabetes using partial least squares reveals spatial and temporal distribution of changes to …
  1291. Self-glycolipids modulate dendritic cells changing the cytokine profiles of committed autoreactive T cells
  1292. Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model
  1293. The Perfect Storm?
  1294. Anti-diabetic property and phytochemical composition of aqueous and methanol extracts of buchholzia coriacea seeds in alloxan-induced diabetic rats
  1295. Antihyperglycemic and antioxidant activities of alcoholic extract of Commiphora mukul gum resin in streptozotocin induced diabetic rats
  1296. Chromatin remodeling resets the immune system to protect against autoimmune diabetes in mice
  1297. Zinc is the modulator of the calcium-dependent activation of post-translationally acting thiol-enzymes in autoimmune diseases
  1298. Interindividual glucose dynamics in different frequency bands for online prediction of subcutaneous glucose concentration in type 1 diabetic subjects
  1299. α4β7 integrin/MAdCAM-1 adhesion pathway is crucial for B cell migration into pancreatic lymph nodes in nonobese diabetic mice
  1300. γδ T cells recognize the insulin B: 9–23 peptide antigen when it is dimerized through thiol oxidation
  1301. NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis
  1302. Optimal T-cell receptor affinity for inducing autoimmunity
  1303. Study of polymorphisms in 4q27, 10p15, and 22q13 regions in autoantibodies stratified type 1 diabetes patients
  1304. Institutional Repository of Lund University
  1305. The role of Coxsakie virus in the development of type i diabetes mellitus
  1306. Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity
  1307. Enhanced anti-serpin antibody activity inhibits autoimmune inflammation in type 1 diabetes
  1308. Chapter III. Re-establishing Tolerance
  1309. pancreatic acinar-specific overexpression of Reg2 gene offered no protection against either experimental diabetes or pancreatitis in mice
  1310. Death waits for no man–does it wait for a virus? How enteroviruses induce and control cell death
  1311. T cell-driven initiation and propagation of autoimmune diabetes
  1312. Type 1 diabetes mellitus in mice increases hippocampal D-serine in the acute phase after streptozotocin injection
  1313. Contractile functions of slow and fast skeletal muscles in streptozotocin induced type 1 diabetic sprague dawley rats
  1314. CCL22-producing CD8α− myeloid dendritic cells mediate regulatory T cell recruitment in response to G-CSF treatment
  1315. The role of AIRE in human autoimmune disease
  1316. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice
  1317. Dose the C-Peptide Level Predict Remission Phase in Type 1 diabetes Mellitus Pediatric Patients Tawfeeq FR AL-Auqbi* Maan AJ Bahrani** Noor TT Al …
  1318. Development of autoimmune diabetes in the absence of detectable IL-17A in a CD8-driven virally induced model
  1319. To B or not to B—pathogenic and regulatory B cells in autoimmune diabetes
  1320. Distribution of insulin mRNA transcripts within the human body
  1321. HSP65 serves as an immunogenic carrier for a diabetogenic peptide P277 inducing anti-inflammatory immune response in NOD mice by nasal administration
  1322. Mathematical modeling of autoimmune disease
  1323. 1H NMR-based Metabonomic Analysis of Metabolic Changes in Streptozotocin-induced Diabetic Rats
  1324. Pharmacological evaluation of “Glyoherb”: A polyherbal formulation on streptozotocin-induced diabetic rats
  1325. Biochemical evaluation of antidiabetic and antioxidant potentials of Annona squamosa leaves extracts studied in STZ induced diabetic rats
  1326. Metabolic abnormalities in the pathogenesis of type 1 diabetes
  1327. Glucagon responses of isolated a cells to glucose, insulin, somatostatin, and leptin
  1328. Effect of red Hibiscus aqueous extract on alloxan-induced diabetes in adult male albino rats
  1329. Oral Administration of Recombinant Lactococcus lactis Expressing HSP65 and Tandemly Repeated P277 Reduces the Incidence of Type I diabetes in Non …
  1330. Investigation into mechanism of action of anti-diabetic activity of Emblica officinalis on streptozotocin induced type I diabetic rat
  1331. DC-SIGN polymorphisms are associated to type 1 diabetes mellitus
  1332. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs
  1333. Regulatory T cell phenotype and function 4 years after GAD–alum treatment in children with type 1 diabetes
  1334. D-Saccharic acid 1, 4-lactone protects diabetic rat kidney by ameliorating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via NF-κB and …
  1335. Linoleic and alpha linolenic acids ameliorate streptozotocin-induced diabetes in mice
  1336. Reduced deaf1 mRNA expression during STZ-induced diabetes mellitus inhibits foxp3+ regulatory T-cells differentiations in rat’ s pancreatic lymph nodes
  1337. Anti-diabetic effects of red rose flowers in streptozotocin-induced diabetic mice
  1338. Structural and functional characterization of a single-chain peptide–MHC molecule that modulates both naive and activated CD8+ T cells
  1339. Role of thirst and visual barriers in the differential behavior displayed by streptozotocin-treated rats in the elevated plus-maze and the open field test
  1340. Antidiabetic effect of Gymnema sylvestre in streptozotocin induced diabetes in rats
  1341. … and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets
  1342. Effect of Kombucha, a fermented black tea in attenuating oxidative stress mediated tissue damage in alloxan induced diabetic rats
  1343. MCS-18, a novel natural plant product prevents autoimmune diabetes
  1344. Anti-serpin antibody-mediated regulation of proteases in autoimmune diabetes
  1345. Analysis of modification of liver proteome in diabetic rats by 2d electrophoresis and MALDI-TOF-MS
  1346. TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice
  1347. Assessment of antidiabetic activity of the traditional indian ayurvedic formulation brahmi gritham in streptozotocin-induced diabetic rats
  1348. Viral triggers for autoimmunity: is the ‘glass of molecular mimicry’half full or half empty?
  1349. Pax4 is not essential for beta-cell differentiation in zebrafish embryos but modulates alpha-cell generation by repressing arx gene expression
  1350. Molecular pathway alterations in CD4 T-cells of nonobese diabetic (NOD) mice in the preinsulitis phase of autoimmune diabetes
  1351. Gender‐dimorphic regulation of DJ 1 and its interactions with metabolic proteins in streptozotocin‐induced diabetic rats
  1352. Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells
  1353. Naturally occurring anthraquinones: chemistry and therapeutic potential in autoimmune diabetes
  1354. Development of a luciferase-based system for the detection of ZnT8 autoantibodies
  1355. Application of Robust Fixed Point control in case of T1DM
  1356. Protective effect of hedgehog signaling on cytokine-induced cytotoxicity in pancreatic beta-cells
  1357. Variable immune cell frequencies in peripheral blood of LEW.1AR1-iddm rats over time compared to other congenic LEW strains
  1358. Vitamin D status in diabetic Egyptian children and adolescents: a case–control study
  1359. The application of a model of glucose and insulin dynamics to explain an observed effect of leptin administration in reversal of developmental programming
  1360. Evaluation of the Antiradical Activity of Schisandra Chinensis Lignans Using Different Experimental Models
  1361. Formulation and Evaluation of Herbal Anti-diabetic Formulation Containing Eugenia Jambolana, Gymnema Sylvestre, Tinospora Cordifolia, Pterocarpus Marscipum …
  1362. Iridoid glucoside attenuates hyperglycemia-mediated oxidative stress and thyroid hormone function in streptozotocin–induced diabetic rats
  1363. Insulin in the brain: sources, localization and functions
  1364. RAE1ε ligand expressed on pancreatic islets recruits NKG2D receptor-expressing cytotoxic T cells independent of T cell receptor recognition
  1365. New approaches for predicting T cell–mediated drug reactions: A role for inducible and potentially preventable autoimmunity
  1366. dsAAV8-mediated gene transfer and β-cell expression of IL-4 and β-cell growth factors are capable of reversing early-onset diabetes in NOD mice
  1367. Antidiabetic activity of aqueous bark extract of Cassia glauca in streptozotocin-induced diabetic rats
  1368. A subset of interleukin-21+ chemokine receptor CCR9+ T helper cells target accessory organs of the digestive system in autoimmunity
  1369. The prophylactic role of D-saccharic acid-1, 4-lactone against hyperglycemia-induced hepatic apoptosis via inhibition of both extrinsic and intrinsic pathways in …
  1370. Mechanisms of beta cell dysfunction associated with viral infection
  1371. The effect of glutathione treatment on the biochemical and immunohistochemical profile in streptozotocin-induced diabetic rats
  1372. The link between psychological stress and autoimmune response in children
  1373. Comparative Hypoglycemic Property of Aqueous and Ethanolic Extracts of Viscum album (Mistletoe) and Their Effects on Body and Organ Weights of Diabetic …
  1374. Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity
  1375. CTLA 4+ 49G allele associates with early onset of type 1 diabetes in North Indians
  1376. N-terminal segment of proinsulin C-peptide active in insulin interaction/desaggregation
  1377. Regulation of GAD65 expression by SMAR1 and p53 upon Streptozotocin treatment
  1378. Antihyperglycemic activity of Mangifera indica Linn. in alloxan induced diabetic rats
  1379. No association between vitamin D and β‐cell autoimmunity in Finnish and Estonian children
  1380. Effect of Persian shallot (Allium hirtifolium Boiss.) extract on glucokinase (GCK), glycogen phosphorylase and phosphoenolpyruvate carboxykinase (PEPCK) …
  1381. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds
  1382. Antidiabetic and antihyperlipidemic activity of ethyl acetate: isopropanol (1: 1) fraction of Vernonia anthelmintica seeds in streptozotocin induced diabetic rats
  1383. The role of cell plasticity in tissue repair: adaptive cellular reprogramming
  1384. The renaissance of Ca2+-binding proteins in the nervous system: secretagogin takes center stage
  1385. Comparative efficacy of stevia leaf (stevia rebaudiana bertoni), methi seeds (trigonella foenum-graecum) and glimepiride in streptozotocin induced rats
  1386. Tolerant anti-insulin B cells are effective APCs
  1387. Effect of dietary gluten on dendritic cells and innate immune subsets in BALB/c and NOD mice
  1388. Reduced numbers of dendritic cells with a tolerogenic phenotype in the prediabetic pancreas of NOD mice
  1389. Susceptibility influence of a PTPN22 haplotype with thyroid autoimmunity in Koreans
  1390. Altered Islet Morphology but Normal Islet Secretory Function In Vitro in a Mouse Model with Microvascular Alterations in the Pancreas
  1391. Expression of insulin-like growth factor-1 by canine insulinomas and their metastases
  1392. Neuronostatin inhibits glucose-stimulated insulin secretion via direct action on the pancreatic α-cell
  1393. Anti-diabetic activity of Lagenaria siceraria pulp and seed extract in normal and alloxan-induced diabetic rats
  1394. Dendritic cells transduced to express interleukin 4 reduce diabetes onset in both normoglycemic and prediabetic nonobese diabetic mice
  1395. Low expression of CD39+/CD45RA+ on regulatory T cells (Treg) cells in type 1 diabetic children in contrast to high expression of CD101+/CD129+ on Treg cells …
  1396. Galectin‐3 deficiency protects pancreatic islet cells from cytokine‐triggered apoptosis in vitro
  1397. A multidisciplinary guided practical on type I diabetes engaging students in inquiry-based learning
  1398. In vitro inhibitory activity of Atuna racemosa, Euphorbia hirta and Diplazium esculentum juices against α-amylase and α-glucosidase
  1399. IL-15 promotes regulatory T cell function and protects against diabetes development in NK-depleted NOD mice
  1400. Taurine ameliorate alloxan induced oxidative stress and intrinsic apoptotic pathway in the hepatic tissue of diabetic rats
  1401. Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice
  1402. Polymorphism in the innate immune receptor SIRPα controls CD47 binding and autoimmunity in the nonobese diabetic mouse
  1403. Natural isothiocyanates: genotoxic potential versus chemoprevention
  1404. Cataract as a Phenotypic Marker for a Mutation in WFS1, the Wolfram Syndrome Gene
  1405. Glycemic control and anti-osteopathic effect of propolis in diabetic rats
  1406. Novel diabetes mellitus treatment: mature canine insulin production by canine striated muscle through gene therapy
  1407. Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats
  1408. Gene/environment interactions in the pathogenesis of autoimmunity: new insights on the role of Toll-like receptors
  1409. Antihyperglycemic and hypolipidemic effects of methanolic extract of Euphorbia prostrata on alloxan induced induced diabetic rabbits
  1410. A Human CD4 T Cell-Mediated Model of Insulitis in the HLA-DR4-positive Transgenic Mouse
  1411. The pathogenicity of self-antigen decreases at high levels of autoantigenicity: a computational approach
  1412. GATA4 and GATA6 control mouse pancreas organogenesis
  1413. Injections of Insulin in Pig Tissue Visualized by µCT
  1414. Transcriptional activation of Reg2 and Reg3β genes by glucocorticoids and interleukin-6 in pancreatic acinar and islet cells
  1415. The IL-2 diphtheria toxin fusion protein denileukin diftitox modulates the onset of diabetes in female nonobese diabetic animals in a time-dependent manner and …
  1416. Protective Effects and Its Relative Mechanisms of Low Dose Ionizing Radiation on pancreatic cells of Male Diabetic Rat’s
  1417. Novel monoclonal antibodies against Pdx1 reveal feedback regulation of Pdx1 protein levels
  1418. Selective cognitive and psychiatric manifestations in Wolfram Syndrome
  1419. Leptin deficiency causes insulin resistance induced by uncontrolled diabetes
  1420. PTPN22 controls virally-induced autoimmune diabetes by modulating cytotoxic T lymphocyte responses in an epitope-specific manner
  1421. Hypoglycaemic and anti-diabetic activity of stem bark extracts Erythrina indica in normal and alloxan-induced diabetic rats
  1422. Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cells
  1423. Vitamin D and pregnancy
  1424. Methylmalonic acidemia mimicking diabetic ketoacidosis in an infant
  1425. Islet-associated T-cell receptor-β CDR sequence repertoire in prediabetic NOD mice reveals antigen-driven T-cell expansion and shared usage of VβJβ TCR chains
  1426. Nkx2. 2 activates the ghrelin promoter in pancreatic islet cells
  1427. Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma
  1428. Identifying a Possible Link between Ectopic Germinal Centers and the Evolution of Type I diabetes
  1429. Hagedorn Research Institute, Department of Beta-cell Regeneration, Gentofte, Denmark; 2 Novo Nordisk A/S, Department of Antibody Technology, Måløv …
  1430. Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma
  1431. Reversal of autoimmunity by boosting memory-like autoregulatory T cells
  1432. Neural tube alteration in fetuses of diabetic rats
  1433. Patient‐related risk factors for implant therapy. A critique of pertinent literature
  1434. Interleukin-7: fuel for the autoimmune attack
  1435. Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2
  1436. IgA deficiency: what is new?
  1437. Hyperglycaemia alters thymic epithelial cell function
  1438. ST2 gene-deletion reveals a role of Foxp3+ regulatory T cells in diabetes modulation in BALB/c mice
  1439. Type I interferon in organ-targeted autoimmune and inflammatory diseases
  1440. Antagonistic Salubrious Effects of Macerated Allium Sativum (garlic) on Cytoarchitectural Alterations in the Pancreas of Alloxan Induced Diabetic Rats.
  1441. Research Article Isolation of Antidiabetic Principle from Fruit Rinds of Punica granatum
  1442. Synthesis, characterization and anti-diabetic activity of 1, 3, 5-triaryl-2-pyrazolines in acetic acid solution under ultrasound irradiation
  1443. Molecular sport nutrition
  1444. Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3
  1445. A Jekyll and Hyde profile: type 1 interferon signaling plays a prominent role in the initiation and maintenance of a persistent virus infection
  1446. Beta cells transfer vesicles containing insulin to phagocytes for presentation to T cells
  1447. pancreatic T cell protein-tyrosine phosphatase deficiency ameliorates cerulein-induced acute pancreatitis
  1448. Crosstalk between the developing pancreas and its blood vessels: an evolving dialog
  1449. Molecular mimicry
  1450. Effect of Honey Bee Venom (Apis mellifera) on Hyperglycemia and Hyperlipidemia in Alloxan Induced Diabetic Rabbits. J diabetes Metab 6: 507. doi: 10.4172 …
  1451. Insulin dosage optimization based on prediction of postprandial glucose excursions under uncertain parameters and food intake
  1452. Advances in Biomedicine and Pharmacy
  1453. Protective role of D-saccharic acid-1, 4-lactone in alloxan induced oxidative stress in the spleen tissue of diabetic rats is mediated by suppressing mitochondria …
  1454. The Impact of Microbiome Alterations in the NOD Mouse Model of Type 1 diabetes
  1455. The Impact of Microbiome Alterations in the NOD Mouse Model of Type 1 diabetes
  1456. Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an …
  1457. Streptozotocin induced activation of oxidative stress responsive splenic cell signaling pathways: protective role of arjunolic acid
  1458. On data-driven multistep subspace-based linear predictors
  1459. AUTHOR CONTRIBUTIONS 15 ASS, MME, WKS, JAC, and GLCY designed the experiments and interpreted the data. 16 ASS, MME, WKS, and GLCY performed the …
  1460. Chapter I. Pathogenesis
  1461. Targeting of a T cell agonist peptide to lysosomes by DNA vaccination induces tolerance in the nonobese diabetic mouse
  1462. Characterization of the antidiabetic role of Parkinsonia aculeata (Caesalpineaceae)
  1463. Male and female NOD mice differentially express peroxisome proliferator-activated receptors and pathogenic cytokines
  1464. Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats
  1465. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory …
  1466. Exposure to the viral by-product dsRNA or Coxsackievirus B5 triggers pancreatic beta cell apoptosis via a Bim/Mcl-1 imbalance
  1467. Effect of nicotinamide on amino acids content in bone collagen depending on biological availability of vitamins in diabetic rats
  1468. Amadori-glycated phosphatidylethanolamine, a potential marker for hyperglycemia, in streptozotocin-induced diabetic rats
  1469. Promotion and prevention of autoimmune disease by CD8+ T cells
  1470. Antihyperglycemic, antihyperlipidemic, and renoprotective effects of Chlorella pyrenoidosa in diabetic rats exposed to cadmium
  1471. Cognitive and developmental outcome of conservatively treated children with congenital hyperinsulinism
  1472. The effect of methanolic extract of Otostegia persica on serum glucose level and renal function indicators in streptozotocin induced diabetic rats
  1473. Results in Immunology
  1474. The gut, immunoregulation and micro‐organisms from man’s evolutionary past
  1475. Prevention and reversal of diabetes by all-trans retinoid acid and exendin-4 in NOD mice
  1476. Biochemical evaluation of anti diabetic activity of aqueous extract of Gmelina arborea in Alloxan induced albino rats
  1477. The Idd13 congenic interval defines the number of merocytic dendritic cells, a novel trait associated with autoimmune diabetes susceptibility
  1478. Forty-year-old diabetic lady with tightness in lower limbs
  1479. Postmortem chemistry update part I
  1480. miR-466 is putative negative regulator of Coxsackie virus and Adenovirus Receptor
  1481. Quercetin and ferulic acid aggravate renal carcinoma in long-term diabetic victims
  1482. Alcohol extract of Pterogyne nitens leaves fails to reduce severity of streptozotocin-induced diabetes in rats
  1483. Proteome and phytochemical analysis of Cynodon dactylon leaves extract and its biological activity in diabetic rats
  1484. Endocrine and metabolic responses to exercise
  1485. Leptin and Intermediary Metabolism: Focus on Glucoregulation and Lipids
  1486. CNTF protects MIN6 cells against apoptosis induced by Alloxan and IL-1β through downregulation of the AMPK pathway
  1487. Function and regulation of retinoic acid-inducible gene-I
  1488. Dual microfluidic perifusion networks for concurrent islet perifusion and optical imaging
  1489. Saffron (Crocus sativus L.) Powder as an Ingredient of Rye Bread: An Anti-Diabetic Evaluation
  1490. Attenuation of biochemical, haematological and histological indices of alloxan toxicity in male rats by aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem
  1491. Ferulic acid and derivatives: molecules with potential application in the pharmaceutical field
  1492. Effects of aqueous root extract of Treculia africana on blood glucose, lipid profile and body weight changes of streptozotocin-induced diabetic and normal rats
  1493. The hypoglycemic effect of the aqueous extract of the fruits of Balanites aegypticea in Alloxan-induced diabetic rats
  1494. SEL1L deficiency impairs growth and differentiation of pancreatic epithelial cells
  1495. Mathematical Analysis Of Insulin-Glucose Feedback System Of Diabeties
  1496. Implementation of Novel Group Delay Decomposition Method and Surgical Protocol for Assessing Peripheral Neuropathy
  1497. SOX9 protein induces a chondrogenic phenotype of mesangial cells and contributes to advanced diabetic nephropathy
  1498. A review on the formulation and analysis of anti-diabetic agent: gliclazide
  1499. Thermodynamic and structural determinants of differential Pdx1 binding to elements from the insulin and IAPP promoters
  1500. IL-1β Amplification of Nitric Oxide Production and Its Inhibitory Effects on Glucose Induced Early Growth Response-1 Expression in INS-1 Cells
  1501. Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection
  1502. Perspectives of the relationship between IL-7 and autoimmune diseases
  1503. Curative therapeutics take the stage
  1504. Low Cost Production Of Proinsulin In Tobacco And Lettuce Chloroplasts For Injectable Or Oral Delivery Of Functional Insulin And
  1505. Ebselen reduces hyperglycemia temporarily-induced by diazinon: A compound with insulin-mimetic properties
  1506. Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats
  1507. Lymphopenia-induced proliferation in aire-deficient mice helps to explain their autoimmunity and differences from human patients
  1508. Ultra-structural changes in cells from the CNS in offspring from diabetic rats
  1509. Zinc supplementation attenuates metallothionein and oxidative stress changes in kidney of streptozotocin-induced diabetic rats
  1510. EFFECTS OF NIGELLA SATIVA SEEDS POWDER IN BODY WEIGHT, INSULIN, C-PEPTIDES AND BLOOD INDICES IN ADULT DIABETIC MALE RATS
  1511. Post-traumatic diabetes and Graves-Basedow disease: Are these entities evidence based?
  1512. LCP1 up-regulated by partial pancreatectomy supports cell proliferation and differentiation
  1513. Spider venom components as drug candidates
  1514. AZADIRACHTA INDICA AND ITS ANTIDIABETIC POTENTIAL–A REVIEW
  1515. Oxidative stress status and lipid profiles of diabetic pregnant rats exposed to cigarette smoke
  1516. New insights into the signaling system and function of insulin in fish
  1517. Influence of treatment with quercetin on lipid parameters and oxidative stress of pregnant diabetic rats
  1518. Technologies for plasma membrane proteomics
  1519. Effects of insulin on CYP3A activity and nicardipine disposition in streptozotocin-induced diabetic rats
  1520. Can we vaccinate against depression?
  1521. Biomarkers for diagnosis and monitoring of celiac disease
  1522. Stiff person syndrome
  1523. Brain IL-6—Where Amylin and GLP-1 Antiobesity Signaling Congregate
  1524. Analysis of the repertoire of insulin-reactive CD8+ T cells
  1525. A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?
  1526. Anti-hyperglycemic activity of the leaves of Terminalia tomentosa against normal and alloxan induced diabetic rats
  1527. Intrinsic molecular factors cause aberrant expansion of the splenic marginal zone B cell population in nonobese diabetic mice
  1528. Frequency domain hammerstein model of glucose-insulin process in IDDM patient
  1529. Antidiabetic effects of air potatoes (Dioscorea bulbifera) on alloxan induced Diabetic rats
  1530. Vitamin D: a potential role in reducing suicide risk?
  1531. Transcriptional profiling reveals functional links between RasGrf1 and Pttg1 in pancreatic beta cells
  1532. EVALUATION OF ANTIDIABETIC, ANTIHYPERLIPIDEMIC AND ANTIOXIDANT ACTIVITIES OF THE METHANOLIC EXTRACT OF Bauhinia variegata AND …
  1533. Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice
  1534. Wound healing activity of Withania coagulans in streptozotocin-induced diabetic rats
  1535. Permanent Neonatal DM in Monozygotic Twins with p
  1536. Transient alteration of gene expression in adipose-derived stem cells using liposomal-driven protein extracts
  1537. Role of Interleukin 21 in CD4 T cell regulation
  1538. Notch 1 tumor expression is lacking in highly proliferative pancreatic neuroendocrine tumors
  1539. Poly-γ-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin
  1540. The effect of gestation and fetal mismatching on the development of autoimmune diabetes in non-obese diabetic mice
  1541. The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: insights from genomic-wide association studies
  1542. Clinical Profile and outcome of stress hyperglycemia in critically ill children
  1543. Mechanisms Of Cytokine-Induced Metabolic Dysfunction Of The pancreatic Beta-Cell
  1544. Development of memory-like autoregulatory CD8+ T cells is CD4+ T cell dependent
  1545. Therapeutic uses of somatostatin and its analogues: Current view and potential applications
  1546. Antihyperglycemic, antihyperlipidemic, and antioxidant effects of Chaenomeles sinensis fruit extract in streptozotocin-induced diabetic rats
  1547. Molecular analysis of persistent enterovirus infections.
  1548. Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic mice
  1549. Genetic disorders leading to hypoglycaemia
  1550. Any role for probiotics in the therapy or prevention of autoimmune diseases? Up-to-date review
  1551. In vitro cytokine profiles and viability of different human cells treated with whole cell lysate of Mycobacterium avium subsp. paratuberculosis
  1552. Anti-diabetic effects of Ganoderma lucidum
  1553. CD8+ CD122+ PD‐1− effector cells promote the development of diabetes in NOD mice
  1554. Functional diversity of laminins
  1555. Antihyperglycemic of Sargassum sp. extract
  1556. Optimal antisense target reducing INS intron 1 retention is adjacent to a parallel G quadruplex
  1557. T cell affinity regulates asymmetric division, effector cell differentiation, and tissue pathology
  1558. GPR41 gene expression is mediated by internal ribosome entry site (IRES)-dependent translation of bicistronic mRNA encoding GPR40 and GPR41 proteins
  1559. Involvement of autoimmunity to REG, a regeneration factor, in patients with primary Sjögren’s syndrome
  1560. Phytomedicines: safety and efficacy studies on Ghanaian medicinal plants
  1561. Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes
  1562. Regulation of cytokine-driven functional differentiation of CD8 T cells by suppressor of cytokine signaling 1 controls autoimmunity and preserves their proliferative …
  1563. The role of gut microbiota in immune homeostasis and autoimmunity
  1564. Anti-diabetic effect of Cyclo-His-Pro (CHP)-enriched yeast hydrolysate in streptozotocin-induced diabetic mice
  1565. Antidiabetic and safety of Lantana rhodesiensis in alloxan induced diabetic rats
  1566. Cytokine production profiles in chronic relapsing–remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack …
  1567. A possible primary cause of cancer: deficient cellular interactions in endocrine pancreas
  1568. Transdermal nanoemulsions of Foeniculum vulgare Mill. essential oil: Preparation, characterization and evaluation of antidiabetic potential
  1569. Role of gamma‐delta (γδ) T cells in autoimmunity
  1570. Reversing tolerance in isotype switch–competent anti-insulin B lymphocytes
  1571. Immune cell function in the Clec16a Knock-down Mouse
  1572. VP7 of Rhesus monkey rotavirus RRV contributes to diabetes acceleration in association with an elevated anti-rotavirus antibody response
  1573. Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats
  1574. ANTIDIABETIC, ANTIATHEROSCLEROTIC AND HEPATOPROTECTIVE PROPERTIES OF DECALEPIS HAMILTONII IN STREPTOZOTOCIN‐INDUCED DIABETIC …
  1575. NK Cells and Autoimmunity
  1576. Rescuing of deficient killing and phagocytic activities of macrophages derived from non-obese diabetic mice by treatment with geldanamycin or heat shock: potential …
  1577. Leptin in immuno-rheumatological diseases
  1578. Mitochondrial dynamics and mitochondrial quality control
  1579. The dual effects of B cell depletion on antigen-specific T cells in BDC2. 5NOD mice
  1580. Targeting Pink1-Parkin-mediated mitophagy for treating liver injury
  1581. Histopathological study of evening primrose oil effects on experimental diabetic neuropathy
  1582. Activation profile of dorsal root ganglia Iba-1 (+) macrophages varies with the type of lesion in rats
  1583. Physiological and pathological roles for MicroRNAs: implications for immunity complications
  1584. DNA methylation in the pathogenesis of autoimmunity
  1585. Blood glucose regulation in IDDM patient by H∞ control: An LMI approach
  1586. Peripheral gating of pain signals by endogenous lipid mediators
  1587. Selectin-mediated leukocyte trafficking during the development of autoimmune disease
  1588. Different toll-like receptor stimuli have a profound impact on cytokines required to break tolerance and induce autoimmunity
  1589. Human microbiome: when a friend becomes an enemy
  1590. Targeting miRNAs for drug discovery: a new paradigm
  1591. Sepsis-induced acute lung injury (ALI) is milder in diabetic rats and correlates with impaired NFkB activation
  1592. Annual Microbiology Research Retreat
  1593. Impact of glucocorticoids on insulin resistance in the critically ill
  1594. Modulation of neuropathic pain in experimental diabetes mellitus
  1595. Extracellular cell stress proteins as biomarkers of human disease
  1596. High levels of adenosine deaminase on dendritic cells promote autoreactive T cell activation and diabetes in nonobese diabetic mice
  1597. Enhanced burn wound healing through controlled and sustained delivery of bioactive insulin from alginate sponge dressings
  1598. Autophagy in health and disease. 5. Mitophagy as a way of life
  1599. Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities
  1600. Restriction of Rho signaling by the RhoGAP STARD13 integrates growth and morphogenesis in the pancreas
  1601. Anti diabetic and anti hyperlipidemic activities of different extract of Ailanthus malabarica stem bark in Alloxan-induced diabetic rats
  1602. The mitochondrial citrate carrier (CIC) is present and regulates insulin secretion by human male gamete
  1603. PACAP intraperitoneal treatment suppresses appetite and food intake via PAC1 receptor in mice by inhibiting ghrelin and increasing GLP-1 and leptin
  1604. Expression of biologically active TAT-fused recombinant islet transcription factors
  1605. Breakdown in repression of IFN-γ mRNA leads to accumulation of self-reactive effector CD8+ T cells
  1606. Application of Liquid Chromatography-Tandem Mass Spectrometry Techniques to the Study of Two Biological Systems
  1607. Disorders of glucose metabolism: post mortem analyses in forensic cases–part II
  1608. Lymphotoxin and TNF: how it all began—a tribute to the travelers
  1609. Mild gestational hyperglycemia in rat induces fetal overgrowth and modulates placental growth factors and nutrient transporters expression
  1610. NRXN1 deletions identified by array comparative genome hybridisation in a clinical case series–further understanding of the relevance of NRXN1 to …
  1611. Ligand transduction mechanisms of inwardly-rectifying potassium channels
  1612. The Calbindins: Calbindin-D28K and Calbindin-D9K and the Epithelial Calcium Channels TRPV5 and TRPV6
  1613. Plant-made oral vaccines evaluation of capsules
  1614. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas …
  1615. Biological Activities of Pepper Alkaloids 45
  1616. Sweet talk in the brain: glucosensing, neural networks, and hypoglycemic counterregulation
  1617. Cell signaling and receptors in toxicity of advanced glycation end products (AGEs): α-dicarbonyls, radicals, oxidative stress and antioxidants
  1618. Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice
  1619. Erythropoietin protects retinal cells in diabetic rats through upregulating ZnT8 via activating ERK pathway and inhibiting HIF-1α expression
  1620. Systemic activation of glutamate dehydrogenase increases renal ammoniagenesis: implications for the hyperinsulinism/hyperammonemia syndrome
  1621. Pharmacology in 7 days for medical students
  1622. Reovirus type-2–triggered autoimmune cholangitis in extrahepatic bile ducts of weanling DBA/1J mice
  1623. Osteoblasts, osteoclasts, and osteocytes: unveiling their intimate-associated responses to applied orthodontic forces
  1624. Altered hypothalamic protein expression in a rat model of Huntington’s disease
  1625. The forkhead transcription factor, FOXP3, is required for normal pituitary gonadotropin expression in mice
  1626. The hidden life of NAD+-consuming ectoenzymes in the endocrine system
  1627. Chronic maternal hyperglycemia induced during mid-pregnancy in rats increases RAGE expression, augments hippocampal excitability, and alters behavior of the …
  1628. ICA1L forms BAR-domain complexes with PICK1 and is crucial for acrosome formation in spermiogenesis
  1629. Gut glucose metabolism in rainbow trout: implications in glucose homeostasis and glucosensing capacity
  1630. Enter at your own risk: how enteroviruses navigate the dangerous world of pattern recognition receptor signaling
  1631. Ubiquitination-deubiquitination by the TRIM27-USP7 Complex Regulates TNF-α-induced Apoptosis
  1632. Autoantigen recognition is required for recruitment of IGRP206–214-autoreactive CD8+ T cells but is dispensable for tolerance
  1633. Dysregulation of thymic clonal deletion and the escape of autoreactive T cells
  1634. MOLECULAR AND BIOCHEMICAL MECHANISMS IN STREPTOZOTOCIN-INDUCED diabetes AND ASSOCIATED BEHAVIORAL INDICES
  1635. Modulation of macrophage function and immune response by a helminth-derived cysteine protease
  1636. Biosensors for diagnostic applications
  1637. Molecular and biochemical mechanisms in streptozotocin-induced diabetes and associated behavioral indices
  1638. Studies on peripheral tolerance in Aire deficient mice
  1639. Elicitation of T-cell responses by structural and non-structural proteins of coxsackievirus B4
  1640. Running Title: PACAP INTRAPERITONEAL TREATMENT SUPPRESSES APPETITE AND FOOD INTAKE VIA PAC1 RECEPTOR IN MICE, BY INHIBITING GHRELIN …
  1641. Hydrogen Sulfide and Neurogenic Inflammation in a Murine Model of Polymicrobial Sepsis
  1642. ERAP1 in the pathogenesis of ankylosing spondylitis
  1643. Neuroendocrine regulation of food intake
  1644. Dietary avocado oil supplementation attenuates the alterations induced by type I diabetes and oxidative stress in electron transfer at the complex II-complex III …
  1645. The SLC8 gene family of sodium–calcium exchangers (NCX)–Structure, function, and regulation in health and disease
  1646. Can diabetes I and early blindness be prevented using a tylenol combination which inhibits oxidative and nitrosative stress?
  1647. Comparative proximate composition and hypoglycemic properties of three medicinal plants (Verononia amygdalina, Azadirachta indica and Moringa oleifera)
  1648. The Role of MDA5 and TLR3 in Response to dsRNA and Viral Infection
  1649. Challenges for molecular magnetic resonance imaging
  1650. pancreatic Insufficiency
  1651. The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis
  1652. Interleukin-21: A Pleiotropic Mediator of Immunity and Inflammation with Broad Therapeutic Potential
  1653. Detecting and quantitating physiological endoplasmic reticulum stress
  1654. MODULATING EFFECT OF CAMEL’S MILK ON ALLOXAN-INDUCED EXPERIMENTAL diabetes IN LABORATORY ANIMAL MODEL
  1655. Corticotropin-releasing hormone exerts direct effects on neuronal progenitor cells: implications for neuroprotection
  1656. Pathophysiology of the hepoxilins
  1657. The Brisbane Systems Genetics Study: genetical genomics meets complex trait genetics
  1658. Hereditary 1, 25-dihydroxyvitamin-D-resistant rickets
  1659. Natural anti-insulin autoantibodies in cats: enzyme-linked immunosorbent assay for the determination of plasma anti-insulin IgG and its concentrations in domestic …
  1660. GABA receptors and the immune system
  1661. The role of IL-2-/IL-2r signaling for Treg cell development, homeostasis and function
  1662. Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential
  1663. Regulation of leukocyte-derived matrix metalloproteinases and azurophilic enzymes in human diabetic ketoacidosis
  1664. Simulating glycemic variability in critically ill burn patients
  1665. Influence of Male Hyperinsulinemia on IVF Outcome
  1666. Roles of c-Rel signalling in inflammation and disease
  1667. Energy metabolism in adult neural stem cell fate
  1668. Silymarin as a natural antioxidant: an overview of the current evidence and perspectives
  1669. Amylin stimulates fatty acid esterification in 3T3-L1 adipocytes
  1670. Effect of endurance exercise on the combination of streptoxotocin induced diabetes and doxorubicin
  1671. Investigating the effect of soluble BiP on human regulatory T cell frequency and function
  1672. POSTTRANSLATIONAL MODIFICATION OF COLLAGEN TYPE II
  1673. Posttranslational Modification of Collagen Type Ii: Effects on Antigen-Specific T-Cell Tolerance and Autoreactivity in Collagen-Induced Arthritis
  1674. Regulation of Insulin-and Insulin Receptor-Encoding mRNAS in Rainbow Trout, Oncorhynchus Mykiss
  1675. Kiss1 Neurons and Metabolic Sensing
  1676. Identification of key residues for the binding of glucagon to the N-terminal domain of its receptor: an alanine scan and modeling study
  1677. Role of Wnt signaling in heart disease
  1678. The zinc-sensing receptor, ZnR/GPR39: Signaling and significance
  1679. Selective and active targeting of neuropeptide Y receptors in experimental oncology: use of gold nanocages conjugated to short peptides
  1680. Low glucose sensitivity and polymodal chemosensing in neonatal rat adrenomedullary chromaffin cells
  1681. Targets and off-targets of kinase inhibitors in diabetes
  1682. Intestinal bacteria and probiotics: effects on the immune system and impacts on human health
  1683. The effects of centering in care on self-management of type II diabetes in medically underserved co-residing adults
  1684. The diabetogenic mouse MHC class II molecule IAg7 is endowed with a switch that modulates TCR affinity
  1685. Cytosolic Protein Phosphatases
  1686. The c-Rel transcription factor in development and disease
  1687. Effect of IL-22 on T cell-derived cytokine production
  1688. The effect of three dosages of supplemental vitamin D (400, 1000 and 2000 IU) on maternal and newborn 25-hydroxyvitamin D concentrations
  1689. Regulation of Human Carbonyl Reductase 3 (CBR3) Expression
  1690. The role of TGF-β1 signalling in peripheral CD4⁺ T cells
  1691. Fluorinated paramagnetic probes for 19-F and 1-H MRS/MRI
  1692. Molecular determinants of different gating mechanisms in inwardly-rectifying potassium channels
  1693. Detection and characterization of retinal disruption in mice using high angular resolution diffusion microscopy (HARDM)
  1694. The effect of ascorbic acid supplementation on brain oxidative events in experimental diabetes
  1695. ARGENTINE SOCIETY OF BIOLOGY
  1696. Study of T cell pathogenicity in central nervous system autoimmunity
  1697. Novel vitamin D compounds and skin cancer prevention
  1698. SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells
  1699. Signaling Cross-Talk Regulating the Expression of Arginase 1 in Murine Macrophages
  1700. Insights into the control of growth and axon guidance by the Drosophila insulin receptor
  1701. Predictors of vitamin D status in New Zealand adults and the effect of vitamin D2 and vitamin D3 supplementation on 25-hydroxyvitamin D and parathyroid hormone …
  1702. Identification of shared and distinct gene-disease associations among multiple related diseases and multiple subtypes of a disease
  1703. Use of the 5′ untranslated region and VP1 region to examine the molecular diversity in enterovirus B species
  1704. Neostigmine-induced contraction and nitric oxide-induced relaxation of isolated ileum from STZ diabetic guinea pigs
  1705. Localisation of equilibrative nucleoside transporter 3 (ENT3) in mouse brain
  1706. The role of GPR65 in T cell function and demyelinating autoimmune disease
  1707. Characterization of mitochondrial membrane proteins as novel components in mitochondrial dynamics
  1708. The role of the cytokines IL-17A and IL-33 in inflammatory arthritis and psoriasis
  1709. Neonatal Hypoglycaemia
  1710. Doing psychiatry wrong: A critical and prescriptive look at a faltering profession
  1711. Expression of CD47 in the pancreatic β‐cells of people with recent‐onset type 1 diabetes varies according to disease endotype
  1712. Potential Mimicry of Viral and pancreatic β Cell Antigens Through Non-Spliced and cis-Spliced Zwitter Epitope Candidates in Type 1 diabetes
  1713. Persistence of coxsackievirus B4 in pancreatic β cells disturbs insulin maturation, pattern of cellular proteins, and DNA methylation
  1714. Vitamin D induces autophagy of pancreatic β-cells and enhances insulin secretion
  1715. Formation of pancreatic β-cells from precursor cells contributes to the reversal of established type 1 diabetes
  1716. Cyclin D3 promotes pancreatic β cell fitness and viability in a cell cycle
  1717. eIF5A inhibition influences T cell dynamics in the pancreatic microenvironment of the humanized mouse model of Type 1 diabetes
  1718. IFN-γ activated sites in the survivin gene promoter region: the point of no return of cytokine-induced pancreatic β-cells death?
  1719. In vitro Analysis of Exocrine Pancreas Secretome on Islet Cell Phenotype–A Potential Therapy for Type 1 diabetes
  1720. The T1D-associated lncRNA Lnc13 modulates human pancreatic β cell inflammation by allele-specific stabilization of STAT1 mRNA
  1721. Immune Modulation and Vascular Repair Sustain pancreatic Beta Cell Regeneration To Reverse Late Stage Type 1 diabetes
  1722. Type 1 diabetes associated autoimmunity
  1723. The decline in cancer incidence in patients with long-duration type 1 diabetes: what really happens over time?
  1724. Grape seed proanthocyanidin extract and insulin prevents cognitive decline in type 1 diabetic rat by impacting Bcl-2 and Bax in the prefrontal cortex
  1725. An overview of the epidemiology of type 1 diabetes mellitus
  1726. CHOP deficiency ameliorates ERK5 inhibition-mediated exacerbation of streptozotocin-induced hyperglycemia and pancreatic β-Cell apoptosis
  1727. Probiotics and prebiotics for the amelioration of type 1 diabetes: present and future perspectives
  1728. Participation of Hsp70 and Hsp90α heat shock proteins in stress response in the course of type 1 diabetes mellitus
  1729. GATA6 plays an important role in the induction of human definitive endoderm, development of the pancreas, and functionality of pancreatic β cells
  1730. Retracted: Baicalin prevents tumor necrosis factor‐α−induced apoptosis and dysfunction of pancreatic β‐cell line Min6 via upregulation of miR‐205
  1731. … Factor-Alpha (TNF-α) and Sperm Count Increase in Type 1 diabetes Mellitus Rat (Rattus norvegicus) Model with Turmeric Rhizome (Curcuma longa L) Extract
  1732. Potentials of Aqueous Extract of Bambusa vulgaris to Reactivate β-cells of Pancreas in Alloxan-Induced Diabetic Wistar Rats
  1733. A viral link for type 1 diabetes
  1734. Post-translational modifications contribute to neoepitopes in Type-1 diabetes: Challenges for inducing antigen-specific tolerance
  1735. Tetrahedral framework nucleic acids induce immune tolerance and prevent the onset of type 1 diabetes
  1736. From insulin synthesis to secretion: Alternative splicing of type 2 ryanodine receptor gene is essential for insulin secretion in pancreatic β cells
  1737. … the potential impact of post translational modification of auto-antigens by tissue transglutaminase on humoral islet autoimmunity in type 1 diabetes
  1738. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes
  1739. Fulminant type 1 diabetes: 20 years of discovery and development
  1740. Nanoceria suppresses multiple low doses of streptozotocin-induced Type 1 diabetes by inhibition of Nrf2/NF-κB pathway and reduction of apoptosis
  1741. The role of coupling factors on the emergence of synchronization and chimera patterns in network of non-locally coupled pancreatic β-cells
  1742. Control of TRPM3 ion channels by protein kinase Ck2-mediated phosphorylation in pancreatic β-cells of the line INS-1
  1743. Generation of pancreatic β cells from CD177+ anterior definitive endoderm
  1744. New-onset type 1 diabetes mellitus with diabetic ketoacidosis and pancreatitis in a patient with COVID-19
  1745. A new therapeutic approach for type 1 diabetes: rationale for GNbAC1, an anti‐HERV‐W‐Env monoclonal antibody
  1746. Tetrahedral framework nucleic acids reverse new-onset type 1 diabetes
  1747. Do be so immature: dedifferentiated β cells help mice evade Type 1 diabetes
  1748. Immunotherapy strategies for the prevention and treatment of distinct stages of type 1 diabetes: an overview
  1749. Biomimetic carbon monoxide nanogenerator ameliorates streptozotocin induced type 1 diabetes in mice
  1750. Leaf extract of Morinda lucida improves pancreatic beta-cell function in alloxan-induced diabetic rats
  1751. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B
  1752. A zinc finger protein, Zfp444, is expressed in differentiating pancreatic β-cells and activates Glut2 gene expression
  1753. A map of human type 1 diabetes progression by imaging mass cytometry
  1754. Insulin‐producing cells derived from ‘induced pluripotent stem cells’ of patients with fulminant type 1 diabetes: vulnerability to cytokine insults and increased …
  1755. A Single L/D-Substitution at Q4 of the mInsA2-10 Epitope Prevents Type 1 diabetes in Humanized NOD Mice
  1756. Effects of anti-CD20 monoclonal antibody and IL-10 on pancreatic β cell regeneration in nonobese diabetic mice
  1757. Preventing type 1 diabetes in childhood
  1758. On the role IL-4/IL-13 heteroreceptor plays in regulation of type 1 diabetes
  1759. … and anti-inflammatory effects of Acrocarpus fraxinifolius on hyperglycemia, hyperlipidemia and liver/kidney dysfunctions against alloxan induced Type 1 diabetes in …
  1760. An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes
  1761. CD8+ regulatory T cells are critical in prevention of autoimmune-mediated diabetes
  1762. Macrophage IFN-I signaling promotes autoreactive T cell infiltration into islets in type 1 diabetes model
  1763. The ameliorative effect of bromelain on STZ-induced type 1 diabetes in rats through Oxi-LDL/LPA/LPAR1 pathway
  1764. A Lanosteryl triterpene from Protorhus longifolia augments insulin signaling in type 1 diabetic rats
  1765. Antibodies against H1N1 influenza virus cross‐react with α‐cells of pancreatic islets
  1766. Tetraspanin‐7 regulation of L‐type voltage‐dependent calcium channels controls pancreatic β‐cell insulin secretion
  1767. IL-17F induces inflammation, dysfunction and cell death in mouse islets
  1768. Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL‐4—producing T cells and regulatory T cells
  1769. Role of pro-inflammatory cytokines and biochemical markers in the pathogenesis of type 1 diabetes: correlation with age and glycemic condition in diabetic …
  1770. The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes
  1771. The reconstructed natural history of type 1 diabetes mellitus
  1772. Pathogenesis of Type 1 diabetes: Role of Dietary Factors
  1773. Association Between Enterovirus Infection and Type 1 diabetes Risk: A Meta-Analysis of 38 Case-Control Studies
  1774. Psychological stress and type 1 diabetes mellitus: what is the link?
  1775. Tellurium compounds prevent and reverse type-1 diabetes in NOD mice by modulating α4β7 integrin activity, IL-1β, and T regulatory cells
  1776. An Insulin‐Inspired Supramolecular Hydrogel for Prevention of Type 1 diabetes
  1777. Cell type–specific immune phenotypes predict loss of insulin secretion in new-onset type 1 diabetes
  1778. BIOACTIVE CONSTITUENTS AND ANTIOXIDANT ACTIVITY OF POLYHERBAL ETHANOLIC EXTRACT IN STREPTOZOTOCIN INDUCED DIABETIC RATS
  1779. Preventive effect of fermented brown rice and rice bran on spontaneous type 1 diabetes in NOD female mice
  1780. Nitric oxide and antiviral defense in pancreatic β-cells: evidence for inhibition of mitochondrial oxidative metabolism as a novel antiviral mechanism
  1781. P2X7 receptor knockout prevents streptozotocin-induced type 1 diabetes in mice
  1782. Acute pancreatitis may be a pathogenic factor of fulminant type 1 diabetes mellitus
  1783. Resveratrol inhibits macrophage infiltration of pancreatic islets in streptozotocin-induced type 1 diabetic mice via attenuation of the CXCL16/NF-κΒ p65 signaling …
  1784. Diabetic ketoacidosis precipitated by atypical coronavirus disease in a newly diagnosed diabetic girl
  1785. Possible involvement of autoimmunity in fulminant type 1 diabetes
  1786. The protective effects of human milk-derived peptides on the pancreatic islet biology
  1787. Innate inflammation in type 1 diabetes
  1788. Decrement in cellular iron and reactive oxygen species, and improvement of insulin secretion in a pancreatic cell line using green tea extract
  1789. Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-α signaling
  1790. A cell-based assay for the detection of pathogenic anti-voltage-gated calcium channel autoantibodies in immunoglobulin G from patients with type 1 diabetes
  1791. Oligonol, a low-molecular-weight polyphenol derived from lychee fruit, protects the pancreas from apoptosis and proliferation via oxidative stress in …
  1792. Abnormalities in proinsulin processing in islets from individuals with longstanding T1D
  1793. Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetes
  1794. Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes
  1795. Localization of enteroviral RNA within the pancreas in donors with T1D and T1D-associated autoantibodies
  1796. Examining the Co-localization and Distribution of Insulin Receptor on CD3 Cells in Type 1 Diabetic Human pancreatic Cadaver Samples
  1797. The DNA sensor AIM2 protects against streptozotocin-induced type 1 diabetes by regulating intestinal homeostasis via the IL-18 pathway
  1798. Tracking the antibody immunome in type 1 diabetes using protein arrays
  1799. Effect of different cereal peptides on the development of type 1 diabetes is associated with their anti‐inflammatory ability: In vitro and in vivo studies
  1800. Type 1 diabetes mellitus and enterovirus linkage: search for associated etiopathology
  1801. Toll-like receptor 7 deficiency suppresses type 1 diabetes development by modulating B-cell differentiation and function
  1802. The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes
  1803. 115-OR: Microbiome Antigens as a Vaccination Strategy in Type 1 diabetes
  1804. Structural characters and protecting β-cells of a polysaccharide from flowers of Inula japonica
  1805. Restoration of Insulin Productionin Induced Diabetic Rats, by Wakouba an Extract of Local Plant
  1806. Partial remission in Brazilian children and adolescents with type 1 diabetes. Association with a haplotype of class II human leukocyte antigen and synthesis of …
  1807. Curcumin alleviates liver oxidative stress in type 1 diabetic rats
  1808. Oral Therapy with Colonization Factor Antigen I (CFA/I) Activates Stable Regulatory T Cells (Tregs) in the pancreatic Lymph Nodes (PaLNs) of Non-Obese Diabetic …
  1809. The innate immune receptor MDA 5 limits rotavirus infection but promotes cell death and pancreatic inflammation
  1810. Towards a coxsackievirus B-based vaccine to combat T1DM
  1811. Metabolic abnormalities exacerbate Sjögren’s syndrome by and is associated with increased the population of interleukin–17–producing cells in NOD/ShiLtJ …
  1812. No Compensatory Increase in Non-ß Hormone Expressing Cells in the pancreatic Duct Glands in Type 1 diabetes
  1813. Proteomic and transcriptional profiles of human stem cell-derived β cells following enteroviral challenge
  1814. Image-based machine learning algorithms for disease characterization in the human type 1 diabetes pancreas
  1815. IL-17 in pancreatic disease: pathogenesis and pharmacotherapy
  1816. Sex-dependent effects of bisphenol A on type 1 diabetes development in non-obese diabetic (NOD) mice
  1817. In silico analysis reveals interrelation of enriched pathways and genes in type 1 diabetes
  1818. Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes
  1819. The Effect of Immunosuppressive Adjuvant Kynurenine on Type 1 diabetes Vaccine
  1820. Association between antioxidant enzyme activities and enterovirus-infected type 1 diabetic children
  1821. Nerve growth factor receptor TrkA signaling in streptozotocin-induced type 1 diabetes rat brain
  1822. Nitric oxide suppresses β-cell apoptosis by inhibiting the DNA damage response
  1823. The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus
  1824. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes
  1825. Peptidome Analysis of pancreatic Tissue Derived from T1DM Mice: Insights into the Pathogenesis and Clinical Treatments of T1DM
  1826. Glycated whey proteins protect NOD mice against type 1 diabetes by increasing anti-inflammatory responses and decreasing autoreactivity to self-antigens
  1827. Celiac crisis in an adult type 1 diabetes mellitus patient presented with diarrhea, weight loss and hypoglycemic attacks
  1828. Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment
  1829. T cells in type 1 diabetes: instructors, regulators and effectors: a comprehensive review
  1830. CREM variant rs17583959 conferred susceptibility to T1D risk in the Tunisian families
  1831. Combined treatment of sinapic acid and ellagic acid attenuates hyperglycemia in streptozotocin-induced diabetic rats
  1832. Alterations in pancreatic β cell function and Trypanosoma cruzi infection: evidence from human and animal studies
  1833. Specific inulin‐type fructan fibers protect against autoimmune diabetes by modulating gut immunity, barrier function, and microbiota homeostasis
  1834. β-cell dedifferentiation prior to insulitis prevents T1DM
  1835. Laser capture microdissection tailored to type 1 diabetes mellitus research
  1836. Cellular localisation of the kinin B1R in the pancreas of streptozotocin-treated rat and the anti-diabetic effect of the antagonist SSR240612
  1837. Protection from vomiting and β-cell death
  1838. The SARS‐CoV‐2 pandemic is associated with increased severity of presentation of childhood onset type 1 diabetes mellitus: A multi‐centre study of the first COVID …
  1839. Systemic TNFα correlates with residual β-cell function in children and adolescents newly diagnosed with type 1 diabetes
  1840. Punica granatum L. Fruit aqueous extract suppresses reactive oxygen species-mediated p53/p65/miR-145 expressions followed by Elevated Levels of irs-1 in …
  1841. Ketogenic diet for refractory epilepsy with MEHMO syndrome: caution for acute necrotizing pancreatitis
  1842. Glucose‐lowering effect of Gryllus bimaculatus powder on streptozotocin‐induced diabetes through the AKT/mTOR pathway
  1843. Reg3g overexpression promotes β cell regeneration and induces immune tolerance in nonobese‐diabetic mouse model
  1844. The role of Sechium edule fruits ethanolic extract in insulin production and malondialdehyde level in stz-induced diabetic rat
  1845. Children with type 1 diabetes of early age at onset–immune and metabolic phenotypes
  1846. Tolerogenic nanoparticles inhibit T cell–mediated autoimmunity through SOCS2
  1847. Resveratrol and resveratrol-hydroxypropyl-β-cyclodextrin complex recovered the changes of creatine kinase and Na+, K+-ATPase activities found in the spleen from …
  1848. Crucial role of Reg I from acinar-like cell cluster touching with islets (ATLANTIS) on mitogenesis of beta cells in EMC virus-induced diabetic mice
  1849. Engineering extracellular vesicles to target pancreatic tissue in vivo
  1850. Assessing effector T cells in type 1 diabetes
  1851. Biochemical and histopathological investigations of antidiabetic potential of polyherbal formulation in alloxan induced diabetic rats.
  1852. Interference with pancreatic sympathetic signaling halts the onset of diabetes in mice
  1853. Gut microbial metabolites alter IgA immunity in type 1 diabetes
  1854. Bacteroidetes and Firmicutes levels in gut microbiota and effects of hosts TLR2/TLR4 gene expression levels in adult type 1 diabetes patients in Istanbul, Turkey
  1855. Retracted: Bilobalide alleviates tumor necrosis factor‐alpha‐induced pancreatic beta‐cell MIN6 apoptosis and dysfunction through upregulation of miR‐153
  1856. A novel RT-QPCR-based assay for the relative quantification of residue specific m6A RNA methylation
  1857. Biogenic integrated ZnO/Ag nanocomposite: Surface analysis and in vivo practices for the management of type 1 diabetes complications
  1858. Nanoparticles Containing an Insulin-ChgA Hybrid Peptide Prevent Transfer of Type 1 diabetes in NOD Mice by Expanding Foxp3+ Tregs
  1859. Antidiabetic effects of aqueous extract of Baillonella toxisperma Pierre (Sapotacae) in streptozotocin-induced diabetic rats
  1860. Population dynamics of MafA-positive cells during ontogeny of human pancreas
  1861. Imaging the emergence and natural progression of spontaneous autoimmune diabetes
  1862. Glis3 Regulates pancreatic ß-Cell Development in Part through Coordination with Other Islet Transcription Factors
  1863. New-onset diabetes mellitus with COVID-19: Coincidence or cause
  1864. Characterization of proinsulin T cell epitopes restricted by type 1 diabetes–associated HLA class II molecules
  1865. Effectiveness of ethanolic extract Ketepeng cina leaves (Senna alata L.) as antidiabetic activity test in male Wistar rats induced by alloxan
  1866. Th1 chemokines in autoimmune endocrine disorders
  1867. Interleukin-33 prevents the development of autoimmune diabetes in NOD mice
  1868. Oral probiotic promotes indoleamine 2, 3-dioxygenase-and TGF-β–Producing plasmacytoid dendritic cells to initiate protection against type 1 diabetes
  1869. Green synthesis of gold nanoparticle using Eclipta alba and its antidiabetic activities through regulation of Bcl-2 expression in pancreatic cell line
  1870. Self-renewing islet TCF1+ CD8 T cells undergo IL-27–controlled differentiation to become TCF1− terminal effectors during the progression of type 1 diabetes
  1871. Down-regulation of microRNA-28 in peripheral blood mononuclear cell plays a role in pathogenesis of type 1 diabetes
  1872. … a Strong Effect of HLA and Identifying Variants in CSAD/lnc-ITGB7-1 on Chromosome 12q13.13 Associated With Susceptibility to Fulminant Type 1 diabetes
  1873. Antihyperglycemic and diabetic wound healing activity of smallanthus sonchifolius leaves extract
  1874. Immune cell trafficking to the islets during type 1 diabetes
  1875. … -α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes
  1876. Evaluation for type 1 diabetes associated autoantibodies in diabetic and non-diabetic Australian terriers and Samoyeds
  1877. Gestational diabetes promotes germ cell cCyst breakdown and primordial follicle formation in newborn mice via the AKT signaling pathway
  1878. PROGRESSION OF AUTOANTIBODIES ANTI-GAD AND ANTI-IA2 IN TYPE 1A DIABETICS AGED OF 5 TO 21 YEARS IN CÔTE D’IVOIRE
  1879. Higher abundance of enterovirus A species in the gut of children with islet autoimmunity
  1880. Antibodies against H1N1 influenza virus hemagglutinin cross-react with prohibitin
  1881. Protective effects of lyophilized ethanolic extract of Achillea arabica Kotschy. On the islet β cells of streptozotocin-induced diabetic rats
  1882. The Aerobic Training and Berberine Chloride Intervention on pancreatic Tissue Antioxidant Enzymes and Lipid Peroxidation in Type 1 Diabetic Rats
  1883. Signaling, stress response and apoptosis in pre-diabetes and diabetes: restoring immune balance in mice with alloxan-induced type 1 diabetes mellitus
  1884. Biomedical Data Commons (BMDC) prioritizes B-lymphocyte non-coding genetic variants in Type 1 diabetes
  1885. Chromatin loops and expression QTL colocalization reveal novel gene targets for T1D-associated GWAS variants in immune cells
  1886. Formulation and evaluation of capsules and suppositories containing Gongrenema Latifolium
  1887. Pancreas‐Specific Delivery of β‐Cell Proliferating Small Molecules
  1888. Knowledge, attitudes and practices of school teachers regarding acute complications of type 1 diabetes mellitus in Abha city, southwestern Saudi Arabia.
  1889. Comparative and correlative assessments of cytokine, complement and antibody patterns in paediatric type 1 diabetes
  1890. Association of KIR gene polymorphisms with Type 1 diabetes: a meta-analysis
  1891. MicroRNAs: Markers of β-cell stress and autoimmunity
  1892. Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at …
  1893. Anti-serum with anti-autoantibody activity decreases autoantibody-positive B lymphocytes and type 1 diabetes of female NOD mice
  1894. Spatial variations in gut permeability are linked to type 1 diabetes development in non-obese diabetic mice
  1895. Cytosolic phosphoenolpyruvate carboxykinase is expressed in α‐cells from human and murine pancreas
  1896. Avenanthramides of oats: medicinal importance and future perspectives.
  1897. Epidemiology of enteroviruses and their association with type 1 diabetes in Finland
  1898. Oral tolerance therapy in type 1 diabetes mellitus
  1899. Hypoglycemic and hypolipidemic effects of triterpenoid-enriched Jamun (Eugenia jambolana Lam.) fruit extract in streptozotocin-induced type 1 diabetic mice
  1900. The role of metabolic flexibility in the regulation of the DNA damage response by nitric oxide
  1901. Loss of interleukin‐10 exacerbates early Type‐1 diabetes‐induced bone loss
  1902. Type 1 diabetes: Through the lens of human genome and metagenome interplay
  1903. Contrast-enhanced ultrasound with sub-micron sized contrast agents detects insulitis and β-cell mass decline in mouse models of type 1 diabetes
  1904. Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
  1905. Adoptive transfer of GRP78‐treated dendritic cells alleviates insulitis in NOD mice
  1906. Impact of acute pancreatic injury on sphingolipid metabolism in the salivary glands
  1907. Interleukin-27 is essential for type 1 diabetes development and sjögren syndrome-like inflammation
  1908. Roselle (Hibiscus sabdiriffa) polyphenol-rich extract prevents testicular damage of diabetic rats
  1909. Reduced PD-1 expression on circulating follicular and conventional FOXP3+ Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk …
  1910. The Critical Role of Bach2 in Shaping the Balance between CD4+ T Cell Subsets in Immune-Mediated Diseases
  1911. Proteomic landscape of patient-derived CD4+ T cells in recent-onset type 1 diabetes
  1912. Carbenoxolone Could Deteriorate Streptozotocin-induced diabetes through Induction of Heat Shock Protein 70 and IFN-γ in C57BL/6 Mice
  1913. Treatment of type 1 diabetes by regulatory T‐cell infusion via regulating the expression of inflammatory cytokines
  1914. Usefulness of postmortem biochemistry in identification of ketosis: Diagnosis of ketoacidosis at the onset of autoimmune type 1 diabetes in an autopsy case with cold …
  1915. New onset of diabetes in a child infected with COVID-19: a case report
  1916. Perfluoroalkyl substances stimulate insulin secretion by islet β cells via G protein-coupled receptor 40
  1917. Data on investigation of hypoglycemic, anti-cholesteremic, in vivo antioxidant and pancreatic beta cell protective effect of Putranjiva roxburghii Wall bark in …
  1918. Thymic B cell-mediated attack of thymic stroma precedes type 1 diabetes development
  1919. Pharmacological targeting of the unfolded protein response for disease intervention
  1920. Angiopoietin-like protein 8 (betatrophin) is a stress-response protein that down-regulates expression of adipocyte triglyceride lipase
  1921. Cells produced during in vitro β-cell differentiation characterized
  1922. Lipid mediators and biomarkers associated with type 1 diabetes development
  1923. Broad induction of immunoregulatory mechanisms after a short course of anti-IL-7Rα antibodies in NOD mice
  1924. Research Article Impact of Acute pancreatic Injury on Sphingolipid Metabolism in the Salivary Glands
  1925. Suppression of diabetes by accumulation of non–islet-specific CD8+ effector T cells in pancreatic islets
  1926. Association of Wolfram syndrome with Fallot tetralogy in a girl
  1927. Cutting edge: Origins, recruitment, and regulation of CD11c+ cells in inflamed islets of autoimmune diabetes mice
  1928. Identification and Characterization of Prophages in Bacteroides Spp. Isolates from Children with Type 1 diabetes
  1929. GPU-accelerated discovery of pathogen-derived molecular mimics of a T-cell insulin epitope
  1930. Evaluation of pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [18F]FP-DTBZ in Healthy Subjects and Patients with Type 1 diabetes
  1931. Antidiabetic and Antihyperlipidemic Effects of Sulphurenic Acid, a Triterpenoid Compound from Antrodia camphorata, in Streptozotocin-Induced Diabetic …
  1932. Grape seed proanthocyanidins protects against cadmium induced oxidative pancreatitis in rats by attenuating oxidative stress, inflammation and apoptosis via Nrf-2 …
  1933. A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance
  1934. A multi-epitope DNA vaccine enables a broad engagement of diabetogenic T cells for tolerance in Type 1 diabetes
  1935. Differential role of MyD88 and TRIF signaling in myeloid cells in the pathogenesis of autoimmune diabetes
  1936. Superoxide production by NADPH oxidase intensifies macrophage antiviral responses during diabetogenic coxsackievirus infection
  1937. Aryl Hydrocarbon Receptor Activation and the Prevention of Type 1 diabetes
  1938. Diabetogenic agent alloxan is a proteasome inhibitor
  1939. Functional modulation of gut microbiota in diabetic rats following dietary intervention with pistachio nuts (Pistacia vera L.)
  1940. Loss of β-cell mass—an acute event before T1DM presentation?
  1941. Hypoglycemic effects of a Fructus Mori polysaccharide in vitro and in vivo
  1942. Cutting edge: nonobese diabetic mice deficient in chromogranin A are protected from autoimmune diabetes
  1943. Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes
  1944. Study of 2009 H1N1 pandemic influenza virus as a possible causative agent of diabetes
  1945. Autoimmune diabetes mellitus and the leaky gut
  1946. γ-Aminobutyric acid-rich yogurt fermented by Streptococcus salivarius subsp. thermophiles fmb5 apprars to have anti-diabetic effect on streptozotocin-induced diabetic …
  1947. BET proteins are required for transcriptional activation of the senescent islet cell secretome in type 1 diabetes
  1948. Changes in sperm quality and testicular structure in a rat model of type 1 diabetes
  1949. Metabolic pathways and abnormalities
  1950. Protective effects of a polyphenol-rich extract from Syzygium cumini (L.) skeels leaf on oxidative stress-induced diabetic rats
  1951. Children diagnosed with both type 1 diabetes and celiac disease-an Immunological challenge
  1952. Endocrine pancreas development and regeneration: noncanonical ideas from neural stem cell biology
  1953. Rotavirus and type 1 diabetes—is there a connection? A synthesis of the evidence
  1954. Dietary therapy may be sufficient for type 1 diabetes treatment
  1955. Genetics of fulminant type 1 diabetes
  1956. Novel mutant P277 peptide VP to ameliorate atherogenic side-effects and to preserve anti-diabetic effects in NOD mice
  1957. Nadph Oxidase-Derived Superoxide Production During Coxsackie B Virus Infection Fuels Macrophage Activation to Accelerate Type 1 diabetes
  1958. Effects of Root Extract of Ruellia tuberosa L. on Kidneys of Diabetic Rats.
  1959. (−)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana prevents diabetes and dyslipidemia in streptozotocin-induced diabetic mice
  1960. Phytoremedial effect of fruit extract of Moringa oleifera on alloxan induced diabetic model in Swiss albino mice: Phytoremedial effect of fruit extract of Moringa oleifera …
  1961. MAIT cells in type 1 diabetes mouse models
  1962. Urinary C peptide creatinine ratio in pregnant women with normal glucose tolerance and type 1 diabetes: evidence for insulin secretion
  1963. The emerging role of epigenetics in human autoimmune disorders
  1964. Mouse models of virus-induced type 1 diabetes
  1965. The expression of Tim-1 and Tim-4 molecules in regulatory T cells in type 1 diabetes
  1966. Current and emerging agents for the treatment of hypoglycemia in patients with congenital hyperinsulinism
  1967. P2X7R-Panx1 complex impairs bone mechanosignaling under high glucose levels associated with type-1 diabetes
  1968. Type I IFN–Driven Immune Cell Dysregulation in Rat Autoimmune diabetes
  1969. Type 1 diabetes mellitus with diabetic ketoacidosis after immune checkpoint inhibitor therapy
  1970. Temporal expression profiling of plasma proteins reveals oxidative stress in early stages of Type 1 diabetes progression
  1971. Anti-diabetic activity of Egyptian celery apigenin
  1972. Understanding type 1 diabetes through proteomics
  1973. Dnmt1 activity is dispensable in δ-cells but is essential for α-cell homeostasis
  1974. Exendin-4 derivatives with an albumin-binding moiety show decreased renal retention and improved GLP-1 receptor targeting
  1975. Interleukin-13: A promising therapeutic target for autoimmune disease
  1976. Anti-zinc transporter protein 8 antibody testing is not informative in routine prediabetes screening in young patients with autoimmune thyroiditis and celiac disease
  1977. Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child
  1978. The Effect of MyD88 Expression in Dendritic Cells on Immune Function
  1979. An altered CD8+ T cell epitope of insulin prevents type 1 diabetes in humanized NOD mice
  1980. Timing of immunotherapy in type 1 diabetes: the earlier, the better?
  1981. Antidiabetic activity of extracts of Pithecellobium dulce Benth leaves in alloxan induced diabetic rats
  1982. Human fetal β islets express coagulation factor XIII-A and proteases suggesting amphicrine regulation to facilitate islet fusion
  1983. Antidiabetic activity test of Ethanolic Seri Leave’s (Muntingia calabura L.) extract in male rats induced by Alloxan
  1984. The antidiabetic activity of curry leaves “Murraya Koenigii” on the glucose levels, kidneys, and islets of Langerhans of rats with Streptozotocin induced diabetes
  1985. Channeling β-cell Maturity: KATP Surface Localization Imparts Glucose Sensing
  1986. Benzothiazole: As an antidiabetic agent
  1987. Regulation of B cell homeostasis by Ptpn22 contributes to type 1 diabetes in NOD mice
  1988. … Leads to Enrichment of Treg Cells Which Consequently Regulates Effector T Cell Responses in Peri-pancreatic Lymph Nodes and Pancreas of Humanized Model …
  1989. Glycyrrhiza glabra alcoholic root extract ameliorates hyperglycemia, hyperlipidemia, and glycation‐induced free iron‐mediated oxidative reactions
  1990. Insights on β-cell regeneration from the zebrafish shoal: from generation of cells to functional integration
  1991. Comparative study of hypoglycemic activity of Morus alba with oral glibenclamide in streptozotocin induced diabetic rats
  1992. Rotavirus acceleration of type 1 diabetes in non-obese diabetic mice depends on type I interferon signalling
  1993. Molecular Markers and Drug Treatment for Persistent Enterovirus Infection in pancreatic Cell Lines
  1994. Nanoparticles containing an insulin–ChgA hybrid peptide protect from transfer of autoimmune diabetes by shifting the balance between effector T cells and regulatory …
  1995. 11-Keto-β-Boswellic Acid Inhibits Lymphocyte (CD3) Infiltration Into pancreatic Islets of Young None Obese Diabetic (NOD) Mice
  1996. Understanding autoimmune disease: an update review
  1997. Glutamate decarboxylase 67 contributes to compensatory insulin secretion in aged pancreatic islets
  1998. A case of young diabetes and parasuicide
  1999. Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity
  2000. Immune transcriptome of cells infected with enterovirus strains obtained from cases of type 1 diabetes
  2001. Does infant feeding modulate the manifestation of celiac disease and type 1 diabetes?
  2002. Photobiostimulation reverses allodynia and peripheral nerve damage in streptozotocin-induced type 1 diabetes
  2003. Endocrine effects of immunotherapy for cancer
  2004. Co-occurrence of type 1 diabetes and celiac disease autoimmunity
  2005. “I Live in Constant Fear of Highs,” the Daily Impact of Type 1 diabetes
  2006. Investigation of the utility of the 1.1 B4 cell as a model human beta cell line for study of persistent enteroviral infection
  2007. Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice
  2008. Cytotoxic T-lymphocyte-associated protein 4+ 49A/G polymorphisms contribute to the risk of type 1 diabetes in children: An updated systematic review and …
  2009. RESEARCH HIGHLIGHTSSelections from the
  2010. Antidiabetic and antihyperlipidemic effects of the flower extract of Eriobotrya japonica in streptozotocin-induced diabetic mice and the potential bioactive constituents …
  2011. The glucoregulatory response to high-intensity aerobic exercise following training in rats with insulin-treated type 1 diabetes mellitus
  2012. Effects of Allium tuncelianum on hyperglycemia and oxidative stress in the kidney and liver tissues in rats with diabetes mellitus induced by streptozotocin
  2013. Curcumin attenuates oxidative stress induced NFκB mediated inflammation and endoplasmic reticulum dependent apoptosis of splenocytes in diabetes
  2014. … butyricum CGMCC0313. 1 protects against autoimmune diabetes by modulating intestinal immune homeostasis and inducing pancreatic regulatory T cells
  2015. diabetes in Wolfram Syndrome: Update of Clinical and Genetic Aspects
  2016. Morphometric Study of Changes in GAD 65 Expressing Beta Cell Mass In The Islets Of Langerhans In Pregnant Mice
  2017. Rpl13a small nucleolar RNAs regulate systemic glucose metabolism
  2018. Antidiabetic potency of jeruju (Acanthus ilicifolius L.) ethanol extract and taurine on histopathological response of mice kidney (Mus musculus L.) induced by alloxan
  2019. Adenovirus-mediated suppression of hypothalamic glucokinase affects feeding behavior
  2020. Investigation of type 1 diabetes in NOD mice knockout for the osteopontin gene
  2021. Fluoxetine can inhibit coxsackievirus-B4 E2 in vitro and in vivo
  2022. Hyperglycemia in a type 1 diabetes Mellitus model causes a shift in mitochondria coupled-glucose phosphorylation and redox metabolism in rat brain
  2023. Hyperinsulinaemic hypoglycaemia—an overview of a complex clinical condition
  2024. Evaluation of Protective Effects of Hydroalcoholic Extract of Cassia fistula Linn. Pod on Pancreas in Streptozotocin‑induced Diabetic Rats
  2025. Loss of sympathetic innervation to islets of Langerhans in canine diabetes and pancreatitis is not associated with insulitis
  2026. Vav1 sustains the in vitro differentiation of normal and tumor precursors to insulin producing cells induced by all-trans retinoic acid (ATRA)
  2027. diabetes MELLITUS A SHORT REVIEW
  2028. Cytocidal macrophages in symbiosis with CD4 and CD8 T cells cause acute diabetes following checkpoint blockade of PD-1 in NOD mice
  2029. Enteric parasitic infection disturbs bacterial structure in Mexican children with autoantibodies for type 1 diabetes and/or celiac disease
  2030. No contribution of GAD-65 and IA-2 autoantibodies around time of diagnosis to the increasing incidence of juvenile type 1 diabetes: a 9-year nationwide …
  2031. A1 and A2 beta casein: Twin faces of milk
  2032. Insulin’s centenary: the birth of an idea
  2033. … structures by optical coherence tomography and optical coherence tomography angiography in children and adolescents with type 1 diabetes mellitus without clinical …
  2034. Astragaloside IV as potential antioxidant against diabetic ketoacidosis in juvenile mice through activating JNK/Nrf2 signaling pathway
  2035. Insulitis and lymphoid structures in the islets of Langerhans of a 66-year-old patient with long-standing type 1 diabetes
  2036. The MHC-II peptidome of pancreatic islets identifies key features of autoimmune peptides
  2037. … and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes
  2038. Assessment of anti-diabetic activity of Vinca Rosea extract on induced diabetic mice
  2039. Roles of keratin filaments on β-cell mitochondrial behavior and functionality
  2040. Enhanced CD4+ and CD8+ T cell infiltrate within convex hull defined pancreatic islet borders as autoimmune diabetes progresses
  2041. Wheat compounds—a comprehensive review
  2042. Alpha to Beta cell reprogramming: stepping toward a new treatment for diabetes
  2043. Developing a Novel Model System to Target Insulin-Reactive CD8 T Cells
  2044. Cutting edge: Dual TCRα expression poses an autoimmune hazard by limiting regulatory T cell generation
  2045. In vivo and in vitro antidiabetic potentials of methanol extract of Tephrosia pumila against alloxan-induced diabetes in experimental animals
  2046. Interleukin-1 receptor-induced nitric oxide production in the pancreas controls hyperglycemia caused by scorpion envenomation
  2047. On the emergent dynamics and synchronization of β-cells networks in response to space-time varying glucose stimuli
  2048. Methylcellulose and polyacrylate binary hydrogels used as rectal suppository to prevent type I diabetes
  2049. Wolfram syndrome 1 in the Italian population: Genotype–phenotype correlations
  2050. STAT3 modulates β-cell cycling in injured mouse pancreas and protects against DNA damage
  2051. Refractory Hypoglycemia Due to Massive Unintentional Insulin Overdose
  2052. Contrast-enhanced ultrasound with sub-micron sized contrast agents detects insulitis in mouse models of type1 diabetes
  2053. … Article No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 diabetes: A 9-Year …
  2054. Genetic and small molecule disruption of the AID/RAD51 axis similarly protects nonobese diabetic mice from type 1 diabetes through expansion of regulatory B …
  2055. Tests of blood-borne DNA pinpoint tissue damage
  2056. Possible interaction of sympathetic nerves with macrophages via fractalkine-CX3CR1 ligation in pancreatic islets
  2057. Ectopic expression of self-antigen drives regulatory T cell development and not deletion of autoimmune T cells
  2058. Effect of gluten-free diet on potentially regulatory immune mechanisms in human type 1 diabetes
  2059. T–B Lymphocyte Interactions Promote Type 1 diabetes Independently of SLAM-Associated Protein
  2060. Ethanol extract of Tephrosia bracteolata leaves and its fractions ameliorates alloxan-induced diabetes and its associated complications in Wistar rat model
  2061. GLP-1/Exendin-4 induces β-cell proliferation via the epidermal growth factor receptor
  2062. Future glycemic control of children diagnosed with type 1 diabetes mellitus at toddler and preschool/school age
  2063. Al Humayed
  2064. Infectious triggers
  2065. Fibroblast growth factor 21: a novel long-acting hypoglycemic drug for canine diabetes
  2066. Structural features of cells of the islets of Langerhans in offspring with alloxonic diabetes
  2067. Mechanisms of Igf2 inhibition in thymic epithelial cells infected by coxsackievirus CV-B4
  2068. Silica nanoparticles on the oral delivery of insulin
  2069. A predictive CD8+ T cell phenotype for T1DM progression
  2070. Combined effect of glutamine at position 70 of HLA-DRB1 and alanine at position 57 of HLA-DQB1 in type 1 diabetes: An epitope analysis
  2071. Autoimmunity in picornavirus infections
  2072. Coxsackievirus-B4 infection can induce the expression of human endogenous retrovirus W in primary cells
  2073. PDIA6 regulates insulin secretion by selectively inhibiting the RIDD activity of IRE1
  2074. Effect of diabetes on the male reproductive system—A histomorphological study
  2075. Genetic and Immunological Features of Insulin-Dependent diabetes Mellitus as a Clinical Manifestation of Type 1 Autoimmune Polyglandular Syndrome
  2076. Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut …
  2077. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy
  2078. Antibiotic-associated manipulation of the gut microbiota and phenotypic restoration in NOD mice
  2079. Immunogenetic Prediction of VDR Gene SNPs: Lack of Association with Susceptibility to Type 1 diabetes in Jordanian Patients
  2080. Friends in low places: intestinal commensals limit colitis through molecular mimicry
  2081. Effect of flavonoid rich fraction of Tephrosia purpurea (Linn.) Pers. on complications associated with streptozotocin-induced type I diabetes mellitus
  2082. New developments implicating IL-21 in autoimmune disease
  2083. Ameliorative Effect of Moringa Oleifera Biochemical Constituents on Blood Glucose Level of Streptozocin-Induced Diabetic Wistar Rats
  2084. The antihyperglycemic and antihyperlipidemic effect of ethanolic extract of Apium Graveolens (celery) in Streptozocin/high fat diet induced hyperglycemic mice.
  2085. Beneficial impacts of dietary zinc supplementation on islet β-cells regeneration and glycemic Profile in Diabetic Rats (P24-015-19)
  2086. Ventromedial hypothalamic lesions downregulate multiple immune signaling pathways in rat pancreatic islets
  2087. The Evaluation of Serum IFN-γ and TGF-β in Some Patients with Type1 diabetes mellitus in Al-diwanyah Province
  2088. Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?
  2089. Regulatory B cells in an experimental model of type 1 diabetes
  2090. Exopolysaccharide from Leuconostoc pseudomesenteroides XG5 delay the onset of autoimmune diabetes by modulating gut microbiota and its metabolites …
  2091. EFFECT OF BALANITES AEGYPTIACA (HEGLIG DATES) AND PERSEA AMERICANA (AVOCADO FRUIT) ON SOME HEMATOLOGICAL AND BIOCHEMICAL …
  2092. Fractional order Bergman’s minimal model-a better representation of blood glucose-insulin system
  2093. Assessment of metals induced histopathological and gene expression changes in different organs of non-diabetic and diabetic rats
  2094. Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance
  2095. Transdifferentiation of both intra-and extra-islet cells into beta cells in nicotinamide treated neonatal diabetic rats: An in situ hybridization and double …
  2096. Upregulation of INS-IGF2 read-through expression and identification of a novel INS-IGF2 splice variant in insulinomas
  2097. Assessment of growth among children with type 1 diabetes mellitus: A cross-sectional study of factors contributing to stunting
  2098. Streptozotocin (STZ) and schistosomiasis mansoni change the biodistribution of radiopharmaceutical sodium 99mTc-pertechnetate in mice
  2099. Mitochondrial uncoupling proteins regulate angiotensin‐converting enzyme expression: crosstalk between cellular and endocrine metabolic regulators suggested by …
  2100. Mitochondrial-encoded MOTS-c prevents pancreatic islet destruction in autoimmune diabetes
  2101. A century of progress
  2102. LIM-domain transcription complexes interact with ring-finger ubiquitin ligases and thereby impact islet β-cell function
  2103. Modulation of the diet and gastrointestinal microbiota normalizes systemic inflammation and β-cell chemokine expression associated with autoimmune …
  2104. Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity
  2105. Screening for coeliac disease in adult patients with type 1 diabetes mellitus: myths, facts and controversy
  2106. Emerging role of air pollution in autoimmune diseases
  2107. Dimethyl fumarate ameliorates diabetes-associated vascular complications through ROS-TXNIP-NLRP3 inflammasome pathway
  2108. The Ca2+/calmodulin/CaMKK2 axis: nature’s metabolic CaMshaft
  2109. Insulin/adenosine axis linked signalling
  2110. Aqueous extract of Digitaria exilis grains ameliorate diabetes in streptozotocin-induced diabetic male Wistar rats
  2111. A RANDOMISED SINGLE BLIND ACTIVE CONTROLLED, PARALLEL GROUP STUDY COMPARING THE EFFICACY & SAFETY OF THE KARNIM PLUS® …
  2112. Ameliorative role of ferulic acid against diabetes associated oxidative stress induced spleen damage
  2113. In vivo evidences of Curcuma longa on oxidative stress in STZ-induced diabetes on sperm parameters in male wistar rats
  2114. Association of HLA class II alleles and haplotypes with type 1 diabetes in Tunisian Arabs
  2115. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity
  2116. Aegle marmelos Leaf Extract is an Effective Herbal Remedy in Reducing Hyperglycemic Condition: A Pre-clinical Study
  2117. Associations of CTLA4 +49 A/G Dimorphism and HLA-DRB1*/DQB1* Alleles With Type 1 diabetes from South India
  2118. Low CD25 on autoreactive Tregs impairs tolerance via low dose IL-2 and antigen delivery
  2119. AND TYPE 1 diabetes
  2120. Ghrelin mitigates β‐cell mass loss during insulitis in an animal model of autoimmune diabetes mellitus, the BioBreeding/Worcester rat
  2121. Insulin-loaded hydroxypropyl methyl cellulose-co-polyacrylamide-co-methacrylic acid hydrogels used as rectal suppositories to regulate the blood glucose of diabetic …
  2122. Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model
  2123. Enteric parasitic infection disturbs bacterial structure in Mexican children with autoantibodies for type 1 diabetes and/or celiac disease.
  2124. Osteoprotegerin promotes islet β cell proliferation in intrauterine growth retardation rats through the PI3K/AKT/FoxO1 pathway
  2125. Expression of adenosine receptors in rodent pancreas
  2126. Highlight: IL-2 receptor signaling
  2127. Research Article Protective Effects of a Polyphenol-Rich Extract from Syzygium cumini (L.) Skeels Leaf on Oxidative Stress-Induced Diabetic Rats
  2128. Possible link of genetic variants to autoimmunity in GAD-antibody-associated neurological disorders
  2129. Radioprotective Effects of Allium jesdianum Extract on Reduction of Pancrease Damages Following γ-Radiation through Down-regulation of Apoptotic Genes …
  2130. Intestinal permeability and autoimmune diseases
  2131. Androgen derivatives affect immunopresence but not activity of antioxidant enzymes in pancreatic islets during diabetogen-induced apoptosis
  2132. Asparaginyl ligase-catalyzed one-step cell surface modification of red blood cells
  2133. Closed-Loop Blood Glucose Control for Type I diabetes Patients Using PID Controller
  2134. Evidence of immunosuppressive and Th2 immune polarizing effects of antidiabetic momordica charantia fruit juice
  2135. Hypoglycemic and antioxidant effects of Hibiscus rosa-sinensis L. leaves extract on liver and kidney damage in streptozotocin induced diabetic rats
  2136. Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review
  2137. Case 17: Wolfram Syndrome WFS1
  2138. Inhibition of coxsackievirus B4 by Lactobacillus plantarum
  2139. The antidiabetic activity of Nigella sativa and propolis on streptozotocin-induced diabetes and diabetic nephropathy in male rats
  2140. Study of hypoglycemic effect of corosolic acid & its comparative evaluation with standard drug glibenclamide in alloxan induced diabetes in female albino mice
  2141. Influence of aerobic exercise training on serum markers of oxidative stress in diabetic rats
  2142. Shared and unique immune alterations in pre-clinical autoimmunity
  2143. Antidiabetic and antioxidant activities of extract of entandrophragma cylindricum (sprague) leaves in male wistar rats
  2144. Cellular proliferation in mouse and human pancreatic islets is regulated by serpin B13 inhibition and downstream targeting of E-cadherin by cathepsin L
  2145. Roles of microRNAs in chronic pediatric diseases and their use as potential biomarkers: A review
  2146. De novo germline mutation in the dual specificity phosphatase 10 gene accelerates autoimmune diabetes
  2147. Development of a neonatal mouse model for coxsackievirus B1 antiviral evaluation
  2148. Association Between Enterovirus Infections and Type 1 diabetes in Different Countries
  2149. Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity
  2150. A biomimetic five-module chimeric antigen receptor (5MCAR) designed to target and eliminate antigen-specific T cells
  2151. Null mutations of NEUROG3 are associated with delayed-onset diabetes mellitus
  2152. ASIA syndrome and endocrine autoimmune disorders
  2153. Antioxidant and anti-inflammatory effects of curcumin nanoparticles on drug-induced acute myocardial infarction in diabetic rats
  2154. Low-level fluoride exposure reduces glycemia in NOD mice
  2155. Pancreas development and the Polycomb group protein complexes
  2156. Effects of garlic extract on TNF-α expression and oxidative stress status in the kidneys of rats with STZ+ nicotinamide-induced diabetes
  2157. Breakdown in peripheral immune tolerance in experimental diabetes Mellitus
  2158. EVALUATION OF ANTIDIABETIC ACTIVITY OF WHOLE PLANT OF 70% ETHANOLIC EXTRACTS OF INDIGOFERABARBERI GAMBLES
  2159. A Protective Role for NKG2D–H60a Interaction via Homotypic T Cell Contact in Nonobese Diabetic Autoimmune diabetes Pathogenesis
  2160. The murine natural cytotoxic receptor NKp46/NCR1 controls TRAIL protein expression in NK cells and ILC1s
  2161. Anti PD-1 monoclonal antibody induced autoimmune diabetes mellitus: a case report and brief review
  2162. Chaos and coexisting attractors in glucose-insulin regulatory system with incommensurate fractional-order derivatives
  2163. Engineering commensal bacteria to rewire host–microbiome interactions
  2164. Protein A functionalized polyelectrolyte microcapsules as a universal platform for enhanced targeting of cell surface receptors
  2165. Lysosomal cathepsin creates chimeric epitopes for diabetogenic CD4 T cells via transpeptidation
  2166. Probiotic treatment reduces appetite and glucose level in the zebrafish model
  2167. Activation of the aryl hydrocarbon receptor by 10-Cl-BBQ prevents insulitis and effector T cell development independently of Foxp3+ regulatory T cells in nonobese …
  2168. Polyphenolic composition, enzyme inhibitory effects ex-vivo and in-vivo studies on two Brassicaceae of north-central Italy
  2169. Immunohistochemical and biochemical study of the effect of Rheum ribes on the pancreas of diabetic rats
  2170. Antihyperglycemic, antihyperlipidemic and hepatoprotective effects of Ficus ottoniifolia (Miq.) Miq. supplementation in alloxan-induced diabetic rats
  2171. MERTK on mononuclear phagocytes regulates T cell antigen recognition at autoimmune and tumor sites
  2172. Bach2 repression mediates Th17 cell induced inflammation and associates with clinical features of advanced disease in chronic pancreatitis
  2173. Preproinsulin autoantigen processing by ER aminopeptidase 1 is upregulated during ER stress via IRE1α-mediated miR-17 degradation
  2174. β‐Catenin stabilization in NOD dendritic cells increases IL‐12 production and subsequent induction of IFN‐γ‐producing T cells
  2175. Infections: a double-edge sword in autoimmunity
  2176. Adoptive transfer of mRNA-transfected T cells redirected against diabetogenic CD8 T cells can prevent diabetes
  2177. Biological Activities of Red Pepper (Capsicum annuum) and Its Pungent Principle Capsaicin: A Review
  2178. Comprehensive analysis of liver and blood miRNA in precancerous conditions
  2179. Wilson Disease With Novel Compound Heterozygote Mutations in the ATP7B Gene Presenting With Severe diabetes
  2180. Stimulator of interferon genes agonists attenuate type I diabetes progression in NOD mice
  2181. Role of NFAT5 in the immune system and pathogenesis of autoimmune diseases
  2182. Antidiabetic effects of fermented milk contained with Gardenia jasminoides water extracts on streptozotocin‐induced mice
  2183. Epigenetic modulation of selected immune response genes and altered functions of T lymphocytes and macrophages collectively contribute to autoimmune …
  2184. Excess of glucocorticoids during late gestation impairs the recovery of offspring’s β‐cell function after a postnatal injury
  2185. Galangin attenuates diabetic cardiomyopathy through modulating oxidative stress, inflammation and apoptosis in rats
  2186. Origins of brain insulin and its function
  2187. Effect of ginger on hyperglycemia induced by streptozotocin in pregnant rats and postnatal neurodevelopment of their offspring
  2188. Identification of four novel mutations of the WFS1 gene in Iranian Wolfram syndrome pedigrees
  2189. Changes in the composition and function of the gut microbiome accompany type 1 diabetes in pregnancy
  2190. Continuous glucose monitoring systems for the diagnosis of cystic fibrosis‐related diabetes
  2191. Pharmacological activity and flavonoids constituents of Artemisia judaica L aerial parts
  2192. pancreatic ductal cell antigens are important in the development of invasive insulitis in non-obese diabetic mice
  2193. Anti-hyperglycemic activity of polyherbal formulation (Herbinsulplus) in experimental diabetes and its effects on key metabolic enzymes of carbohydrate metabolism
  2194. 25-Hydroxyvitamin D and peripheral immune mediators: results from two nationwide Danish pediatric cohorts
  2195. Unique features in the presentation of insulin epitopes in autoimmune diabetes: an update
  2196. Heparanase: historical aspects and future perspectives
  2197. Insights on the effects of resveratrol and some of its derivatives in cancer and autoimmunity: a molecule with a dual activity
  2198. Ameliorative effects of aloe vera gel extract on circulatory and tissue lipid profile status in streptozotocin-induced diabetic rats
  2199. Aliskiren and captopril improve cognitive deficits in poorly controlled STZ-induced diabetic rats via amelioration of the hippocampal P-ERK, GSK3β, P-GSK3β pathway
  2200. Synthesis and characterization of [125I] TZ6544, a promising radioligand for investigating sphingosine-1-phosphate receptor 2
  2201. Antidiabetic and anti-hyperlipidemic effects of ethanolic extract of Dryopteris dilatata leaves
  2202. Regulatory T cells induced by single-peptide liposome immunotherapy suppress islet-specific T cell responses to multiple antigens and protect from autoimmune …
  2203. pancreatic inflammation redirects acinar to β cell reprogramming
  2204. Single-cell RNA sequencing of murine islets shows high cellular complexity at all stages of autoimmune diabetes
  2205. Effect of Boswellia serrata supplementation in addition to insulin on glycemic control in a diabetic dog
  2206. Protective effect of quercetin on alteration of antioxidant genes expression and histological changes in the dental pulp of the streptozotocin-diabetic rats
  2207. Antidiabetic Activity of Indian Medicinal Plants
  2208. Anti‐inflammatory effects of melatonin in multiple sclerosis
  2209. Role of exercise on S-Klotho protein regulation: a systematic review
  2210. Implication of Vitamin D Deficiency on Autoimmune Disorders
  2211. An in vitro evaluation of anti-aging effect of guluronic acid (G2013) based on enzymatic oxidative stress gene expression using healthy individuals PBMCs
  2212. Oral supplementation with p‐coumaric acid protects mice against diabetes‐associated spontaneous destruction of periodontal tissue
  2213. The multifaceted functional role of DNA methylation in immune-mediated rheumatic diseases
  2214. Effects of Talinum triangulare leaf flavonoid extract on streptozotocin‐induced hyperglycemia and associated complications in rats
  2215. MHC class I expression in intestinal cells is reduced by rotavirus infection and increased in bystander cells lacking rotavirus antigen
  2216. Nanoparticles versus dendritic cells as vehicles to deliver mRNA encoding multiple epitopes for immunotherapy
  2217. Effect of glabridin on collagen deposition in liver and amelioration of hepatocyte destruction in diabetes rats
  2218. Blood leukocytes recapitulate diabetogenic peptide–MHC-II complexes displayed in the pancreatic islets
  2219. Heparan Sulfate of ß Cells Regulates Insulin Secretion and Contributes to Normal Glucose Homeostasis
  2220. Prevalence of exposure of heavy metals and their impact on health consequences
  2221. Antidiabetic activity of phytosaponin in STZ-induced type I diabetes in rats
  2222. De novo germline mutation in the Dual Specificity Phosphatase 10 gene accelerates autoimmune diabetes in Non-Obese Diabetic (NOD) mice
  2223. Decreased 68Ga-NOTA-exendin-4 renal uptake in patients pretreated with Gelofusine infusion: a randomized controlled study
  2224. Expression of Pichia pastoris-derived secreted insulin precursor
  2225. Urinary Tract Involvement in Wolfram Syndrome: A Narrative Review
  2226. Protective role of Excoecaria agallocha L. against streptozotocin-induced diabetes and related complications
  2227. Regulated endocrine-specific protein-18, an emerging endocrine protein in physiology: A literature review
  2228. Flexible Bayesian joint models for longitudinal biomarkers and time-to-event outcomes with applications to type 1 diabetes research
  2229. Class-switched anti-insulin antibodies originate from unconventional antigen presentation in multiple lymphoid sites
  2230. APPRAISAL OF PHYTOCONSTITUENTS AND ANTI-DIABETIC PROPERTIES OF THE STEM BARK EXTRACT OF ANISOPUS MANNIIIN ALLOXAN INDUCED …
  2231. Direct cell reprogramming for tissue engineering and regenerative medicine
  2232. Journal of Comprehensive Pharmacy
  2233. Follow-Up Support for Effective type 1 diabetes self-management (The FUSED Model)
  2234. Ectopic expression of Pax4 in pancreatic δ cells results in β-like cell neogenesis
  2235. 248-LB: Spexin Promotes Insulin Secretion and ß-Cell Proliferation
  2236. Therapeutic Effect of Banana Flower (Banana Male Bud) on Diabetic Rats
  2237. Studying the heterogeneous pathogenesis of canine diabetes: Observational characterization of an island population
  2238. Canine fibroblast growth factor 21 ameliorates hyperglycemia associated with inhibiting hepatic gluconeogenesis and improving pancreatic beta-cell survival …
  2239. PLAGL1: an important player in diverse pathological processes
  2240. Research Article Evidence of Immunosuppressive and Th2 Immune Polarizing Effects of Antidiabetic Momordica charantia Fruit Juice
  2241. T Cells from NOD-PerIg Mice Target Both pancreatic and Neuronal Tissue
  2242. Endocrinopathy and aging in ferrets
  2243. Molecular Imaging of Autoimmune Diseases
  2244. The improvement effects of Gordonia bronchialis on male fertility of rats with diabetes mellitus induced by streptozotocin
  2245. 110-OR: Generation of a Novel Mouse Model to Study ß-Cell Proliferation
  2246. EVALUATION OF ANTIDIABETIC ACTION OF ARAUCARIA COLUMNARIS LEAF EXTRACTS
  2247. High glucose-induced ubiquitylation of G6PD leads to the injury of podocyte
  2248. PTY 2 As DPP-IV Inhibitor Prevents Intestinal Cell’s Apoptosis
  2249. Role of gut microbiota in autoimmune diseases: a review
  2250. Effect of alpha-lipoic acid on antioxidant gene expression and kidney injury in alloxan-induced diabetic rats.
  2251. Ninjurin 1 has two opposing functions in tumorigenesis in a p53-dependent manner
  2252. Mycobacteria, Immunoregulation, and Autoimmunity
  2253. The clearance of dead cells by efferocytosis
  2254. A new role for NKG2D signaling in CD8+ T cells and autoimmune diabetes
  2255. The burden of congenital hyperinsulinism in the United Kingdom: a cost of illness study
  2256. Anti-diabetic activity of hydro-alcoholic root extract of echinops echinatus and its beneficial effects on nephropathy in experimental rats
  2257. Silymarin ameliorates liver damage by modulating oxidative stress and apoptosis in liver of streptozotocininduced diabetic rats
  2258. Menin regulates Inhbb expression through an Akt/Ezh2-mediated H3K27 histone modification
  2259. Two-photon imaging of pancreatic beta cells in real time in vivo
  2260. Impaired glucose tolerance after streptozotocin microinjection into the mediodorsal prefrontal cortex of the rat
  2261. Probiotics: Role in the Prevention of Chronic Viral Diseases
  2262. Forkhead transcription factors in health and disease
  2263. Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action
  2264. Nigella sativa L. seed and seed oil: potential sources of high-value components for development of functional foods and nutraceuticals/pharmaceuticals
  2265. CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins
  2266. Antioxidant Enzymes and Lipid Peroxidation in Alloxan-Induced Diabetic Rabbits
  2267. Assessing the anti-hyperglycemic and anti-hyperlipidemic effects of an aqueous extract of lannea edulis in alloxan-induced diabetic rats
  2268. Opuntia stricta cladode Extract reduces blood glucose levels in Alloxan-induced diabetic mice.
  2269. Insulin influences LPS-Induced TNF-α and IL-6 release through distinct pathways in mouse macrophages from different compartments
  2270. Paradoxical development of polymyositis-like autoimmunity through augmented expression of autoimmune regulator (AIRE)
  2271. Strategies for Using Open Innovation to Establish a Next-generation NDB Data Research Platform
  2272. Peptide hormones as tumor markers in clinical practice
  2273. Biochemical Implications of Biotransformation of Some Toxic Floras Using Natural Local Enzyme Sources
  2274. Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: From pathogenic factors to therapeutic targets
  2275. The importance of educational activities promoting health in obstetrics and gynaecology—selected issues taking into account nutritional aspects
  2276. Engineering bacteria for diagnostic and therapeutic applications
  2277. Synthesis and antidiabetic activity of selenium nanoparticles in the presence of polysaccharides from Catathelasma ventricosum
  2278. Antioxidant and Anti-Inflammatory Effects of Curcumin Nanoparticles on Drug-Induced Acute Myocardial Infarction in Diabetic Rats
  2279. The islet-resident macrophage is in an inflammatory state and senses microbial products in blood
  2280. Effect of Aqueous Extract of Citrullus lanatus (Water Melon) Seeds on Alloxan Induced-Diabetic Wistar Rats
  2281. Bifidobacteria-derived lipoproteins inhibit infection with coxsackievirus B4 in vitro
  2282. Role of endocannabinoid CB1 receptors in Streptozotocin-induced uninephrectomised Wistar rats in diabetic nephropathy
  2283. Effects of Low-Level Laser Therapy on Tooth Socket Repair in Diabetic Male Rats: An Animal Study
  2284. RelA as a Potential Regulator of Inflammation and Tissue Damage in Streptozotocin-Induced Diabetic STAT5 Knockout Mice
  2285. SOX9+/PTF1A+ cells define the tip progenitor cells of the human fetal pancreas of the second trimester
  2286. Preproinsulin designer antigens excluded from endoplasmic reticulum suppressed diabetes development in NOD mice by DNA vaccination
  2287. Effect of β-D-mannuronic acid (M2000) on oxidative stress enzymes’ gene using healthy donor peripheral blood mononuclear cells for evaluating the anti-aging …
  2288. Hypoglycemic, Antihyperlipidemic and Antioxidant Effects of Manniophyton fulvum Aqueous Root Extract on Streptozotocin-induced Hyperglycemic Wistar Rats
  2289. A minimum number of autoimmune T cells to induce autoimmunity?
  2290. Novel gene mutations regulating immune responses in autoimmune polyglandular syndrome with an atypical course
  2291. Possible regulatory effects of application of alpha lipoic acid and insulin against cadmium exposed diabetic rats
  2292. Prevention and treatment of autoimmune diseases with plant virus nanoparticles
  2293. Random Matrix Analysis of Ca2+ Signals in β-Cell Collectives
  2294. Critical role of P2Y12 receptor in regulation of Th17 differentiation and experimental autoimmune encephalomyelitis pathogenesis
  2295. Transcriptomic segregation of human autoantigens useful for the diagnosis of autoimmune diseases
  2296. Programmed cell death factor 4 (PDCD4), a novel therapy target for metabolic diseases besides cancer
  2297. Development of monoclonal mouse antibodies that specifically recognize pancreatic polypeptide
  2298. Basics of inducible lymphoid organs
  2299. Effect of Hydroalcoholic Extract of Cynodon Dactylon on Clinical and Histopathological Aspects and Leukocyte Infiltrations of Pancreas in Experimental Autoimmune …
  2300. ROS-associated immune response and metabolism: a mechanistic approach with implication of various diseases
  2301. Viruses in the pathogenesis of coeliac disease
  2302. The treatment of hyperinsulinemic hypoglycaemia in adults: an update
  2303. Coxsackievirus B4 transplacental infection severely disturbs central tolerogenic mechanisms in the fetal thymus
  2304. Evaluation of in vitro antioxidant activity of okra mucilage and its antidiabetic and antihyperlipidemic effect in alloxan‐induced diabetic mice
  2305. Endocrine autoimmune disease as a fragility of immune surveillance against hypersecreting mutants
  2306. Pdx1-Cre-driven conditional gene depletion suggests PAK4 as dispensable for mouse pancreas development
  2307. PHARMACOGNOSTICAL AND PHYTOCHEMICAL STANDARDIZATION OF MAHADADIMADI GHRITA-AN AYURVEDIC POLYHERBAL FORMULATION
  2308. POLYPHENOLIC WEALTHY MORINGA LEAVES EXTRACTS AS ANTICOXSACKIE B VIRUSES (COX-BV)
  2309. Jabuticaba (Plinia trunciflora (O. Berg) Kausel) improved the lipid profile and immune system and reduced oxidative stress in streptozotocin‐induced diabetic rats
  2310. The individual and joint effects of maternal 25 (OH) D deficiency and gestational diabetes on infant birth size
  2311. Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
  2312. Failed PET application attempts in the past, can we avoid them in the future?
  2313. The early gut microbiome and the risk of chronic disease
  2314. An overview of tolerogenic immunotherapies based on plant-made antigens
  2315. Royal Sun Culinary-Medicinal Mushroom Agaricus brasiliensis (Agaricomycetes) as a Functional Food in Gestational diabetes Mellitus Before and After Fetus …
  2316. Collective genetic interaction effects and the role of antigen-presenting cells in autoimmune diseases
  2317. Understanding autoimmunity: The ion channel perspective
  2318. Effect of Zanthoxylum alkylamides on glucose metabolism in streptozotocin-induced diabetic Sprague–Dawley rats
  2319. Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases
  2320. MicroRNA expression in antiphospholipid syndrome: a systematic review and microRNA target genes analysis
  2321. Dynamic proteomic analysis of pancreatic mesenchyme reveals novel factors that enhance human embryonic stem cell to pancreatic cell differentiation
  2322. Functional domains of autoimmune regulator (AIRE) modulate INS-VNTR transcription in human thymic epithelial cells
  2323. Leaf extracts of Glyphaea brevis attenuate high blood glucose and lipids in diabetic rats induced with streptozotocin
  2324. Serum metabolic fingerprinting identified putatively annotated sphinganine isomer as a biomarker of Wolfram syndrome
  2325. β-Casomorphins: A1 Milk, Milk Peptides and Human Health
  2326. PD-1 aborts the activation trajectory of autoreactive CD8+ T cells to prohibit their acquisition of effector functions
  2327. Genetic characteristics and long-term follow-up of 11 patients with congenital hyperinsulinism followed in a single center
  2328. Non-Lyn src family kinases activate SIRPα–SHP-1 to inhibit PI3K–Akt2 and dampen proinflammatory macrophage polarization
  2329. T cell receptor recognition of hybrid insulin peptides bound to HLA-DQ8
  2330. Generalizing RNA velocity to transient cell states through dynamical modeling
  2331. Dual mode of action of acetylcholine on cytosolic calcium oscillations in pancreatic beta and acinar cells in situ
  2332. A review on the effectiveness of oral insulin in type I and type II diabetes mellitus
  2333. Role of extracellular vesicles in cell death and inflammation
  2334. Adaptation of striated muscles to Wolframin deficiency in mice: alterations in cellular bioenergetics
  2335. Botryosphaeran reduces obesity, hepatic steatosis, dyslipidaemia, insulin resistance and glucose intolerance in diet-induced obese rats
  2336. Cosmeceutical aptitudes of niacinamide: a review
  2337. INSL5 activates multiple signalling pathways and regulates GLP-1 secretion in NCI-H716 cells
  2338. 4.2 Capítulo II-Protective effects of a polyphenol-rich extract from Syzygium cumini (L.) Skeels leaf on oxidative stress-induced diabetic rats
  2339. Anticipating regime shifts in gene expression: The case of an autoactivating positive feedback loop
  2340. Targeting mitochondria with folic acid and vitamin B12 ameliorates nicotine mediated islet cell dysfunction
  2341. Red Wine and Yacon as a Source of Bioactive Compounds with Antidiabetic and Antioxidant Potential
  2342. The chemistry and pharmacology of genistein
  2343. Immunophenotypic and Morphometric Evaluation of Bone Marrow Macrophage Culture Stimulated by Sodium Aminodihydrophthalazinedione In Vitro
  2344. Case reports of pre-clinical replication studies in metabolism and diabetes
  2345. Gluten peptide immunomodulatory strategies
  2346. Backstepping Nonlinear Control for Blood Glucose Based on Sliding Mode Meal Observer
  2347. MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells
  2348. Modulation of IGF2 expression in the murine thymus and thymic epithelial cells following coxsackievirus-B4 infection
  2349. Identification and characterization of anti-diabetic principle in Senna alata (Linn.) flower using alloxan-induced diabetic male Wistar rats
  2350. Fiona Campbell1, Julia Lawton2, David Rankin2, Mark Clowes1, Elizabeth Coates1, Simon Heller4
  2351. NOD-like receptors in autoimmune diseases
  2352. Gene Expression-Based Identification of Antigen-Responsive CD8+ T Cells on a Single-Cell Level
  2353. Immunoengineering approaches for cytokine therapy
  2354. In silico and ex vivo approaches indicate immune pressure on capsid and non-capsid regions of coxsackie B viruses in the human system
  2355. Increased expression of pyloric ERβ is associated with diabetic gastroparesis in streptozotocin-induced male diabetic rats
  2356. An evaluation of the antioxidant and antidiabetic potential of Cynometra cauliflora (nam-nam, Fabaceae)
  2357. Nanoceria, the versatile nanoparticles: Promising biomedical applications
  2358. Effect of levosimendan, an inodilator, on streptozotocin-induced diabetic nephropathy in rats
  2359. Neutrophils in animal models of autoimmune disease
  2360. Preventive effect of phloroglucinol against adverse protein alterations in streptozotocin induced diabetic rats
  2361. PROFILES IN FORENSIC TOXICOLOGY
  2362. Novel Spatiotemporal Analysis for Exploring a-Cell Differentiation
  2363. Involvement of spinal angiotensin II system in streptozotocin-induced diabetic neuropathic pain in mice
  2364. FoxP3+ Regulatory T Cell Fate in Inflamed Tissues
  2365. Musings on the wanderer: What’s new in our understanding of vago-vagal reflexes? VI. Central vagal circuits that control glucose metabolism
  2366. diabetes type 4: a paradigm shift in the understanding of glaucoma, the brain specific diabetes and the candidature of insulin as a therapeutic agent
  2367. Chromosome 17q21 genes ORMDL3 and GSDMB in asthma and immune diseases
  2368. Critique of the Hypothesis
  2369. Dopamine D1 receptor activity is involved in the increased anxiety levels observed in STZ-induced diabetes in rats
  2370. A study on the effect of estrogen on the insulin signaling pathway in diabetic rats
  2371. JAK/STAT inhibitor therapy partially rescues the lipodystrophic autoimmune phenotype in Clec16a KO mice
  2372. SUMO-defective c-Maf preferentially transactivates Il21 to exacerbate autoimmune diabetes
  2373. Antidiabetic effects of unexplored Syzygium kanarense (Talbot) Raizada leaves extract in streptozotocin-induced diabetic rats
  2374. Single-cell RNA-sequencing reveals widespread personalized, context-specific gene expression regulation in immune cells
  2375. Modulating cell fate as a therapeutic strategy
  2376. Gli-Similar (Glis) Proteins: Their Mechanisms of Action, Physiological Functions, and Roles in Disease
  2377. Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors
  2378. Relevance of the materno-fetal interface for the induction of antigen-specific immune tolerance
  2379. Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer
  2380. Unusual Iron and Copper Studies in a Patient with Liver Injury and Normocytic Anemia
  2381. Clinical and molecular assessment of 13 Iranian families with Wolfram syndrome
  2382. Genome-wide methylomic analysis in individuals with HNF1B intragenic mutation and 17q12 microdeletion
  2383. Mucin and Splice Variant Profiles of pancreatic Adenocarcinoma Predict Patient Survival and Subtyping
  2384. Interactions between Phenols and Alkylamides of Sichuan Pepper (Zanthoxylum Genus) in α-Glucosidase Inhibition: A Structural Mechanism Analysis
  2385. T cell exosome–derived miR-142-3p impairs glandular cell function in Sjögren’s syndrome
  2386. Insulin autoimmune syndrome in a pregnant female: a rare case report
  2387. Antidiabetic activity of Abelmoschus esculentus (Ex-Maradi Okra) fruit in alloxan-induced diabetic rats
  2388. LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII
  2389. Octreotide-related exocrine pancreatic insufficiency (EPI) in congenital hyperinsulinism
  2390. The modulation of autoimmune disease progression in mouse models
  2391. The influence of type II cytokines in central tolerance
  2392. The Complete Chloroplast Genomes of Two Lespedeza Species: Insights into Codon Usage Bias, RNA Editing Sites, and Phylogenetic Relationships in Desmodieae …
  2393. Wolfram syndrome: clinical and genetic profiling of a cohort from a tertiary care centre with characterization of the primary gonadal failure
  2394. Calbindin-D28K and calbindin-D9K and the epithelial calcium channels TRPV5 and TRPV6
  2395. Development of thymic tumor in [LSL:KrasG12D; Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis
  2396. Canine and Human Insulinoma: prognostic factors, druggable genes and cancer stem cells
  2397. Taurine ameliorates oxidative stress induced inflammation and ER stress mediated testicular damage in STZ-induced diabetic Wistar rats
  2398. The impact of moderate Hypoxia on cytokines-driven beta cell apoptosis.
  2399. Investigation of the utility of Curcuma caesia in the treatment of diabetic neuropathy
  2400. Research Article Dynamic Proteomic Analysis of pancreatic Mesenchyme Reveals Novel Factors That Enhance Human Embryonic Stem Cell to pancreatic Cell …
  2401. How Kiss-and-Run Can Make Us Sick: SOX4 Puts a Break on the Pore
  2402. Pathophysiological consequences of isoform-specific IP3 receptor mutations
  2403. Combined vitamin D, ibuprofen and glutamic acid decarboxylase-alum treatment in recent onset Type I diabetes: lessons from the DIABGAD randomized pilot trial
  2404. A profluorescent nitroxide probe for ascorbic acid detection and its application to quantitative analysis of diabetic rat plasma
  2405. Metabolic Responses to Whole-Body Vibration Exercise
  2406. Neuropods
  2407. Comparative study to evaluate in vivo and in vitro antioxidant potential of processed and unprocessed Curcuma logna L. using Allxon induced diabetic rats
  2408. … Supplementation with Hydroethanolic Extract of Campomanesia xanthocarpa (Berg.) Leaves and Two Isolated Substances from the Extract on Metabolic Parameters …
  2409. Computer-aided analysis for quantitative assessment of FoxA1 to estimate pancreatic subpopulation, oxidative phosphorylation, & morphogenesis in late pregnancy of …
  2410. Evaluation of the immunoradiometric and electrochemiluminescence method for the measurement of serum insulin in children
  2411. Thymus-specific serine protease, a protease that shapes the CD4 T cell repertoire
  2412. Prospecting the Antidiabetic Potential of Alisma orientale
  2413. Smoke and autoimmunity: The fire behind the disease
  2414. The dual roles of A20 in cancer
  2415. Association of vitamin D pathway gene polymorphisms with vitamin D level during pregnancy was modified by season and vitamin D supplement
  2416. Herbal tablet of Pueraria tuberosa water extract suppresses the alloxan induced liver damage and hyperglycemia in rats
  2417. Interleukin-15 (dys) regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer
  2418. 22 LABORATORY DIAGNOSIS OF GASTROINTESTINAL AND pancreatic DISORDERS
  2419. Synthesis, molecular modeling and antiviral activity of novel 5-fluoro-1H-indole-2, 3-dione 3-thiosemicarbazones
  2420. The dual role of Reactive Oxygen Species in autoimmune and inflammatory diseases: evidence from preclinical models
  2421. Enzymatic System of Antioxidant Protection of Erythrocytes in Diabetic Rats Treated with Medicinal Mushrooms Agaricus brasiliensis and Ganoderma lucidum …
  2422. Effect of photobiomodulation therapy on oxidative stress markers of gastrocnemius muscle of diabetic rats subjected to high-intensity exercise
  2423. The interaction of type 1 and 2 interferons with neutrophils in Juvenile-onset Systemic Lupus Erythematosus (JSLE)
  2424. The interaction of type 1 and 2 interferons with neutrophils in Juvenile-onset Systemic Lupus Erythematosus
  2425. Macromolecular confinement of therapeutic protein in polymeric particles for controlled release: insulin as a case study
  2426. The interaction of type 1 and 2 interferons with neutrophils in Juvenile-onset Systemic Lupus Erythematosus (JSLE)
  2427. Nutritional and therapeutic perspectives of camel milk and its protein hydrolysates: A review on versatile biofunctional properties
  2428. Dynamic regulation of JAK-STAT signaling through the prolactin receptor predicted by computational modeling
  2429. Insulin and lispro insulin: what is common and different in their behavior?
  2430. tHe CoURse, BRAnCHes oF tHe InFeRIoR ALveoLAR neRve AnD Its AnAtoMICAL FoRMs In tHe MAnDIBULAR CAnAL
  2431. Loss of P2X7 receptor function dampens whole body energy expenditure and fatty acid oxidation
  2432. Invariant natural killer T cells balance B cell immunity
  2433. Genetic predisposition to autoimmune diseases conferred by the major histocompatibility complex: utility of animal models
  2434. Bardet–Biedl Syndrome ciliopathy is linked to altered hematopoiesis and dysregulated self‐tolerance
  2435. Increased C-peptide immunoreactivity in insulin autoimmune syndrome (Hirata disease) due to high molecular weight proinsulin
  2436. Vitamin A and the immune system
  2437. Nanosponges as protein delivery systems: Insulin, a case study
  2438. Kidney histology in streptozotocin-induced diabetic male Wistar rats treated with combined extract of temulawak rhizome and belimbing wuluh fruit
  2439. Ethyl pyruvate as a potential defense intervention against cytokine storm in Covid-19?
  2440. Notch controls multiple pancreatic cell fate regulators through direct Hes1-mediated repression
  2441. Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events
  2442. Three Sisters With Heterozygous Gene Variants of CYP24A1: Maternal Hypercalcemia, New-Onset Hypertension, and Neonatal Hypoglycemia
  2443. A1/A2 Milk Hypothesis
  2444. Autoantigen-specific immune tolerance in pathological and physiological cell death: Nanotechnology comes into view
  2445. Distinct Roles of GABA (A) R Signaling in the Regulation of Two Human T lymphocyte Lines
  2446. Mechanisms of autoimmunity
  2447. Investigating Harmine, a β-Carboline Alkaloid, as a Novel Nutraceutical in pancreatic Cancer
  2448. Hereditary pancreatitis model by blastocyst complementation in mouse
  2449. Protein crystallization promotes type 2 immunity and is reversible by antibody treatment
  2450. Functional characterization of antigen repertoires inHLA-associated complex diseases to investigate antagonistic selection on HLA genes
  2451. New hPSC SOX9 and INS reporter cell lines facilitate the observation and optimization of differentiation into insulin-producing cells
  2452. Rapid and sensitive analytical method for the determination of insulin in liposomes by reversed-phase HPLC
  2453. Current strategies and future perspective for the effective treatment of diabetic retinopathy
  2454. Oral dysbiosis and autoimmunity: from local periodontal responses to an imbalanced systemic immunity. A review
  2455. Immunoglobulin-G glycation by fructose leads to structural perturbations and drop off in free lysine and arginine residues
  2456. Evaluation of a labdane diterpene forskolin isolated from Solena amplexicaulis (Lam.) Gandhi (Cucurbitaceae) revealed promising antidiabetic and …
  2457. The Role of TGF-β in CTB-Insulin Regulated Human Dendritic Cell Tolerance
  2458. Acetate modulates T cell dependent humoral immune response in secondary lymphoid organs
  2459. Evaluation of antihyperglycemic activity of modified Nisha Amalaki yoga in swiss albino mice
  2460. Spontaneous Breakdown of Long‐Lived Proteins in Aging and Their Implications in Disease
  2461. An Update on the Emerging Role of Visfatin in the Pathogenesis of Osteoarthritis and Pharmacological Intervention
  2462. Screening of GABA-producing lactic acid bacteria and increasing the GABA content in soymilk
  2463. Endocrinological toxicity secondary to treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs)
  2464. First report of insulin receptor in Thysanoptera and its expression variation with development of western flower thrips, Frankliniella occidentalis
  2465. Biological activity versus physiological function of proinsulin C-peptide
  2466. The immunobiology of autoimmune encephalitides
  2467. LABORATORY OF GASTROINTESTINAL DIAGNOSIS AND pancreatic DISORDERS
  2468. AN UPDATES ON ANTIDIABETIC ACTIVITY OF CUCUMIS SPECIES–AN EVIDENCE BASED OVERVIEW
  2469. Vitamin D in human health
  2470. Antihyperlipidemic and cardioprotective effects of plant natural products: A review
  2471. Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers
  2472. Naringin abrogates HIV-1 protease inhibitors-induced atherogenic dyslipidemia and oxidative stress in vivo
  2473. The Role of Myosin II in Stabilizing Actin Tethers Promoting GLUT4 Exocytosis in 3T3-L1 Adipocytes
  2474. Mathematical Model of Glucose-Insulin Metabolism and Model Predictive Glycemic Control for Critically Ill Patients Considering Time Variability of Insulin …
  2475. Streptomyces strains producing mitochondriotoxic antimycin A found in cereal grains
  2476. The impact of the COVID-19 pandemic on child health
  2477. Use of SRPK1 inhibitors for the treatment of Diabetic Retinopathy
  2478. An Evaluation of the PrediXcan Method for the Identification of Lipid Associated Genes
  2479. Effect of melatonin on hypertension and diabetes induced experimentally in adult male albino rats
  2480. Addition of sialic acid to insulin confers superior physical properties and bioequivalence
  2481. Physical exercise as a modulator of the anti-ageing Klotho protein: health-related cardiometabolic implications. The FIT-AGEING study
  2482. Involvement of spinal angiotensin II system in streptozotocin-induced diabetic neuropathic pain in mice
  2483. The Chemotactic Role of Metallothionein in the Extracellular Environment
  2484. Glycyrrhizic acid: a natural plant ingredient as a drug candidate to treat COVID-19
  2485. Across the spectrum: integrating multidimensional metal analytics for in situ metallomic imaging
  2486. Acetalated dextran based nano-and microparticles: synthesis, fabrication, and therapeutic applications
  2487. Single-cell RNA sequencing reveals metallothionein heterogeneity during hESC differentiation to definitive endoderm
  2488. Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery
  2489. AMPK Activation by Zyflamend: A novel pathway regulating metabolism and growth in prostate cancer
  2490. Redox Enzymes of the Thioredoxin Family as Potential and Novel Markers in Pemphigus
  2491. Synthesis and characterization of coralline CuBiS2 nanocomposite hybridized with reduced graphene oxide: a novel electrocatalyst for ultra-trace detection of insulin …
  2492. Sodium transporters in human health and disease
  2493. Animal pain models for spinal cord stimulation
  2494. Therapeutic potential of phytoestrogens
  2495. Genetic analysis of endoplasmic reticulum homeostasis during stress and infection of Caenorhabditis elegans
  2496. Growth factors in the intestinal tract
  2497. Design of Antigen-Specific Immunotherapies Through Modulation of Peripheral Tolerance Pathways
  2498. Cellular senescence in vivo: From cells to tissues to pathologies
  2499. Roles of Phosphatidylinositol 4-Phosphate in Secretory Granule Biogenesis
  2500. Rossmann MG, Arnold E, Erickson JW, et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 1985; 317: 145–153 …
  2501. Sensitivity and Specificity of Diagnostic Biomarkers in Thyroid Diseases: From circulating chemistry to molecular cytogenetics.
  2502. Effects of carbohydrate supplementation on resistance exercise performance, blood glucose, endocrine and metabolite responses, immediately before exercise and …
  2503. PROTECTIVE EFFICACY OF NOBILETIN AND PHYSIOLOGICAL PATHWAYS IT USES
  2504. Toll like receptor 2 and Toll like receptor 4 activation and vitamin D effects in mouse osteoblasts
  2505. Development of tools for the analysis of cell-free DNA in human blood: Application in the noninvasive prenatal testing field
  2506. Vitamin D levels of anaesthetists in the Department of Anaesthesiology at the
  2507. Ageing and sources of transcriptional heterogeneity
  2508. Good pyridine hunting: a biomimic compound, a modifier and a unique pharmacophore in agrochemicals
  2509. Oral dysbiosis and autoimmunity: from local periodontal responses to an imbalanced systemic immunity. A review
  2510. Collection of initial and current control tests for 4th course students of medical and pediatric faculties content modules: gastroenterology, endocrinology, pulmonology …
  2511. Phosphometabolite Enrichment With Metal Oxide Microtips and Purification of Albumin From Canine Plasma
  2512. Altered hematopoietic system and self-tolerance in Bardet-Biedl Syndrome
  2513. Management of asymptomatic patients with positive coronary artery calcium scans
  2514. The cytoprotective activity of Nrf2 is regulated by phytochemicals (sulforaphane, curcumin, and silymarin)
  2515. Gastrointestinal disease 358
  2516. Brain inflammation and neuronal activity in diabetes and metabolic syndrome
  2517. The implication of natural killer cells and neutrophils in autoimmune disorders of the central nervous system
  2518. Hereditary 1, 25-dihydroxyvitamin D resistant rickets
  2519. Cytokines in the germinal centre reaction to T-dependent antigen
  2520. Identification of a novel WFS1 homozygous nonsense mutation in Jordanian children with Wolfram syndrome
  2521. Chemical transdifferentiation: closer to regenerative medicine
  2522. Evaluating the contribution of immune gene variants to schizophrenia
  2523. The role of invariant natural killer T Cells in autoimmune diseases
  2524. Current and emerging technologies for the analysis of the genome-wide and locus-specific DNA methylation patterns
  2525. The role of heat-shock proteins and chaperonins in the pathogenesis and progression of cancer
  2526. Vitamin D during Pregnancy
  2527. Hypothalamic Releasing Hormones
  2528. Defining the role of the human intestinal microbiota in childhood asthma and atopic disease
  2529. Investigating the effects of host factors (proteins and non-proteins) on mycobacteria
  2530. Role of the Bcl-2 family of cell death regulators at the Endoplasmic Reticulum
  2531. 17 11 Water-soluble vitamins
  2532. The Role of Phosphohistidine Phosphatase 1 in Ethanol-induced Liver Injury
  2533. Effects of Sodium Bicarbonate on Glucose Homeostasis and Blood Pressure in Chronic Kidney Disease
  2534. Tregs that accumulate in the encephalomyocarditis virus-infected mouse brain: Origin, compartmentalization, function, and gene signature
  2535. Bioinformatcs and Functional Data Implicate the GABA System in Cancer Progression
  2536. Analyzing cooperative post-transcriptional gene regulation by Roquin in the prevention of autoimmunity
  2537. The MAP Kinase/MAP Kinase Phosphatase-1 Pathway in the Anti-Inflammatory Effects of β2-Agonists and Dexamethasone
  2538. Effect of C1q null mutation on mammary gland development and breast cancer susceptibility
  2539. Investigating the role of Junctional Adhesion Molecule-C (JAM-C) in endothelial cell biology in vitro and in vivo using human and mouse models
  2540. Host defense peptides’ effects on wound healing
  2541. VDR-RIPK1 Interaction and its Implications in Cell Death and Cancer Intervention
  2542. Small molecule modulators of amine oxidation, nuclear receptor signaling and glucuronidation: 3-phenylcoumarin as a scaffold of interest
  2543. Development and Function of Self-Specific Memory-Phenotype CD8+ T Cells
  2544. Aus der Klinik für Neurologie der Heinrich-Heine-Universität Düsseldorf
  2545. Control of mast cell regulated exocytosis by Munc18 proteins
  2546. The Role and Regulation of Insulin-Like Growth Factor Binding Protein-4 in the Rodent Intestinal Mucosa
  2547. Multi-Scale Modeling and Sensitivity Analysis in Biological Systems
  2548. The Role of β2-Glycoprotein I-Reactive T Cells in the Development of Systemic Lupus Erythematosus
  2549. Growth hormone and growth hormone gene of the American mink (Neovison vison)-the current state of knowledge of one of the key hormones in one of the …
  2550. The Torpid State: Recent Advances in Metabolic Adaptations and Protective Mechanisms†
  2551. Vibrational Microscopy for Super-multiplexing, Vibrational Sensing and High-throughput Metabolic Imaging
  2552. The Role of Kisspeptin in Energy Balance
  2553. Patent application title: REVERSIBLE PEGYLATED DRUGS Inventors: Yoram Shechter (Rehovot, IL) Yoram Shechter (Rehovot, IL) Matityahu Fridkin …
  2554. Energetics in wild female Assamese macaques (Macaca assamensis): a behavioral and physiological approach
  2555. A bovine milk-derived peptide ameliorates alloxan-injured pancreatic β cells through IRS2/PI3K/Akt signaling
  2556. Repeated low-dose streptozotocin and alloxan induced long-term and stable type 1 diabetes model in beagle dogs
  2557. … -Modifying Nanoparticles Encapsulating Multiple Recombinant pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 diabetes in Nonobese Diabetic …
  2558. Loss of tetraspanin‐7 expression reduces pancreatic β‐cell exocytosis Ca2+ sensitivity but has limited effect on systemic metabolism
  2559. The protective roles of allicin on type 1 diabetes mellitus through AMPK/mTOR mediated autophagy pathway
  2560. Onopordum acanthium L. extract attenuates pancreatic β-cells and cardiac inflammation in streptozocin-induced diabetic rats
  2561. Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus
  2562. Interferon‐α promotes MHC I antigen presentation of islet β cells through STAT1‐IRF7 pathway in type 1 diabetes
  2563. Detection of antiviral tissue responses and increased cell stress in the pancreatic islets of newly diagnosed type 1 diabetes patients: Results from the DiViD …
  2564. Blocking Kir6. 2 channels with SpTx1 potentiates glucose-stimulated insulin secretion from murine pancreatic β cells and lowers blood glucose in diabetic mice
  2565. Gut mucosa alterations and loss of segmented filamentous bacteria in type 1 diabetes are associated with inflammation rather than hyperglycaemia
  2566. Amelioration of oxidative stress mediated inflammation and apoptosis in pancreatic islets by Lupeol in STZ-induced hyperglycaemic mice
  2567. CAMSAP2 localizes to the Golgi apparatus in pancreatic β-cells to facilitate Golgi-endoplasmic reticulum trafficking and support robust insulin secretion
  2568. Phenethyl ester of rosmarinic acid attenuates autoimmune responses during type 1 diabetes development in mice
  2569. Potential of PKM2 as a drug target in mouse models with type 1 diabetes mellitus
  2570. The microtubule minus end-binding protein CAMSAP2 does not regulate microtubule dynamics in primary pancreatic β-cells but facilitates insulin secretion
  2571. β-Cell Cre Expression and Reduced Ins1 Gene Dosage Protect Mice From Type 1 diabetes
  2572. Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic mouse thymus and pancreas
  2573. Genetic overlap between type 1 diabetes and other autoimmune diseases
  2574. Deep Learning the Crosstalk between Follicular Helper T cells and Type 1 diabetes
  2575. The type 1 diabetes-associated lncRNA ARGI participates in virus-induced pancreatic beta cell inflammation.
  2576. Plasma protein biomarkers predict both the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity: the TEDDY …
  2577. Redox Regulation of m6A Methyltransferase METTL3 in Human β-cells Controls the Innate Immune Response in Type 1 diabetes
  2578. MRI Methods for Imaging Beta-Cell Function in the Rodent Pancreas
  2579. Inhibition of RIPK1 kinase does not affect diabetes development: β-cells survive RIPK1 activation
  2580. Probiotics of Lacticaseibacillus paracasei SD1 and Lacticaseibacillus rhamnosus SD11 attenuate inflammation and β-cell death in streptozotocin-induced …
  2581. Globularia alypum Extracts Attenuate Hyperglycemia and Protect against Various Organ Toxicities in Alloxan-Induced Experimental Diabetic Rats
  2582. Host gene effects on gut microbiota in type 1 diabetes
  2583. Correspondence: JDJ
  2584. Type 1 diabetes and asthma: a systematic review and meta-analysis of observational studies
  2585. Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response
  2586. Maternal antibiotic exposure increases total islet number and volume in the neonatal pancreas and reduces HbA1c and insulitis in adult female non‐obese diabetic …
  2587. Pregnancy induces pancreatic insulin secretion in women with long-standing type 1 diabetes
  2588. HETEROGENEITY IN diabetes AND BETA CELLS
  2589. MBD2 acts as a repressor to maintain the homeostasis of the Th1 program in type 1 diabetes by regulating the STAT1-IFN-γ axis
  2590. Dynamic Number and Function of IL-10–Producing Regulatory B Cells in the Immune Microenvironment at Distinct Stages of Type 1 diabetes
  2591. Identification of Heterophilic Epitopes of H1N1 Influenza Virus Hemagglutinin
  2592. Effects of diazoxide on streptozotocin induced β cell damage via HSP70/HSP90/TLR4/AMPK signaling pathways
  2593. Partial clinical remission of type 1 diabetes: the need for an integrated functional definition based on insulin-dose adjusted A1c and insulin sensitivity score
  2594. Aberrant expression of transglutaminase 2 in pancreas and thymus of NOD mice underscores the importance of deamidation in neoantigen generation.
  2595. Toll-Like Receptor 3 Is Critical to the pancreatic Islet Milieu That Is Required for Coxsackievirus B4–Induced Type 1 diabetes in Female Nonobese Diabetic …
  2596. The Extra-Islet Pancreas Supports Autoimmunity in Human Type 1 diabetes
  2597. Actinidia deliciosa Mitigates Oxidative Stress and Changes in pancreatic α-, β-, and δ-Cells and Immunohistochemical and Histological Architecture in …
  2598. Early exposures and inherent factors in premature newborns are associated with type 1 diabetes
  2599. New-onset type 1 diabetes mellitus as a delayed immune-related event after discontinuation of nivolumab: A case report
  2600. Association analysis between the TLR9 gene polymorphism rs352140 and type 1 diabetes
  2601. Therapeutic Nursing Education in Promoting Self-Management of Adolescents with Type 1 diabetes Mellitus: Integrative Literature Review
  2602. An Early Islet Transcriptional Signature is Associated with Local Inflammation in Autoimmune diabetes
  2603. WDFY4 deficiency in NOD mice ameliorates autoimmune diabetes and insulitis
  2604. Triggering type 1 diabetes post-covid: molecular mimicry?
  2605. Antidiabetic and pancreas-protective potential of Parthenium Hysterophorous (Carrot grass) in Alloxan induced diabetic rabbits
  2606. Acute respiratory distress syndrome associated with multisystem Inflammatory syndrome in a child with Covid-19 and diabetic ketoacidosis: a case report
  2607. Food & Function
  2608. The genetic influence of PD-1/PD-L1 axis single nucleotide polymorphisms on the incidence of type 1 diabetes mellitus in pediatric Egyptian patients
  2609. Association of Vitamin D deficiency and vitamin D receptor gene polymorphisms with type 1 diabetes risk: A South Indian familial study
  2610. Mutations in GCK May Lead to MODY2 by Reducing Glycogen Synthesis
  2611. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic
  2612. Emerging trophic activities of mesencephalic astrocyte-derived neurotrophic factor in tissue repair and regeneration
  2613. Genome-wide association study of the age of onset of type 1 diabetes reveals HTATIP2 as a novel T cell regulator
  2614. Images From the Exeter Archival diabetes Biobank Now Accessible via Pancreatlas
  2615. Does a gluten-free diet lead to better glycemic control in children with type 1 diabetes? Results from a feasibility study and recommendations for future trials
  2616. Initial neutrophil/lymphocyte and lymphocyte/monocyte ratios can predict future insulin need in newly diagnosed type 1 diabetes mellitus
  2617. Association of Vitamin D deficiency and vitamin D receptor gene polymorphisms with type 1 diabetes risk: A South Indian familial study
  2618. Glycemic variability patterns strongly correlate with partial remission status in children with newly diagnosed type 1 diabetes
  2619. Using mass spectrometry to identify neoantigens in autoimmune diseases: The type 1 diabetes example
  2620. Possible association of rotavirus IgG with cytokine expression levels and dyslipidemia in rotavirus-infected type 1 diabetic children
  2621. Fulminant type 1 diabetes developed after influenza split vaccination
  2622. Presence of PD-1 similarity genes in monocytes may promote the development of type 1 diabetes mellitus and poor prognosis of pancreatic cancer
  2623. Antidiabetic potential of Hibiscus sabdariffa extract in alloxan-induced diabetic rats
  2624. A novel electrochemical insulin aptasensor: From glassy carbon electrodes to disposable, single-use laser-scribed graphene electrodes
  2625. Barriers and Strategies for Type 1 diabetes Management Among Emerging Adults: A Qualitative Study
  2626. Honey polyphenolic fraction inhibits cyclooxygenase-2 expression via upregulation of microRNA-26a-5p expression in pancreatic islets
  2627. Fabrication and evaluation of quercetin nanoemulsion: A delivery system with improved bioavailability and therapeutic efficacy in diabetes mellitus
  2628. … Activities of Major 5′ Terminally Deleted Group-B Coxsackievirus RNA Forms Decrease PCSK2 mRNA Expression Impairing Insulin Maturation in pancreatic Beta …
  2629. ARID1A loss in pancreas leads to islet developmental defect and metabolic disturbance
  2630. MDA5-dependent responses contribute to autoimmune diabetes progression and hindrance
  2631. Type 1 diabetes mellitus post-COVID-19: a trigger or a coincidence? A case report
  2632. Suppression of RNF213, a susceptibility gene for moyamoya disease, inhibits endoplasmic reticulum stress through SEL1L upregulation
  2633. Evaluation of the antidiabetic activity of hydromethanolic roots extracts of rumex abyssinicus jacq:(polygonaceae) in Swiss albino mice
  2634. Inhibition of Polyamine Biosynthesis Preserves β Cell Function in Type 1 diabetes
  2635. Gene expression signature predicts rate of type 1 diabetes progression
  2636. 100 years of glucagon anniversary, special collection–editorial
  2637. Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors
  2638. SARS-CoV-2 Infection Causes Hyperglycemia in Cats
  2639. A dormant T‐cell population with autoimmune potential exhibits low self‐reactivity and infiltrates islets in type 1 diabetes
  2640. Exploration of autoantibody responses in canine diabetes using protein arrays
  2641. Viral Protein VP1 Virus-like Particles (VLP) of CVB4 Induces Protective Immunity against Lethal Challenges with Diabetogenic E2 and Wild Type JBV Strains …
  2642. NLRP6 deficiency expands a novel CD103+ B cell population that confers immune tolerance in NOD mice
  2643. Guidelines for standardizing T‐cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes
  2644. Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants
  2645. CD1 and MR1: An update after a long-awaited reunion
  2646. Protocol to isolate immune cells from mouse pancreatic lymph nodes and whole pancreas for mass cytometric analyses
  2647. Influence of Sterculia setigera Delile extract on oxidative stress enzyme activity and treatment of impaired glucose homeostasis in Streptozotocin-induced …
  2648. Instability of alloxan-induced diabetes and its impact on sex and thyroid hormones in male wistar rats-a pilot study
  2649. High serum Vitamin D concentrations, induced via diet, trigger immune and intestinal microbiota alterations leading to type 1 diabetes protection in NOD mice
  2650. Viral infection‐related gene upregulation in monocytes in children with signs of β‐cell autoimmunity
  2651. Dissecting the Roles for the Nuclear and Mitochondrial Genomes in diabetes by Pronuclear Transfer Technology
  2652. Accommodative disorders in non‐presbyopic subjects with type 1 diabetes without retinopathy: A comparative, cross‐sectional study
  2653. Assessment of executive function in a rodent model of Type 1 diabetes
  2654. Early Emergence of 5′ Terminally Deleted Coxsackievirus-B3 RNA Forms Is Associated with Acute and Persistent Infections in Mouse Target Tissues
  2655. Benefits of Implementation of Insulin Pump in People with Type 1 diabetes: 10 Case Reports
  2656. Evaluation of bone mineral density in children with type 1 diabetes: A cross-sectional case–control study
  2657. Clinical Characteristics of Hospitalized and Home Isolated Covid-19 Patients with Type 1 diabetes
  2658. The cell cortex as mediator of pancreatic epithelial development and endocrine differentiation
  2659. Clinical correlation of 2D shear wave elastography findings in children with type 1 diabetes mellitus without autoimmune thyroiditis
  2660. Involvement of trained immunity during autoimmune responses
  2661. diabetes Ketoacidosis and COVID-19: An Insight into the Pathophysiology
  2662. A novel somatic mutation implicates ATP6V0D1 in proinsulin processing
  2663. Pharmacological targeting of endoplasmic reticulum stress in disease
  2664. Single-cell infrared phenomics identifies cell heterogeneity of individual pancreatic islets in mouse model
  2665. Emerging role of bystander T cell activation in autoimmune diseases
  2666. Atezolizumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis and Takotsubo cardiomyopathy
  2667. Citrullination: A modification important in the pathogenesis of autoimmune diseases
  2668. Chitosan@ Puerarin hydrogel for accelerated wound healing in diabetic subjects by miR-29ab1 mediated inflammatory axis suppression
  2669. Biodistribution of Insulin Following Massive Insulin Subcutaneous Injection
  2670. Liposome-encapsulated glycyrrhizin alleviates hyperglycemia and glycation-induced iron-catalyzed oxidative reactions in streptozotocin-induced diabetic rats
  2671. Antioxidant Action of Hesperis matronalis L. in Chronic Experimental diabetes
  2672. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens
  2673. Engineering live attenuated vaccines: Old dogs learning new tricks
  2674. Isolated adrenocorticotropic hormone deficiency following immune checkpoint inhibitors treatment often occurred in polyglandular endocrinopathies
  2675. Interferons limit autoantigen-specific CD8+ T-cell expansion in the non-obese diabetic mouse
  2676. MANF regulates neuronal survival and UPR through its ER-located receptor IRE1α
  2677. The Putative Adverse Effects of Bisphenol A on Autoimmune Diseases
  2678. No small matter: Emerging roles for exosomal miRNAs in the immune system
  2679. Persistent coxsackievirus B1 infection triggers extensive changes in the transcriptome of human pancreatic ductal cells
  2680. Pancreas and Gallbladder
  2681. Conversion of gastrointestinal somatostatin-expressing D cells into insulin-producing beta-like cells upon Pax4 misexpression
  2682. Antidiabetic effect of Atriplex halimus L (Sp. Pl. 2: 1052 (1753)) long and short term treatment against Streptozotocin induced diabetes in rat
  2683. Human leukocyte antigen and autoimmunity
  2684. Cathepsin H: molecular characteristics and clues to function and mechanism
  2685. Effectivization of GAD ELISA: Method-transfer from Dynex DSX to Tecan Freedom EVOlyzer
  2686. Research advances in the role and pharmaceuticals of ATP-binding cassette transporters in autoimmune diseases
  2687. Activation of the aryl hydrocarbon receptor inhibits the development of experimental autoimmune pancreatitis through IL-22-mediated signaling pathways
  2688. The role of viral infections in the onset of autoimmune diseases
  2689. Marked Hypoleptinemia Precedes Overt Fat Loss in Immune Checkpoint Inhibitor-induced Acquired Generalized Lipodystrophy
  2690. pancreatic adverse events associated with immune checkpoint inhibitors: A large-scale pharmacovigilance analysis
  2691. Green Synthesis, Characterizations of Zinc Oxide Nanoparticles from Aqueous Leaf Extract of Tridax procumbens Linn. and Assessment of their Anti-Hyperglycemic …
  2692. GABAergic signaling beyond synapses: An emerging target for cancer therapy
  2693. Acute presentation of immunotherapy-related diabetes mellitus without ketoacidosis, low C-peptide or elevated HbA1c
  2694. Ethyl Pyruvate Alleviating Inflammatory Response after Diabetic Cerebral Hemorrhage
  2695. Autonomous regulation of retinal insulin biosynthesis in diabetes
  2696. Vitamin D in autophagy signaling for health and diseases: Insights on potential mechanisms and future perspectives
  2697. Astilbin Activates the Reactive Oxidative Species/PPARγ Pathway to Suppress Effector CD4+ T Cell Activities via Direct Binding With Cytochrome P450 1B1
  2698. Nanoceria Ameliorates Fibrosis, Inflammation, and Cellular Stress in Experimental Chronic Pancreatitis
  2699. Clinical Peculiarities in a Cohort of Patients with Wolfram Syndrome 1
  2700. A mouse pancreatic organoid model to compare PD-L1 blocking antibodies
  2701. Characteristic distribution and molecular properties of normal cellular prion protein in human endocrine and exocrine tissues
  2702. Role of Ayurvedic Medicinal Plants in Auto-immune disorders and their management
  2703. Phagocytosis in the retina promotes local insulin production in the eye
  2704. Cannabinoid-related acute pancreatitis: an update from international literature and individual case safety reports
  2705. Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK
  2706. Activation-induced cytidine deaminase expression by thymic B cells promotes T-cell tolerance and limits autoimmunity
  2707. Astilbin Activates the Reactive Oxidative Species/PPARγ Pathway to Suppress Effector CD4+ T Cell Activities via Direct Binding With Cytochrome P450 1B1
  2708. Extrathymic AIRE-expressing cells: Friends or foes in autoimmunity and cancer?
  2709. Invaluable Role of Consanguinity in Providing Insight into Paediatric Endocrine Conditions: Lessons Learnt from Congenital Hyperinsulinism, Monogenic diabetes …
  2710. Effects benefits and hazards of honey bee venom on wound healing and serum biochemical changes in alloxan-induced diabetic rats
  2711. Effectiveness of an Evidence Based Insulin Injection Guidelines Application on Diabetic Children Mothers’ Awareness about insulin injection: A quasi …
  2712. Nigella sativa and prevention of nephrotoxicity: A comprehensive update
  2713. Scanning electron microscopy of human islet cilia
  2714. Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health
  2715. Insights into peptidylarginine deiminase expression and citrullination pathways
  2716. Limited Efficacy of Decreased Tumor-infiltrating Regulatory T Cells after Transforming Growth Factor-beta Blockade in Murine pancreatic Ductal …
  2717. Endocrine diseases
  2718. Ecdysterone prevents negative effect of acute immobilization stress on energy metabolism of rat liver mitochondria
  2719. IL-15 blockade and rapamycin rescue multifactorial loss of factor VIII from AAV-transduced hepatocytes in hemophilia A mice
  2720. Cross-presentation by the others
  2721. Microbial (co) infections: Powerful immune influencers
  2722. Effects of Blood Flow on Insulin Concentration: A Modelling Study
  2723. Strategies to Improve Insulin Delivery through Oral Route: A Review
  2724. Inhibition of Notch activity suppresses hyperglycemia-augmented polarization of macrophages to the M1 phenotype and alleviates acute pancreatitis
  2725. Allergy and autoimmunity: Share of genetics and environment
  2726. Protocol-dependent morphological changes in human embryonic stem cell aggregates during differentiation towards early pancreatic fate
  2727. Blimp-1 molds the epigenetic architecture of IL-21–mediated autoimmune diseases through an autoregulatory circuit
  2728. Protocol-dependent morphological changes in human embryonic stem cell aggregates during differentiation towards early pancreatic fate
  2729. The pathogenesis of coronavirus-19 disease
  2730. Transcriptional changes in multiple endocrine organs from lethal cases of COVID-19
  2731. Zinc insulin hexamer loaded alginate zinc hydrogel: Preparation, characterization and in vivo hypoglycemic ability
  2732. Molecular basis of differential receptor usage for naturally occurring CD55-binding and-nonbinding coxsackievirus B3 strains
  2733. Isolation and characterization of a novel clade of coxsackievirus B2 associated with hand, foot, and mouth disease in Southwest China
  2734. Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics …
  2735. Physical Properties of Honey
  2736. Effects of cannabidiol on vacuous chewing movements, plasma glucose and oxidative stress indices in rats administered high dose risperidone
  2737. P2X4R/p38 signaling pathway in the spinal cord contribute to hyperalgesia in diabetic neuropathic pain
  2738. Ca2+-Responsive Glyco-insulin
  2739. Micro RNA, circular RNA, neutrophils, and myeloperoxydases in autoimmune diseases
  2740. Acetat moduliert die T-Zell-abhängige humorale Immunreaktion in sekundären lymphoiden Organen
  2741. Enhanced hexamerization of insulin via assembly pathway rerouting revealed by single particle studies
  2742. Patterns of presentations of children to emergency departments across Europe and the impact of the COVID-19 pandemic: retrospective observational multinational …
  2743. Natural killer cells in anti-neutrophil cytoplasmic antibody-associated vasculitis-A review of the literature
  2744. Immunogenetic perspective of inflammatory disorders
  2745. Platelets in the NETworks interweaving inflammation and thrombosis
  2746. Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study
  2747. Biopotency of Pteridophytes: A Review
  2748. GPR43 activation-mediated lipotoxicity contributes to podocyte injury in diabetic nephropathy by modulating the ERK/EGR1 pathway
  2749. COVID-19 and the vasculature: current aspects and long-term consequences
  2750. Integrin Regulated Autoimmune Disorders: Understanding the Role of Mechanical Force in Autoimmunity
  2751. Single-cell RNA-sequencing of peripheral blood mononuclear cells reveals widespread, context-specific gene expression regulation upon pathogenic exposure
  2752. A Study of some fractional-order chaotic systems
  2753. Pharmacological activities of two plants from the Apiaceae family: Ammoides atlantica (Coss. & Durieu.) H. Wolff. and Athamanta sicula L.
  2754. An Update Evolving View of Copy Number Variations in Autoimmune Diseases
  2755. Antiviral Mechanisms of N-Phenyl Benzamides on Coxsackie Virus A9
  2756. PATHOPHYSIOLOGY OF DIGESTION, LIVER, KIDNEYS, REGULATORY SYSTEMS AND EXTREME STATES METHODICAL INSTRUCTIONS for practical classes …
  2757. Insulin-like Peptides of the Western Flower Thrips Frankliniella occidentalis and Their Mediation of Immature Development
  2758. Targeting Transient Receptor Potential channels to modulate the gastro-intestinal function in the weaned piglet: focus on cinnamaldehyde
  2759. Autoimmune Thyroid Diseases: Traces of Viral Infection
  2760. Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK Inhibitors. Pharmaceutics 2022, 14, 2233
  2761. DNA-based Nanomaterials in the Immunotherapy
  2762. Immunological Insights into Cigarette Smoking-Induced Cardiovascular Disease Risk
  2763. Investigating Receptor-Mediated Effects of Select Cannabinoids on the Innate Inflammatory Response
  2764. Targeting tumor-associated macrophages for cancer immunotherapy
  2765. Effects of Endocrine Toxicants on the Growth and Metabolism of Thyroid Glands
  2766. Application of IL-6 antagonists in autoimmune disorders
  2767. Human thymopoiesis produces polyspecific CD8+ α/β T cells responding to multiple viral antigens
  2768. The role of inducible costimulator in autoimmunity
  2769. Regulation of endoplasmic reticulum stress by hesperetin: Focus on antitumor and cytoprotective effects

Related Posts

Shopping Cart
Scroll to Top